1	Regulation	regulation	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Muscle	muscle	NN	_	4	NMOD
4	Fiber	fiber	NN	_	5	NMOD
5	Type	type	NN	_	2	PMOD
6	and	and	CC	_	5	COORD
7	Running	running	NN	_	8	NMOD
8	Endurance	endurance	NN	_	6	CONJ
9	by	by	IN	_	1	NMOD
10	PPARδ	pparδ	NN	_	9	PMOD

1	Abstract	abstract	NN	_	0	ROOT

1	Endurance	endurance	NN	_	3	NMOD
2	exercise	exercise	NN	_	3	NMOD
3	training	training	NN	_	4	SBJ
4	can	can	MD	_	0	ROOT
5	promote	promote	VB	_	4	VC
6	an	an	DT	_	10	NMOD
7	adaptive	adaptive	JJ	_	10	NMOD
8	muscle	muscle	NN	_	9	NMOD
9	fiber	fiber	NN	_	10	NMOD
10	transformation	transformation	NN	_	5	OBJ
11	and	and	CC	_	10	COORD
12	an	an	DT	_	13	NMOD
13	increase	increase	NN	_	11	CONJ
14	of	of	IN	_	13	NMOD
15	mitochondrial	mitochondrial	JJ	_	16	NMOD
16	biogenesis	biogenesis	NN	_	14	PMOD
17	by	by	IN	_	5	MNR
18	triggering	trigger	VBG	_	17	PMOD
19	scripted	script	VBN	_	20	NMOD
20	changes	change	NNS	_	18	OBJ
21	in	in	IN	_	18	ADV
22	gene	gene	NN	_	23	NMOD
23	expression	expression	NN	_	21	PMOD
24	.	.	.	_	4	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	no	no	DT	_	5	NMOD
4	transcription	transcription	NN	_	5	NMOD
5	factor	factor	NN	_	6	SBJ
6	has	have	VBZ	_	0	ROOT
7	yet	yet	RB	_	6	TMP
8	been	be	VBN	_	6	VC
9	identified	identify	VBN	_	8	VC
10	that	that	WDT	_	11	SBJ
11	can	can	MD	_	5	NMOD
12	direct	direct	VB	_	11	VC
13	this	this	DT	_	14	NMOD
14	process	process	NN	_	12	OBJ
15	.	.	.	_	6	P

1	We	we	PRP	_	2	SBJ
2	describe	describe	VBP	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	engineering	engineering	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	a	a	DT	_	7	NMOD
7	mouse	mouse	NN	_	5	PMOD
8	capable	capable	JJ	_	7	NMOD
9	of	of	IN	_	8	AMOD
10	continuous	continuous	JJ	_	11	NMOD
11	running	running	NN	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	up	up	RB	_	17	NMOD
14	to	to	IN	_	13	QMOD
15	twice	twice	RB	_	13	QMOD
16	the	the	DT	_	17	NMOD
17	distance	distance	NN	_	12	PMOD
18	of	of	IN	_	17	NMOD
19	a	a	DT	_	23	NMOD
20	wild	wild	JJ	_	22	NMOD
21	-	-	HYPH	_	20	P
22	type	type	NN	_	23	NMOD
23	littermate	littermate	NN	_	18	PMOD
24	.	.	.	_	2	P

1	This	this	DT	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	achieved	achieve	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	targeted	targeted	JJ	_	6	NMOD
6	expression	expression	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	an	an	DT	_	10	NMOD
9	activated	activated	JJ	_	10	NMOD
10	form	form	NN	_	7	PMOD
11	of	of	IN	_	10	NMOD
12	peroxisome	peroxisome	NN	_	13	NMOD
13	proliferator	proliferator	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	activated	activate	VBN	_	16	NMOD
16	receptor	receptor	NN	_	19	NMOD
17	δ	δ	SYM	_	16	P
18	(	(	-LRB-	_	19	P
19	PPARδ	pparδ	NN	_	11	PMOD
20	)	)	-RRB-	_	19	P
21	in	in	IN	_	10	LOC
22	skeletal	skeletal	JJ	_	23	NMOD
23	muscle	muscle	NN	_	21	PMOD
24	,	,	,	_	10	P
25	which	which	WDT	_	26	SBJ
26	induces	induce	VBZ	_	10	NMOD
27	a	a	DT	_	28	NMOD
28	switch	switch	NN	_	26	OBJ
29	to	to	TO	_	28	NMOD
30	form	form	VB	_	29	IM
31	increased	increase	VBN	_	32	NMOD
32	numbers	number	NNS	_	30	OBJ
33	of	of	IN	_	32	NMOD
34	type	type	NN	_	37	NMOD
35	I	i	CD	_	34	NMOD
36	muscle	muscle	NN	_	37	NMOD
37	fibers	fiber	NNS	_	33	PMOD
38	.	.	.	_	2	P

1	Treatment	treatment	NN	_	10	SBJ
2	of	of	IN	_	1	NMOD
3	wild	wild	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	type	type	NN	_	6	NMOD
6	mice	mouse	NNS	_	2	PMOD
7	with	with	IN	_	1	NMOD
8	PPARδ	pparδ	NN	_	9	NMOD
9	agonist	agonist	NN	_	7	PMOD
10	elicits	elicit	VBZ	_	0	ROOT
11	a	a	DT	_	18	NMOD
12	similar	similar	JJ	_	18	NMOD
13	type	type	NN	_	15	NMOD
14	I	i	CD	_	13	NMOD
15	fiber	fiber	NN	_	18	NMOD
16	gene	gene	NN	_	17	NMOD
17	expression	expression	NN	_	18	NMOD
18	profile	profile	NN	_	10	OBJ
19	in	in	IN	_	10	LOC
20	muscle	muscle	NN	_	19	PMOD
21	.	.	.	_	10	P

1	Moreover	moreover	RB	_	7	ADV
2	,	,	,	_	7	P
3	these	these	DT	_	6	NMOD
4	genetically	genetically	RB	_	5	AMOD
5	generated	generate	VBN	_	6	NMOD
6	fibers	fiber	NNS	_	7	SBJ
7	confer	confer	VBP	_	0	ROOT
8	resistance	resistance	NN	_	7	OBJ
9	to	to	IN	_	8	NMOD
10	obesity	obesity	NN	_	9	PMOD
11	with	with	IN	_	7	ADV
12	improved	improve	VBN	_	14	NMOD
13	metabolic	metabolic	JJ	_	14	NMOD
14	profiles	profile	NNS	_	11	PMOD
15	,	,	,	_	7	P
16	even	even	RB	_	17	PMOD
17	in	in	IN	_	7	LOC
18	the	the	DT	_	19	NMOD
19	absence	absence	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	exercise	exercise	NN	_	20	PMOD
22	.	.	.	_	7	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	demonstrate	demonstrate	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	complex	complex	JJ	_	7	NMOD
6	physiologic	physiologic	JJ	_	7	NMOD
7	properties	property	NNS	_	17	SBJ
8	such	such	JJ	_	9	PMOD
9	as	as	IN	_	7	NMOD
10	fatigue	fatigue	NN	_	9	PMOD
11	,	,	,	_	10	P
12	endurance	endurance	NN	_	10	CONJ
13	,	,	,	_	12	P
14	and	and	CC	_	12	COORD
15	running	running	NN	_	16	NMOD
16	capacity	capacity	NN	_	14	CONJ
17	can	can	MD	_	4	SUB
18	be	be	VB	_	17	VC
19	molecularly	molecularly	RB	_	18	MNR
20	analyzed	analyze	VBN	_	18	VC
21	and	and	CC	_	20	COORD
22	manipulated	manipulate	VBN	_	21	CONJ
23	.	.	.	_	3	P

1	Introduction	introduction	NN	_	0	ROOT

1	Skeletal	skeletal	JJ	_	3	NMOD
2	muscle	muscle	NN	_	3	NMOD
3	fibers	fiber	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	generally	generally	RB	_	4	ADV
6	classified	classify	VBN	_	4	VC
7	as	as	IN	_	6	ADV
8	type	type	NN	_	23	NMOD
9	I	i	CD	_	8	NMOD
10	(	(	-LRB-	_	13	P
11	oxidative	oxidative	JJ	_	13	AMOD
12	/	/	HYPH	_	11	P
13	slow	slow	JJ	_	8	PRN
14	)	)	-RRB-	_	13	P
15	or	or	CC	_	8	COORD
16	type	type	NN	_	15	CONJ
17	II	ii	CD	_	16	NMOD
18	(	(	-LRB-	_	21	P
19	glycolytic	glycolytic	JJ	_	21	AMOD
20	/	/	HYPH	_	19	P
21	fast	fast	JJ	_	16	PRN
22	)	)	-RRB-	_	21	P
23	fibers	fiber	NNS	_	7	PMOD
24	.	.	.	_	4	P

1	They	they	PRP	_	2	SBJ
2	display	display	VBP	_	0	ROOT
3	marked	marked	JJ	_	4	NMOD
4	differences	difference	NNS	_	2	OBJ
5	in	in	IN	_	2	ADV
6	respect	respect	NN	_	5	PMOD
7	to	to	IN	_	6	NMOD
8	contraction	contraction	NN	_	7	PMOD
9	,	,	,	_	8	P
10	metabolism	metabolism	NN	_	8	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	susceptibility	susceptibility	NN	_	12	CONJ
14	to	to	IN	_	13	NMOD
15	fatigue	fatigue	NN	_	14	PMOD
16	.	.	.	_	2	P

1	Type	type	NN	_	3	NMOD
2	I	i	CD	_	1	NMOD
3	fibers	fiber	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	mitochondria	mitochondrion	NNS	_	7	AMOD
6	-	-	HYPH	_	5	P
7	rich	rich	JJ	_	4	PRD
8	and	and	CC	_	4	COORD
9	mainly	mainly	RB	_	10	ADV
10	use	use	VBP	_	8	CONJ
11	oxidative	oxidative	JJ	_	12	NMOD
12	metabolism	metabolism	NN	_	10	OBJ
13	for	for	IN	_	10	PRP
14	energy	energy	NN	_	15	NMOD
15	production	production	NN	_	13	PMOD
16	,	,	,	_	12	P
17	which	which	WDT	_	18	SBJ
18	provides	provide	VBZ	_	12	NMOD
19	a	a	DT	_	25	NMOD
20	stable	stable	JJ	_	25	NMOD
21	and	and	CC	_	20	COORD
22	long	long	JJ	_	24	AMOD
23	-	-	HYPH	_	22	P
24	lasting	last	VBG	_	21	CONJ
25	supply	supply	NN	_	18	OBJ
26	of	of	IN	_	25	NMOD
27	ATP	atp	NN	_	26	PMOD
28	,	,	,	_	10	P
29	and	and	CC	_	10	COORD
30	thus	thus	RB	_	31	ADV
31	are	be	VBP	_	29	CONJ
32	fatigue	fatigue	NN	_	34	AMOD
33	-	-	HYPH	_	32	P
34	resistant	resistant	JJ	_	31	PRD
35	.	.	.	_	4	P

1	Type	type	NN	_	3	NMOD
2	II	ii	CD	_	1	NMOD
3	fibers	fiber	NNS	_	4	SBJ
4	comprise	comprise	VBP	_	0	ROOT
5	three	three	CD	_	6	NMOD
6	subtypes	subtypes	NNS	_	4	OBJ
7	,	,	,	_	6	P
8	IIa	iia	NN	_	6	APPO
9	,	,	,	_	8	P
10	IIx	iix	NN	_	8	CONJ
11	,	,	,	_	10	P
12	and	and	CC	_	10	COORD
13	IIb	iib	NN	_	12	CONJ
14	.	.	.	_	4	P

1	Type	type	NN	_	2	NMOD
2	IIb	iib	NN	_	3	NMOD
3	fibers	fiber	NNS	_	4	SBJ
4	have	have	VBP	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	lowest	low	JJS	_	7	NMOD
7	levels	level	NNS	_	4	OBJ
8	of	of	IN	_	7	NMOD
9	mitochondrial	mitochondrial	JJ	_	10	NMOD
10	content	content	NN	_	8	PMOD
11	and	and	CC	_	10	COORD
12	oxidative	oxidative	JJ	_	13	NMOD
13	enzymes	enzyme	NNS	_	11	CONJ
14	,	,	,	_	4	P
15	rely	rely	VBP	_	4	CONJ
16	on	on	IN	_	15	ADV
17	glycolytic	glycolytic	JJ	_	18	NMOD
18	metabolism	metabolism	NN	_	16	PMOD
19	as	as	IN	_	15	ADV
20	a	a	DT	_	23	NMOD
21	major	major	JJ	_	23	NMOD
22	energy	energy	NN	_	23	NMOD
23	source	source	NN	_	19	PMOD
24	,	,	,	_	15	P
25	and	and	CC	_	15	COORD
26	are	be	VBP	_	25	CONJ
27	susceptible	susceptible	JJ	_	26	PRD
28	to	to	IN	_	27	AMOD
29	fatigue	fatigue	NN	_	28	PMOD
30	,	,	,	_	4	P
31	while	while	IN	_	4	ADV
32	the	the	DT	_	36	NMOD
33	oxidative	oxidative	JJ	_	36	NMOD
34	and	and	CC	_	33	COORD
35	contraction	contraction	NN	_	34	CONJ
36	functions	function	NNS	_	42	SBJ
37	of	of	IN	_	36	NMOD
38	type	type	NN	_	39	NMOD
39	IIa	iia	NN	_	37	PMOD
40	and	and	CC	_	39	COORD
41	IIx	iix	NN	_	40	CONJ
42	lie	lie	VBP	_	31	SUB
43	between	between	IN	_	42	ADV
44	type	type	NN	_	45	NMOD
45	I	i	CD	_	43	PMOD
46	and	and	CC	_	45	COORD
47	IIb	iib	NN	_	46	CONJ
48	(	(	-LRB-	_	49	P
49	Booth	booth	NNP	_	42	DEP
50	and	and	CC	_	49	COORD
51	Thomason	thomason	NNP	_	50	CONJ
52	1991	0	CD	_	49	DEP
53	;	;	:	_	49	P
54	Berchtold	berchtold	NNP	_	49	DEP
55	et	et	FW	_	49	DEP
56	al.	al.	FW	_	49	DEP
57	2000	0	CD	_	49	DEP
58	;	;	:	_	49	P
59	Olson	olson	NNP	_	49	DEP
60	and	and	CC	_	59	COORD
61	Williams	williams	NNP	_	60	CONJ
62	2000	0	CD	_	49	DEP
63	)	)	-RRB-	_	49	P
64	.	.	.	_	4	P

1	Adult	adult	JJ	_	3	NMOD
2	skeletal	skeletal	JJ	_	3	NMOD
3	muscle	muscle	NN	_	4	SBJ
4	shows	show	VBZ	_	0	ROOT
5	plasticity	plasticity	NN	_	4	OBJ
6	and	and	CC	_	4	COORD
7	can	can	MD	_	6	CONJ
8	undergo	undergo	VB	_	7	VC
9	conversion	conversion	NN	_	8	OBJ
10	between	between	IN	_	9	NMOD
11	different	different	JJ	_	13	NMOD
12	fiber	fiber	NN	_	13	NMOD
13	types	type	NNS	_	10	PMOD
14	in	in	IN	_	8	ADV
15	response	response	NN	_	14	PMOD
16	to	to	IN	_	15	NMOD
17	exercise	exercise	NN	_	18	NMOD
18	training	training	NN	_	16	PMOD
19	or	or	CC	_	18	COORD
20	modulation	modulation	NN	_	19	CONJ
21	of	of	IN	_	20	NMOD
22	motoneuron	motoneuron	NN	_	23	NMOD
23	activity	activity	NN	_	21	PMOD
24	(	(	-LRB-	_	25	P
25	Booth	booth	NNP	_	4	CIT
26	and	and	CC	_	25	COORD
27	Thomason	thomason	NNP	_	26	CONJ
28	1991	0	CD	_	25	DEP
29	,	,	,	_	25	P
30	Jarvis	jarvis	NNP	_	25	DEP
31	et	et	FW	_	25	DEP
32	al.	al.	FW	_	25	DEP
33	1996	0	CD	_	25	DEP
34	;	;	:	_	25	P
35	Pette	pette	NNP	_	25	DEP
36	1998	0	CD	_	25	DEP
37	;	;	:	_	25	P
38	Olson	olson	NNP	_	25	DEP
39	and	and	CC	_	38	COORD
40	Williams	williams	NNP	_	39	CONJ
41	2000	0	CD	_	25	DEP
42	;	;	:	_	25	P
43	Hood	hood	NNP	_	25	DEP
44	2001	0	CD	_	25	DEP
45	)	)	-RRB-	_	25	P
46	.	.	.	_	4	P

1	This	this	DT	_	2	NMOD
2	conversion	conversion	NN	_	15	SBJ
3	of	of	IN	_	2	NMOD
4	muscle	muscle	NN	_	5	NMOD
5	fiber	fiber	NN	_	3	PMOD
6	from	from	IN	_	2	NMOD
7	type	type	NN	_	8	NMOD
8	IIb	iib	NN	_	6	PMOD
9	to	to	IN	_	2	NMOD
10	type	type	NN	_	11	NMOD
11	IIa	iia	NN	_	9	PMOD
12	and	and	CC	_	11	COORD
13	type	type	NN	_	12	CONJ
14	I	i	CD	_	13	NMOD
15	is	be	VBZ	_	0	ROOT
16	likely	likely	JJ	_	15	PRD
17	to	to	TO	_	16	AMOD
18	be	be	VB	_	17	IM
19	mediated	mediate	VBN	_	18	VC
20	by	by	IN	_	19	LGS
21	a	a	DT	_	24	NMOD
22	calcium	calcium	NN	_	24	NMOD
23	signaling	signaling	NN	_	24	NMOD
24	pathway	pathway	NN	_	20	PMOD
25	that	that	WDT	_	26	SBJ
26	involves	involve	VBZ	_	24	NMOD
27	calcineurin	calcineurin	NN	_	26	OBJ
28	,	,	,	_	27	P
29	calmodulin	calmodulin	NN	_	31	AMOD
30	-	-	HYPH	_	29	P
31	dependent	dependent	JJ	_	32	NMOD
32	kinase	kinase	NN	_	27	CONJ
33	,	,	,	_	32	P
34	and	and	CC	_	32	COORD
35	the	the	DT	_	37	NMOD
36	transcriptional	transcriptional	JJ	_	37	NMOD
37	cofactor	cofactor	NN	_	50	NMOD
38	Peroxisome	peroxisome	NN	_	39	NMOD
39	proliferator	proliferator	NN	_	41	AMOD
40	-	-	HYPH	_	39	P
41	activated	activate	VBN	_	42	NMOD
42	receptor	receptor	NN	_	45	NMOD
43	-	-	HYPH	_	42	P
44	gamma	gamma	NN	_	45	NMOD
45	coactivator	coactivator	NN	_	50	NMOD
46	1α	0α	CD	_	45	NMOD
47	(	(	-LRB-	_	50	P
48	PGC	pgc	NN	_	50	NMOD
49	-	-	HYPH	_	48	P
50	1α	0α	NN	_	34	CONJ
51	)	)	-RRB-	_	50	P
52	(	(	-LRB-	_	53	P
53	Naya	naya	NNP	_	26	CIT
54	et	et	FW	_	53	DEP
55	al.	al.	FW	_	53	DEP
56	2000	0	CD	_	53	DEP
57	;	;	:	_	53	P
58	Olson	olson	NNP	_	53	DEP
59	and	and	CC	_	58	COORD
60	Williams	williams	NNP	_	59	CONJ
61	2000	0	CD	_	53	DEP
62	;	;	:	_	53	P
63	Lin	lin	NNP	_	53	DEP
64	et	et	FW	_	53	DEP
65	al.	al.	FW	_	53	DEP
66	2002	0	CD	_	53	DEP
67	;	;	:	_	53	P
68	Wu	wu	NNP	_	53	DEP
69	et	et	FW	_	53	DEP
70	al.	al.	FW	_	53	DEP
71	2002	0	CD	_	53	DEP
72	)	)	-RRB-	_	53	P
73	.	.	.	_	15	P

1	However	however	RB	_	19	ADV
2	,	,	,	_	19	P
3	the	the	DT	_	6	NMOD
4	targeted	target	VBN	_	6	NMOD
5	transcriptional	transcriptional	JJ	_	6	NMOD
6	factors	factor	NNS	_	19	SBJ
7	directly	directly	RB	_	8	AMOD
8	responsible	responsible	JJ	_	6	NMOD
9	for	for	IN	_	8	AMOD
10	reprogramming	reprogramming	VBG	_	9	PMOD
11	the	the	DT	_	18	NMOD
12	fiber	fiber	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	specific	specific	JJ	_	18	NMOD
15	contractile	contractile	JJ	_	18	NMOD
16	and	and	CC	_	15	COORD
17	metabolic	metabolic	JJ	_	16	CONJ
18	genes	gene	NNS	_	10	OBJ
19	remain	remain	VBP	_	0	ROOT
20	to	to	TO	_	19	OPRD
21	be	be	VB	_	20	IM
22	identified	identify	VBN	_	21	VC
23	.	.	.	_	19	P

1	Muscle	muscle	NN	_	3	NMOD
2	fiber	fiber	NN	_	3	NMOD
3	specification	specification	NN	_	4	SBJ
4	appears	appear	VBZ	_	0	ROOT
5	to	to	TO	_	4	OPRD
6	be	be	VB	_	5	IM
7	associated	associate	VBN	_	6	VC
8	with	with	IN	_	7	ADV
9	obesity	obesity	NN	_	8	PMOD
10	and	and	CC	_	9	COORD
11	diabetes	diabetes	NN	_	10	CONJ
12	.	.	.	_	4	P

1	For	for	IN	_	15	ADV
2	instance	instance	NN	_	1	PMOD
3	,	,	,	_	15	P
4	rodents	rodent	NNS	_	15	SBJ
5	that	that	WDT	_	6	SBJ
6	gain	gain	VBP	_	4	NMOD
7	the	the	DT	_	9	NMOD
8	most	most	JJS	_	9	NMOD
9	weight	weight	NN	_	6	OBJ
10	on	on	IN	_	6	ADV
11	high	high	JJ	_	13	NMOD
12	-	-	HYPH	_	11	P
13	fat	fat	NN	_	14	NMOD
14	diets	diet	NNS	_	10	PMOD
15	possess	possess	VBP	_	0	ROOT
16	fewer	few	JJR	_	19	NMOD
17	type	type	NN	_	19	NMOD
18	I	i	CD	_	17	NMOD
19	fibers	fiber	NNS	_	15	OBJ
20	(	(	-LRB-	_	21	P
21	Abou	abou	NNP	_	15	CIT
22	et	et	FW	_	21	DEP
23	al.	al.	FW	_	21	DEP
24	1992	0	CD	_	21	DEP
25	)	)	-RRB-	_	21	P
26	.	.	.	_	15	P

1	In	in	IN	_	7	LOC
2	obese	obese	JJ	_	3	NMOD
3	patients	patient	NNS	_	1	PMOD
4	,	,	,	_	7	P
5	skeletal	skeletal	JJ	_	6	NMOD
6	muscle	muscle	NN	_	7	SBJ
7	has	have	VBZ	_	0	ROOT
8	been	be	VBN	_	7	VC
9	observed	observe	VBN	_	8	VC
10	to	to	TO	_	9	OPRD
11	have	have	VB	_	10	IM
12	reduced	reduce	VBN	_	14	NMOD
13	oxidative	oxidative	JJ	_	14	NMOD
14	capacity	capacity	NN	_	11	OBJ
15	,	,	,	_	14	P
16	increased	increase	VBN	_	18	NMOD
17	glycolytic	glycolytic	JJ	_	18	NMOD
18	capacity	capacity	NN	_	14	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	a	a	DT	_	23	NMOD
22	decreased	decrease	VBN	_	23	NMOD
23	percentage	percentage	NN	_	20	CONJ
24	of	of	IN	_	23	NMOD
25	type	type	NN	_	27	NMOD
26	I	i	CD	_	25	NMOD
27	fibers	fiber	NNS	_	24	PMOD
28	(	(	-LRB-	_	29	P
29	Hickey	hickey	NNP	_	9	CIT
30	et	et	FW	_	29	DEP
31	al.	al.	FW	_	29	DEP
32	1995	0	CD	_	29	DEP
33	;	;	:	_	29	P
34	Tanner	tanner	NNP	_	29	DEP
35	et	et	FW	_	29	DEP
36	al.	al.	FW	_	29	DEP
37	2002	0	CD	_	29	DEP
38	)	)	-RRB-	_	29	P
39	.	.	.	_	7	P

1	Similar	similar	JJ	_	2	NMOD
2	observations	observation	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	been	be	VBN	_	3	VC
5	made	make	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	type	type	NN	_	9	AMOD
8	2	0	CD	_	7	NMOD
9	diabetic	diabetic	JJ	_	10	NMOD
10	patients	patient	NNS	_	6	PMOD
11	(	(	-LRB-	_	12	P
12	Lillioja	lillioja	NNP	_	5	CIT
13	et	et	FW	_	12	DEP
14	al.	al.	FW	_	12	DEP
15	1987	0	CD	_	12	DEP
16	;	;	:	_	12	P
17	Hickey	hickey	NNP	_	12	DEP
18	et	et	FW	_	12	DEP
19	al.	al.	FW	_	12	DEP
20	1995	0	CD	_	12	DEP
21	)	)	-RRB-	_	12	P
22	.	.	.	_	3	P

1	Recently	recently	RB	_	4	TMP
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	has	have	VBZ	_	0	ROOT
5	been	be	VBN	_	4	VC
6	shown	show	VBN	_	5	VC
7	that	that	IN	_	6	OBJ
8	increasing	increase	VBG	_	10	NMOD
9	oxidative	oxidative	JJ	_	10	NMOD
10	fibers	fiber	NNS	_	11	SBJ
11	can	can	MD	_	7	SUB
12	lead	lead	VB	_	11	VC
13	to	to	IN	_	12	ADV
14	improved	improve	VBN	_	16	NMOD
15	insulin	insulin	NN	_	16	NMOD
16	action	action	NN	_	13	PMOD
17	and	and	CC	_	16	COORD
18	reduced	reduce	VBN	_	20	NMOD
19	adipocyte	adipocyte	NN	_	20	NMOD
20	size	size	NN	_	17	CONJ
21	(	(	-LRB-	_	22	P
22	Luquet	luquet	NNP	_	6	CIT
23	et	et	FW	_	22	DEP
24	al.	al.	FW	_	22	DEP
25	2003	0	CD	_	22	DEP
26	;	;	:	_	22	P
27	Ryder	ryder	NNP	_	22	DEP
28	et	et	FW	_	22	DEP
29	al.	al.	FW	_	22	DEP
30	2003	0	CD	_	22	DEP
31	)	)	-RRB-	_	22	P
32	.	.	.	_	4	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	previously	previously	RB	_	2	TMP
4	established	establish	VBN	_	2	VC
5	that	that	IN	_	4	OBJ
6	peroxisome	peroxisome	NN	_	7	NMOD
7	proliferator	proliferator	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	activated	activate	VBN	_	10	NMOD
10	receptor	receptor	NN	_	12	NMOD
11	(	(	-LRB-	_	12	P
12	PPAR	ppar	NN	_	15	SBJ
13	)	)	-RRB-	_	12	P
14	δ	δ	SYM	_	12	P
15	is	be	VBZ	_	5	SUB
16	a	a	DT	_	19	NMOD
17	major	major	JJ	_	19	NMOD
18	transcriptional	transcriptional	JJ	_	19	NMOD
19	regulator	regulator	NN	_	15	PRD
20	of	of	IN	_	19	NMOD
21	fat	fat	NN	_	22	NMOD
22	burning	burning	NN	_	20	PMOD
23	in	in	IN	_	15	LOC
24	adipose	adipose	NN	_	25	NMOD
25	tissue	tissue	NN	_	23	PMOD
26	through	through	IN	_	15	MNR
27	activation	activation	NN	_	26	PMOD
28	of	of	IN	_	27	NMOD
29	enzymes	enzyme	NNS	_	28	PMOD
30	associated	associate	VBN	_	29	NMOD
31	with	with	IN	_	30	ADV
32	long	long	JJ	_	34	NMOD
33	-	-	HYPH	_	32	P
34	chain	chain	NN	_	40	NMOD
35	fatty	fatty	JJ	_	37	NMOD
36	-	-	HYPH	_	35	P
37	acid	acid	NN	_	40	NMOD
38	β	β	NN	_	40	NMOD
39	-	-	HYPH	_	38	P
40	oxidation	oxidation	NN	_	31	PMOD
41	(	(	-LRB-	_	42	P
42	Wang	wang	NNP	_	4	CIT
43	et	et	FW	_	42	DEP
44	al.	al.	FW	_	42	DEP
45	2003	0	CD	_	42	DEP
46	)	)	-RRB-	_	42	P
47	.	.	.	_	2	P

1	Although	although	IN	_	17	ADV
2	PPARδ	pparδ	NN	_	3	SBJ
3	is	be	VBZ	_	1	SUB
4	the	the	DT	_	7	NMOD
5	predominant	predominant	JJ	_	7	NMOD
6	PPAR	ppar	NN	_	7	NMOD
7	isoform	isoform	NN	_	3	PRD
8	present	present	JJ	_	7	NMOD
9	in	in	IN	_	8	LOC
10	skeletal	skeletal	JJ	_	11	NMOD
11	muscle	muscle	NN	_	9	PMOD
12	,	,	,	_	17	P
13	its	its	PRP$	_	16	NMOD
14	in	in	FW	_	15	NMOD
15	vivo	vivo	FW	_	16	NMOD
16	function	function	NN	_	17	SBJ
17	has	have	VBZ	_	0	ROOT
18	not	not	RB	_	17	ADV
19	been	be	VBN	_	17	VC
20	determined	determine	VBN	_	19	VC
21	.	.	.	_	17	P

1	Our	our	PRP$	_	3	NMOD
2	current	current	JJ	_	3	NMOD
3	study	study	NN	_	4	SBJ
4	uncovers	uncover	VBZ	_	0	ROOT
5	PPARδ	pparδ	NN	_	4	OBJ
6	as	as	IN	_	4	ADV
7	the	the	DT	_	10	NMOD
8	first	$#ORD#$	JJ	_	10	NMOD
9	transcription	transcription	NN	_	10	NMOD
10	factor	factor	NN	_	6	PMOD
11	able	able	JJ	_	10	NMOD
12	to	to	TO	_	11	AMOD
13	drive	drive	VB	_	12	IM
14	the	the	DT	_	15	NMOD
15	formation	formation	NN	_	13	OBJ
16	of	of	IN	_	15	NMOD
17	functional	functional	JJ	_	21	NMOD
18	type	type	NN	_	21	NMOD
19	I	i	CD	_	18	NMOD
20	muscle	muscle	NN	_	21	NMOD
21	fibers	fiber	NNS	_	16	PMOD
22	,	,	,	_	10	P
23	whose	whose	WP$	_	24	NMOD
24	activation	activation	NN	_	25	SBJ
25	entrains	entrain	VBZ	_	10	NMOD
26	complex	complex	JJ	_	27	NMOD
27	pathways	pathway	NNS	_	25	OBJ
28	both	both	CC	_	29	COORD
29	enhancing	enhance	VBG	_	27	NMOD
30	physical	physical	JJ	_	31	NMOD
31	performance	performance	NN	_	29	OBJ
32	and	and	CC	_	29	COORD
33	creating	create	VBG	_	32	CONJ
34	a	a	DT	_	35	NMOD
35	state	state	NN	_	33	OBJ
36	of	of	IN	_	35	NMOD
37	obesity	obesity	NN	_	38	NMOD
38	resistance	resistance	NN	_	36	PMOD
39	.	.	.	_	4	P

1	Results	result	NNS	_	0	ROOT

1	Activation	activation	NN	_	4	SBJ
2	of	of	IN	_	1	NMOD
3	PPARδ	pparδ	NN	_	2	PMOD
4	Leads	lead	VBZ	_	0	ROOT
5	to	to	IN	_	4	ADV
6	Muscle	muscle	NN	_	7	NMOD
7	Fiber	fiber	NN	_	8	NMOD
8	Transformation	transformation	NN	_	5	PMOD

1	A	a	DT	_	2	NMOD
2	role	role	NN	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	PPARδ	pparδ	NN	_	3	PMOD
5	in	in	IN	_	2	LOC
6	muscle	muscle	NN	_	7	NMOD
7	fiber	fiber	NN	_	5	PMOD
8	was	be	VBD	_	0	ROOT
9	suggested	suggest	VBN	_	8	VC
10	by	by	IN	_	9	LGS
11	its	its	PRP$	_	13	NMOD
12	enhanced	enhance	VBN	_	13	NMOD
13	expression	expression	NN	_	10	PMOD
14	—	—	HYPH	_	13	P
15	at	at	IN	_	13	NMOD
16	levels	level	NNS	_	15	PMOD
17	10	0	CD	_	24	AMOD
18	-	-	HYPH	_	17	P
19	fold	fold	RB	_	17	QMOD
20	and	and	CC	_	17	COORD
21	50	0	CD	_	20	CONJ
22	-	-	HYPH	_	21	P
23	fold	fold	RB	_	21	QMOD
24	greater	great	JJR	_	16	NMOD
25	than	than	IN	_	24	AMOD
26	PPARα	pparα	NN	_	29	NMOD
27	and	and	CC	_	26	COORD
28	γ	γ	SYM	_	26	P
29	isoforms	isoforms	NNS	_	25	PMOD
30	,	,	,	_	9	P
31	respectively	respectively	RB	_	9	ADV
32	(	(	-LRB-	_	34	P
33	unpublished	unpublished	JJ	_	34	NMOD
34	data	datum	NNS	_	9	PRN
35	)	)	-RRB-	_	34	P
36	.	.	.	_	8	P

1	An	an	DT	_	2	NMOD
2	examination	examination	NN	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	PPARδ	pparδ	NN	_	3	PMOD
5	in	in	IN	_	2	LOC
6	different	different	JJ	_	8	NMOD
7	muscle	muscle	NN	_	8	NMOD
8	fibers	fiber	NNS	_	5	PMOD
9	reveals	reveal	VBZ	_	53	DEP
10	a	a	DT	_	13	NMOD
11	significantly	significantly	RB	_	12	AMOD
12	higher	high	JJR	_	13	NMOD
13	level	level	NN	_	9	OBJ
14	in	in	IN	_	9	LOC
15	type	type	NN	_	17	NMOD
16	I	i	CD	_	15	NMOD
17	muscle	muscle	NN	_	14	PMOD
18	(	(	-LRB-	_	19	P
19	soleus	soleus	NN	_	17	PRN
20	)	)	-RRB-	_	19	P
21	relative	relative	JJ	_	9	ADV
22	to	to	IN	_	21	AMOD
23	type	type	NN	_	26	AMOD
24	II	ii	CD	_	23	NMOD
25	–	–	HYPH	_	23	P
26	rich	rich	JJ	_	27	NMOD
27	muscle	muscle	NN	_	22	PMOD
28	(	(	-LRB-	_	31	P
29	extensor	extensor	NN	_	31	NMOD
30	digitorum	digitorum	NN	_	31	NMOD
31	longus	longus	NN	_	27	PRN
32	)	)	-RRB-	_	31	P
33	or	or	CC	_	27	COORD
34	type	type	NN	_	40	NMOD
35	I	i	CD	_	34	NMOD
36	and	and	CC	_	34	COORD
37	type	type	NN	_	36	CONJ
38	II	ii	CD	_	37	NMOD
39	mixed	mixed	JJ	_	40	NMOD
40	muscle	muscle	NN	_	33	CONJ
41	(	(	-LRB-	_	42	P
42	gastrocnemius	gastrocnemius	NN	_	40	PRN
43	)	)	-RRB-	_	42	P
44	(	(	-LRB-	_	45	P
45	Figure	figure	NN	_	9	PRN
46	1A	0a	CD	_	45	NMOD
47	)	)	-RRB-	_	45	P
48	;	;	,	_	53	P
49	this	this	DT	_	51	NMOD
50	expression	expression	NN	_	51	NMOD
51	pattern	pattern	NN	_	53	SBJ
52	closely	closely	RB	_	53	ADV
53	resembles	resemble	VBZ	_	0	ROOT
54	that	that	DT	_	53	OBJ
55	of	of	IN	_	54	NMOD
56	PGC	pgc	NN	_	55	PMOD
57	-	-	HYPH	_	56	P
58	1α	0α	CD	_	56	NMOD
59	(	(	-LRB-	_	60	P
60	Lin	lin	NNP	_	53	CIT
61	et	et	FW	_	60	DEP
62	al.	al.	FW	_	60	DEP
63	2002	0	CD	_	60	DEP
64	)	)	-RRB-	_	60	P
65	.	.	.	_	53	P

1	A	a	DT	_	3	NMOD
2	similar	similar	JJ	_	3	NMOD
3	pattern	pattern	NN	_	9	SBJ
4	but	but	CC	_	5	COORD
5	with	with	IN	_	3	NMOD
6	more	more	RBR	_	7	AMOD
7	pronounced	pronounce	VBN	_	8	NMOD
8	differences	difference	NNS	_	5	PMOD
9	was	be	VBD	_	0	ROOT
10	found	find	VBN	_	9	VC
11	at	at	IN	_	10	ADV
12	the	the	DT	_	14	NMOD
13	protein	protein	NN	_	14	NMOD
14	level	level	NN	_	11	PMOD
15	(	(	-LRB-	_	16	P
16	Figure	figure	NN	_	10	PRN
17	1B	0b	CD	_	16	NMOD
18	)	)	-RRB-	_	16	P
19	.	.	.	_	9	P

1	To	to	TO	_	21	PRP
2	directly	directly	RB	_	1	ADV
3	assess	assess	VB	_	1	IM
4	the	the	DT	_	5	NMOD
5	role	role	NN	_	3	OBJ
6	of	of	IN	_	5	NMOD
7	activation	activation	NN	_	6	PMOD
8	of	of	IN	_	7	NMOD
9	PPARδ	pparδ	NN	_	8	PMOD
10	in	in	IN	_	5	NMOD
11	control	control	NN	_	10	PMOD
12	of	of	IN	_	11	NMOD
13	muscle	muscle	NN	_	14	NMOD
14	fiber	fiber	NN	_	15	NMOD
15	plasticity	plasticity	NN	_	12	PMOD
16	and	and	CC	_	15	COORD
17	mitochondrial	mitochondrial	JJ	_	18	NMOD
18	biogenesis	biogenesis	NN	_	16	CONJ
19	,	,	,	_	21	P
20	we	we	PRP	_	21	SBJ
21	generated	generate	VBD	_	0	ROOT
22	mice	mouse	NNS	_	21	OBJ
23	expressing	express	VBG	_	22	NMOD
24	a	a	DT	_	25	NMOD
25	transgene	transgene	NN	_	23	OBJ
26	in	in	IN	_	38	LOC
27	which	which	WDT	_	26	PMOD
28	the	the	DT	_	36	NMOD
29	78	0	CD	_	33	NMOD
30	-	-	HYPH	_	29	P
31	amino	amino	NN	_	33	NMOD
32	-	-	HYPH	_	31	P
33	acid	acid	NN	_	36	NMOD
34	VP16	vp0	NN	_	35	NMOD
35	activation	activation	NN	_	36	NMOD
36	domain	domain	NN	_	37	SBJ
37	was	be	VBD	_	25	NMOD
38	fused	fuse	VBN	_	37	VC
39	to	to	IN	_	38	ADV
40	the	the	DT	_	43	NMOD
41	N	n	NN	_	43	NMOD
42	-	-	HYPH	_	41	P
43	terminus	terminus	NN	_	39	PMOD
44	of	of	IN	_	43	NMOD
45	full	full	JJ	_	47	NMOD
46	-	-	HYPH	_	45	P
47	length	length	NN	_	48	NMOD
48	PPARδ	pparδ	NN	_	44	PMOD
49	,	,	,	_	38	P
50	under	under	IN	_	38	ADV
51	control	control	NN	_	50	PMOD
52	of	of	IN	_	51	NMOD
53	the	the	DT	_	62	NMOD
54	2.2	0	CD	_	56	NMOD
55	-	-	HYPH	_	54	P
56	kb	kb	NN	_	62	NMOD
57	human	human	JJ	_	62	NMOD
58	α	α	NN	_	60	AMOD
59	-	-	HYPH	_	58	P
60	skeletal	skeletal	JJ	_	62	NMOD
61	actin	actin	NN	_	62	NMOD
62	promoter	promoter	NN	_	52	PMOD
63	.	.	.	_	21	P

1	In	in	IN	_	27	ADV
2	agreement	agreement	NN	_	1	PMOD
3	with	with	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	previous	previous	JJ	_	6	NMOD
6	characterization	characterization	NN	_	3	PMOD
7	of	of	IN	_	6	NMOD
8	this	this	DT	_	9	NMOD
9	promoter	promoter	NN	_	7	PMOD
10	(	(	-LRB-	_	11	P
11	Brennan	brennan	NNP	_	6	NMOD
12	and	and	CC	_	11	COORD
13	Hardeman	hardeman	NNP	_	12	CONJ
14	1993	0	CD	_	11	DEP
15	;	;	:	_	11	P
16	Clapham	clapham	NNP	_	11	DEP
17	et	et	FW	_	11	DEP
18	al.	al.	FW	_	11	DEP
19	2000	0	CD	_	11	DEP
20	)	)	-RRB-	_	11	P
21	,	,	,	_	27	P
22	the	the	DT	_	26	NMOD
23	VP16	vp0	NN	_	25	NMOD
24	-	-	HYPH	_	23	P
25	PPARδ	pparδ	NN	_	26	NMOD
26	transgene	transgene	NN	_	27	SBJ
27	was	be	VBD	_	0	ROOT
28	selectively	selectively	RB	_	27	MNR
29	expressed	express	VBN	_	27	VC
30	in	in	IN	_	29	LOC
31	skeletal	skeletal	JJ	_	32	NMOD
32	muscle	muscle	NN	_	30	PMOD
33	,	,	,	_	29	P
34	with	with	IN	_	29	ADV
35	10	0	CD	_	38	NMOD
36	-	-	HYPH	_	35	P
37	fold	fold	RB	_	35	QMOD
38	less	less	JJR	_	34	SUB
39	in	in	IN	_	38	LOC
40	the	the	DT	_	41	NMOD
41	heart	heart	NN	_	39	PMOD
42	(	(	-LRB-	_	43	P
43	Figure	figure	NN	_	29	PRN
44	1C	0c	CD	_	43	NMOD
45	)	)	-RRB-	_	43	P
46	.	.	.	_	27	P

1	Among	among	IN	_	15	ADV
2	different	different	JJ	_	3	NMOD
3	types	type	NNS	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	muscle	muscle	NN	_	6	NMOD
6	fibers	fiber	NNS	_	4	PMOD
7	,	,	,	_	15	P
8	the	the	DT	_	9	NMOD
9	levels	level	NNS	_	15	SBJ
10	of	of	IN	_	9	NMOD
11	VP16	vp0	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	PPARδ	pparδ	NN	_	14	NMOD
14	expression	expression	NN	_	10	PMOD
15	appeared	appear	VBD	_	0	ROOT
16	to	to	TO	_	15	OPRD
17	be	be	VB	_	16	IM
18	similar	similar	JJ	_	17	PRD
19	(	(	-LRB-	_	21	P
20	unpublished	unpublished	JJ	_	21	NMOD
21	data	datum	NNS	_	17	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	15	P

1	As	as	IN	_	15	ADV
2	shown	show	VBN	_	1	SUB
3	in	in	IN	_	2	LOC
4	Figure	figure	NN	_	3	PMOD
5	1D	0d	CD	_	4	NMOD
6	for	for	IN	_	2	ADV
7	gastrocnemius	gastrocnemius	NN	_	8	NMOD
8	muscle	muscle	NN	_	6	PMOD
9	,	,	,	_	15	P
10	VP16	vp0	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	PPARδ	pparδ	NN	_	14	NMOD
13	fusion	fusion	NN	_	14	NMOD
14	protein	protein	NN	_	15	SBJ
15	was	be	VBD	_	0	ROOT
16	produced	produce	VBN	_	15	VC
17	at	at	IN	_	16	ADV
18	a	a	DT	_	19	NMOD
19	level	level	NN	_	17	PMOD
20	similar	similar	JJ	_	19	NMOD
21	to	to	IN	_	20	AMOD
22	that	that	DT	_	21	PMOD
23	of	of	IN	_	22	NMOD
24	endogenous	endogenous	JJ	_	25	NMOD
25	PPARδ	pparδ	NN	_	23	PMOD
26	in	in	IN	_	16	LOC
27	wild	wild	JJ	_	29	NMOD
28	-	-	HYPH	_	27	P
29	type	type	NN	_	30	NMOD
30	littermates	littermates	NNS	_	26	PMOD
31	.	.	.	_	15	P

1	Interestingly	interestingly	RB	_	14	ADV
2	,	,	,	_	14	P
3	the	the	DT	_	4	NMOD
4	level	level	NN	_	14	SBJ
5	of	of	IN	_	4	NMOD
6	endogenous	endogenous	JJ	_	9	NMOD
7	muscle	muscle	NN	_	9	NMOD
8	PPARδ	pparδ	NN	_	9	NMOD
9	protein	protein	NN	_	5	PMOD
10	in	in	IN	_	4	LOC
11	the	the	DT	_	13	NMOD
12	transgenic	transgenic	JJ	_	13	NMOD
13	mice	mouse	NNS	_	10	PMOD
14	was	be	VBD	_	0	ROOT
15	much	much	RB	_	16	AMOD
16	higher	high	JJR	_	14	PRD
17	than	than	IN	_	16	AMOD
18	in	in	IN	_	17	LOC
19	the	the	DT	_	21	NMOD
20	control	control	NN	_	21	NMOD
21	littermates	littermates	NNS	_	18	PMOD
22	.	.	.	_	14	P

1	The	the	DT	_	3	NMOD
2	substantial	substantial	JJ	_	3	NMOD
3	increase	increase	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	endogenous	endogenous	JJ	_	6	NMOD
6	PPARδ	pparδ	NN	_	4	PMOD
7	may	may	MD	_	0	ROOT
8	have	have	VB	_	7	VC
9	been	be	VBN	_	8	VC
10	caused	cause	VBN	_	9	VC
11	by	by	IN	_	10	LGS
12	a	a	DT	_	13	NMOD
13	switch	switch	NN	_	11	PMOD
14	to	to	IN	_	13	NMOD
15	type	type	NN	_	17	NMOD
16	I	i	CD	_	15	NMOD
17	fiber	fiber	NN	_	14	PMOD
18	(	(	-LRB-	_	19	P
19	see	see	VB	_	17	PRN
20	below	below	RB	_	19	ADV
21	)	)	-RRB-	_	19	P
22	,	,	,	_	17	P
23	which	which	WDT	_	25	SBJ
24	intrinsically	intrinsically	RB	_	25	ADV
25	expresses	express	VBZ	_	17	NMOD
26	higher	high	JJR	_	27	NMOD
27	levels	level	NNS	_	25	OBJ
28	of	of	IN	_	27	NMOD
29	PPARδ	pparδ	NN	_	28	PMOD
30	(	(	-LRB-	_	32	P
31	Figure	figure	NN	_	32	NMOD
32	1A	0a	CD	_	25	PRN
33	and	and	CC	_	32	COORD
34	1B	0b	CD	_	33	CONJ
35	)	)	-RRB-	_	32	P
36	.	.	.	_	7	P

1	Type	type	NN	_	3	NMOD
2	I	i	CD	_	1	NMOD
3	muscle	muscle	NN	_	4	SBJ
4	can	can	MD	_	0	ROOT
5	be	be	VB	_	4	VC
6	readily	readily	RB	_	5	ADV
7	distinguished	distinguish	VBN	_	5	VC
8	from	from	IN	_	7	ADV
9	type	type	NN	_	13	NMOD
10	II	ii	CD	_	9	NMOD
11	or	or	CC	_	9	COORD
12	mixed	mix	VBN	_	11	CONJ
13	muscle	muscle	NN	_	8	PMOD
14	by	by	IN	_	7	MNR
15	its	its	PRP$	_	17	NMOD
16	red	red	JJ	_	17	NMOD
17	color	color	NN	_	14	PMOD
18	,	,	,	_	7	P
19	because	because	IN	_	7	PRP
20	of	of	IN	_	19	PMOD
21	its	its	PRP$	_	23	NMOD
22	high	high	JJ	_	23	NMOD
23	concentration	concentration	NN	_	20	PMOD
24	of	of	IN	_	23	NMOD
25	myoglobin	myoglobin	NN	_	24	PMOD
26	,	,	,	_	25	P
27	a	a	DT	_	28	NMOD
28	protein	protein	NN	_	25	APPO
29	typically	typically	RB	_	30	ADV
30	expressed	express	VBN	_	28	NMOD
31	in	in	IN	_	30	LOC
32	oxidative	oxidative	JJ	_	34	NMOD
33	muscle	muscle	NN	_	34	NMOD
34	fibers	fiber	NNS	_	31	PMOD
35	.	.	.	_	4	P

1	We	we	PRP	_	2	SBJ
2	found	find	VBD	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	muscles	muscle	NNS	_	9	SBJ
5	in	in	IN	_	4	LOC
6	the	the	DT	_	8	NMOD
7	transgenic	transgenic	JJ	_	8	NMOD
8	mice	mouse	NNS	_	5	PMOD
9	appeared	appear	VBD	_	3	SUB
10	redder	red	JJR	_	9	OPRD
11	(	(	-LRB-	_	12	P
12	Figure	figure	NN	_	9	PRN
13	2A	0a	CD	_	12	NMOD
14	)	)	-RRB-	_	12	P
15	,	,	,	_	9	P
16	which	which	WDT	_	17	SBJ
17	is	be	VBZ	_	9	ADV
18	particularly	particularly	RB	_	19	AMOD
19	evident	evident	JJ	_	17	PRD
20	in	in	IN	_	17	LOC
21	the	the	DT	_	27	NMOD
22	mixed	mixed	JJ	_	26	NMOD
23	type	type	NN	_	26	NMOD
24	I	i	CD	_	26	NMOD
25	/	/	HYPH	_	24	P
26	II	ii	CD	_	27	NMOD
27	fibers	fiber	NNS	_	20	PMOD
28	of	of	IN	_	27	NMOD
29	the	the	DT	_	30	NMOD
30	hindlimb	hindlimb	NN	_	28	PMOD
31	(	(	-LRB-	_	32	P
32	Figure	figure	NN	_	17	PRN
33	2B	0b	CD	_	32	NMOD
34	)	)	-RRB-	_	32	P
35	.	.	.	_	2	P

1	Indeed	indeed	RB	_	5	ADV
2	,	,	,	_	5	P
3	metachromatic	metachromatic	JJ	_	4	NMOD
4	staining	staining	NN	_	5	SBJ
5	revealed	reveal	VBD	_	0	ROOT
6	a	a	DT	_	10	NMOD
7	substantial	substantial	JJ	_	10	NMOD
8	muscle	muscle	NN	_	9	NMOD
9	fiber	fiber	NN	_	10	NMOD
10	transformation	transformation	NN	_	5	OBJ
11	(	(	-LRB-	_	12	P
12	Figure	figure	NN	_	5	PRN
13	2C	0c	CD	_	12	NMOD
14	)	)	-RRB-	_	12	P
15	.	.	.	_	5	P

1	In	in	IN	_	6	LOC
2	gastrocnemius	gastrocnemius	NN	_	3	NMOD
3	muscle	muscle	NN	_	1	PMOD
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	estimated	estimate	VBD	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	there	there	EX	_	9	SBJ
9	was	be	VBD	_	7	SUB
10	a	a	DT	_	12	NMOD
11	2-fold	0-fold	JJ	_	12	NMOD
12	increase	increase	NN	_	9	PRD
13	of	of	IN	_	12	NMOD
14	type	type	NN	_	16	NMOD
15	I	i	CD	_	14	NMOD
16	fibers	fiber	NNS	_	13	PMOD
17	.	.	.	_	6	P

1	A	a	DT	_	3	NMOD
2	diagnostic	diagnostic	JJ	_	3	NMOD
3	component	component	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	oxidative	oxidative	JJ	_	6	NMOD
6	fibers	fiber	NNS	_	4	PMOD
7	is	be	VBZ	_	0	ROOT
8	their	their	PRP$	_	13	NMOD
9	high	high	JJ	_	13	NMOD
10	myoglobin	myoglobin	NN	_	13	NMOD
11	and	and	CC	_	10	COORD
12	mitochondrial	mitochondrial	JJ	_	11	CONJ
13	content	content	NN	_	7	PRD
14	,	,	,	_	13	P
15	which	which	WDT	_	16	SBJ
16	is	be	VBZ	_	13	NMOD
17	supported	support	VBN	_	16	VC
18	by	by	IN	_	17	LGS
19	the	the	DT	_	21	NMOD
20	mRNA	mrna	NN	_	21	NMOD
21	analysis	analysis	NN	_	18	PMOD
22	shown	show	VBN	_	21	NMOD
23	in	in	IN	_	22	LOC
24	Figure	figure	NN	_	23	PMOD
25	3A	0a	CD	_	24	NMOD
26	.	.	.	_	7	P

1	In	in	IN	_	33	ADV
2	addition	addition	NN	_	1	PMOD
3	to	to	IN	_	2	NMOD
4	myoglobin	myoglobin	NN	_	3	PMOD
5	,	,	,	_	33	P
6	mitochondrial	mitochondrial	JJ	_	7	NMOD
7	components	component	NNS	_	33	SBJ
8	for	for	IN	_	7	NMOD
9	electron	electron	NN	_	10	NMOD
10	transfer	transfer	NN	_	8	PMOD
11	(	(	-LRB-	_	21	P
12	cytochrome	cytochrome	NN	_	13	NMOD
13	c	c	NN	_	21	NMOD
14	and	and	CC	_	13	COORD
15	cytochrome	cytochrome	NN	_	16	NMOD
16	c	c	NN	_	17	NMOD
17	oxidase	oxidase	NN	_	14	CONJ
18	[	[	-LRB-	_	19	P
19	COX	cox	NN	_	17	PRN
20	]	]	-RRB-	_	19	P
21	II	ii	CD	_	7	PRN
22	and	and	CC	_	21	COORD
23	IV	iv	CD	_	22	CONJ
24	)	)	-RRB-	_	21	P
25	and	and	CC	_	7	COORD
26	fatty	fatty	JJ	_	28	NMOD
27	-	-	HYPH	_	26	P
28	acid	acid	NN	_	32	NMOD
29	β	β	NN	_	31	NMOD
30	-	-	HYPH	_	29	P
31	oxidation	oxidation	NN	_	32	NMOD
32	enzymes	enzyme	NNS	_	25	CONJ
33	were	be	VBD	_	0	ROOT
34	elevated	elevate	VBN	_	33	VC
35	(	(	-LRB-	_	40	P
36	Figure	figure	NN	_	40	DEP
37	3A	0a	CD	_	36	NMOD
38	;	;	:	_	40	P
39	unpublished	unpublished	JJ	_	40	NMOD
40	data	datum	NNS	_	34	PRN
41	)	)	-RRB-	_	40	P
42	.	.	.	_	33	P

1	These	these	DT	_	2	NMOD
2	effects	effect	NNS	_	3	SBJ
3	appear	appear	VBP	_	0	ROOT
4	to	to	TO	_	3	OPRD
5	be	be	VB	_	4	IM
6	direct	direct	JJ	_	7	NMOD
7	consequences	consequence	NNS	_	5	PRD
8	of	of	IN	_	7	NMOD
9	PPARδ	pparδ	NN	_	10	NMOD
10	activation	activation	NN	_	8	PMOD
11	,	,	,	_	5	P
12	as	as	IN	_	5	ADV
13	levels	level	NNS	_	46	SBJ
14	of	of	IN	_	13	NMOD
15	PGC	pgc	NN	_	14	PMOD
16	-	-	HYPH	_	15	P
17	1α	0α	CD	_	15	NMOD
18	,	,	,	_	15	P
19	a	a	DT	_	20	NMOD
20	coactivator	coactivator	NN	_	15	APPO
21	involved	involve	VBN	_	20	NMOD
22	in	in	IN	_	21	ADV
23	muscle	muscle	NN	_	24	NMOD
24	fiber	fiber	NN	_	25	NMOD
25	switch	switch	NN	_	22	PMOD
26	and	and	CC	_	25	COORD
27	mitochondrial	mitochondrial	JJ	_	28	NMOD
28	biogenesis	biogenesis	NN	_	26	CONJ
29	(	(	-LRB-	_	30	P
30	Wu	wu	NNP	_	21	CIT
31	et	et	FW	_	30	DEP
32	al.	al.	FW	_	30	DEP
33	1999	0	CD	_	30	DEP
34	;	;	:	_	30	P
35	Lehman	lehman	NNP	_	30	DEP
36	et	et	FW	_	30	DEP
37	al.	al.	FW	_	30	DEP
38	2000	0	CD	_	30	DEP
39	;	;	:	_	30	P
40	Lin	lin	NNP	_	30	DEP
41	et	et	FW	_	30	DEP
42	al.	al.	FW	_	30	DEP
43	2002	0	CD	_	30	DEP
44	)	)	-RRB-	_	30	P
45	,	,	,	_	46	P
46	remained	remain	VBD	_	12	SUB
47	unchanged	unchanged	JJ	_	46	OPRD
48	.	.	.	_	3	P

1	Southern	southern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	4	SBJ
4	detected	detect	VBD	_	0	ROOT
5	a	a	DT	_	9	NMOD
6	substantially	substantially	RB	_	7	AMOD
7	higher	high	JJR	_	9	NMOD
8	copy	copy	NN	_	9	NMOD
9	number	number	NN	_	4	OBJ
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	17	NMOD
12	mitochondrial	mitochondrial	JJ	_	17	NMOD
13	genome	genome	NN	_	15	AMOD
14	–	–	HYPH	_	13	P
15	encoded	encode	VBN	_	17	NMOD
16	COXII	coxii	NN	_	17	NMOD
17	DNA	dna	NN	_	10	PMOD
18	in	in	IN	_	4	LOC
19	the	the	DT	_	21	NMOD
20	transgenic	transgenic	JJ	_	21	NMOD
21	mice	mouse	NNS	_	18	PMOD
22	(	(	-LRB-	_	23	P
23	Figure	figure	NN	_	4	PRN
24	3B	0b	CD	_	23	NMOD
25	)	)	-RRB-	_	23	P
26	.	.	.	_	4	P

1	Mitochondrial	mitochondrial	JJ	_	2	NMOD
2	DNA	dna	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	increased	increase	VBN	_	3	VC
5	2.3	0	CD	_	4	EXT
6	-	-	HYPH	_	5	P
7	fold	fold	RB	_	5	QMOD
8	in	in	IN	_	4	LOC
9	gastrocnemius	gastrocnemius	NN	_	10	NMOD
10	muscle	muscle	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	transgenic	transgenic	JJ	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	(	(	-LRB-	_	16	P
16	Figure	figure	NN	_	4	PRN
17	3C	0c	CD	_	16	NMOD
18	)	)	-RRB-	_	16	P
19	.	.	.	_	3	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	3	SBJ
3	reveal	reveal	VBP	_	0	ROOT
4	a	a	DT	_	6	NMOD
5	marked	marked	JJ	_	6	NMOD
6	stimulation	stimulation	NN	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	mitochondrial	mitochondrial	JJ	_	9	NMOD
9	biogenesis	biogenesis	NN	_	7	PMOD
10	and	and	CC	_	3	COORD
11	further	far	RB	_	12	ADV
12	support	support	VBP	_	10	CONJ
13	the	the	DT	_	14	NMOD
14	idea	idea	NN	_	12	OBJ
15	that	that	IN	_	14	NMOD
16	there	there	EX	_	17	SBJ
17	is	be	VBZ	_	15	SUB
18	a	a	DT	_	21	NMOD
19	muscle	muscle	NN	_	20	NMOD
20	fiber	fiber	NN	_	21	NMOD
21	switch	switch	NN	_	17	PRD
22	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	conclusion	conclusion	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	also	also	RB	_	3	ADV
5	confirmed	confirm	VBN	_	3	VC
6	by	by	IN	_	5	MNR
7	Western	western	NNP	_	8	NMOD
8	blot	blot	NN	_	9	NMOD
9	analysis	analysis	NN	_	6	PMOD
10	.	.	.	_	3	P

1	As	as	IN	_	23	ADV
2	shown	show	VBN	_	1	SUB
3	in	in	IN	_	2	LOC
4	Figure	figure	NN	_	3	PMOD
5	3D	0d	CD	_	4	NMOD
6	,	,	,	_	23	P
7	the	the	DT	_	12	NMOD
8	characteristic	characteristic	JJ	_	12	NMOD
9	type	type	NN	_	11	NMOD
10	I	i	CD	_	9	NMOD
11	fiber	fiber	NN	_	12	NMOD
12	proteins	protein	NNS	_	23	SBJ
13	,	,	,	_	12	P
14	such	such	JJ	_	15	PMOD
15	as	as	IN	_	12	NMOD
16	myoglobin	myoglobin	NN	_	15	PMOD
17	and	and	CC	_	16	COORD
18	cytochrome	cytochrome	NN	_	21	NMOD
19	c	c	NN	_	21	NMOD
20	and	and	CC	_	19	COORD
21	b	b	NN	_	17	CONJ
22	,	,	,	_	23	P
23	were	be	VBD	_	0	ROOT
24	significantly	significantly	RB	_	23	ADV
25	increased	increase	VBN	_	23	VC
26	.	.	.	_	23	P

1	More	more	RBR	_	2	AMOD
2	importantly	importantly	RB	_	17	ADV
3	,	,	,	_	17	P
4	the	the	DT	_	7	NMOD
5	specialized	specialize	VBN	_	7	NMOD
6	contraction	contraction	NN	_	7	NMOD
7	protein	protein	NN	_	8	NMOD
8	troponin	troponin	NN	_	17	SBJ
9	I	i	CD	_	8	NMOD
10	(	(	-LRB-	_	11	P
11	slow	slow	JJ	_	8	PRN
12	)	)	-RRB-	_	11	P
13	of	of	IN	_	8	NMOD
14	type	type	NN	_	16	NMOD
15	I	i	CD	_	14	NMOD
16	fiber	fiber	NN	_	13	PMOD
17	was	be	VBD	_	22	DEP
18	robustly	robustly	RB	_	17	MNR
19	induced	induce	VBN	_	17	VC
20	;	;	:	_	22	P
21	this	this	DT	_	22	SBJ
22	was	be	VBD	_	0	ROOT
23	accompanied	accompany	VBN	_	22	VC
24	by	by	IN	_	23	LGS
25	a	a	DT	_	27	NMOD
26	marked	marked	JJ	_	27	NMOD
27	reduction	reduction	NN	_	24	PMOD
28	of	of	IN	_	27	NMOD
29	the	the	DT	_	32	NMOD
30	specialized	specialize	VBN	_	32	NMOD
31	contraction	contraction	NN	_	32	NMOD
32	protein	protein	NN	_	33	NMOD
33	troponin	troponin	NN	_	28	PMOD
34	I	i	CD	_	33	NMOD
35	(	(	-LRB-	_	36	P
36	fast	fast	JJ	_	33	PRN
37	)	)	-RRB-	_	36	P
38	of	of	IN	_	33	NMOD
39	type	type	NN	_	41	NMOD
40	II	ii	CD	_	39	NMOD
41	fiber	fiber	NN	_	38	PMOD
42	,	,	,	_	23	P
43	indicating	indicate	VBG	_	23	ADV
44	a	a	DT	_	46	NMOD
45	high	high	JJ	_	46	NMOD
46	degree	degree	NN	_	43	OBJ
47	of	of	IN	_	46	NMOD
48	fiber	fiber	NN	_	49	NMOD
49	transformation	transformation	NN	_	47	PMOD
50	.	.	.	_	22	P

1	We	we	PRP	_	3	SBJ
2	next	next	RB	_	3	TMP
3	examined	examine	VBD	_	0	ROOT
4	whether	whether	IN	_	3	OBJ
5	acute	acute	JJ	_	6	NMOD
6	activation	activation	NN	_	10	SBJ
7	of	of	IN	_	6	NMOD
8	endogenous	endogenous	JJ	_	9	NMOD
9	PPARδ	pparδ	NN	_	7	PMOD
10	would	would	MD	_	4	SUB
11	induce	induce	VB	_	10	VC
12	similar	similar	JJ	_	14	NMOD
13	target	target	NN	_	14	NMOD
14	genes	gene	NNS	_	11	OBJ
15	.	.	.	_	3	P

1	In	in	IN	_	13	ADV
2	agreement	agreement	NN	_	1	PMOD
3	with	with	IN	_	2	NMOD
4	the	the	DT	_	6	NMOD
5	chronic	chronic	JJ	_	6	NMOD
6	effects	effect	NNS	_	3	PMOD
7	in	in	IN	_	6	LOC
8	the	the	DT	_	10	NMOD
9	transgenic	transgenic	JJ	_	10	NMOD
10	mice	mouse	NNS	_	7	PMOD
11	,	,	,	_	13	P
12	we	we	PRP	_	13	SBJ
13	found	find	VBD	_	0	ROOT
14	that	that	IN	_	13	OBJ
15	,	,	,	_	14	P
16	after	after	IN	_	50	TMP
17	treatment	treatment	NN	_	16	PMOD
18	of	of	IN	_	17	NMOD
19	wild	wild	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	type	type	NN	_	23	NMOD
22	C57B6J	c0b0j	NN	_	23	NMOD
23	mice	mouse	NNS	_	18	PMOD
24	with	with	IN	_	17	NMOD
25	the	the	DT	_	30	NMOD
26	PPARδ	pparδ	NN	_	28	AMOD
27	-	-	HYPH	_	26	P
28	specific	specific	JJ	_	30	NMOD
29	agonist	agonist	NN	_	30	NMOD
30	GW501516	gw0	NN	_	24	PMOD
31	for	for	IN	_	17	TMP
32	only	only	RB	_	34	NMOD
33	10	0	CD	_	34	NMOD
34	d	d	NNS	_	31	PMOD
35	,	,	,	_	50	P
36	genes	gene	NNS	_	50	SBJ
37	for	for	IN	_	36	NMOD
38	slow	slow	JJ	_	39	NMOD
39	fiber	fiber	NN	_	41	NMOD
40	contractile	contractile	JJ	_	41	NMOD
41	proteins	protein	NNS	_	37	PMOD
42	,	,	,	_	41	P
43	mitochondrial	mitochondrial	JJ	_	44	NMOD
44	biogenesis	biogenesis	NN	_	41	CONJ
45	,	,	,	_	44	P
46	and	and	CC	_	44	COORD
47	β	β	NN	_	49	NMOD
48	-	-	HYPH	_	47	P
49	oxidation	oxidation	NN	_	46	CONJ
50	were	be	VBD	_	14	SUB
51	all	all	RB	_	50	ADV
52	upregulated	upregulated	VBN	_	50	VC
53	(	(	-LRB-	_	54	P
54	Figure	figure	NN	_	52	PRN
55	3E	0e	CD	_	54	NMOD
56	)	)	-RRB-	_	54	P
57	.	.	.	_	13	P

1	This	this	DT	_	2	SBJ
2	indicates	indicate	VBZ	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	rapid	rapid	JJ	_	10	NMOD
5	,	,	,	_	4	P
6	systematic	systematic	JJ	_	4	CONJ
7	,	,	,	_	6	P
8	and	and	CC	_	6	COORD
9	coordinated	coordinate	VBN	_	8	CONJ
10	changes	change	NNS	_	18	SBJ
11	of	of	IN	_	10	NMOD
12	muscle	muscle	NN	_	14	NMOD
13	fiber	fiber	NN	_	14	NMOD
14	properties	property	NNS	_	11	PMOD
15	toward	toward	IN	_	10	NMOD
16	type	type	NN	_	15	PMOD
17	I	i	CD	_	16	NMOD
18	can	can	MD	_	3	SUB
19	be	be	VB	_	18	VC
20	achieved	achieve	VBN	_	19	VC
21	by	by	IN	_	20	MNR
22	activation	activation	NN	_	21	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	27	NMOD
25	endogenous	endogenous	JJ	_	27	NMOD
26	PPARδ	pparδ	NN	_	27	NMOD
27	pathway	pathway	NN	_	23	PMOD
28	.	.	.	_	2	P

1	Muscle	muscle	NN	_	2	NMOD
2	Fiber	fiber	NN	_	3	NMOD
3	Switch	switch	NN	_	6	SBJ
4	by	by	IN	_	3	NMOD
5	PPARδ	pparδ	NN	_	4	PMOD
6	Protects	protect	VBZ	_	0	ROOT
7	Against	against	IN	_	6	ADV
8	Obesity	obesity	NN	_	7	PMOD

1	A	a	DT	_	2	NMOD
2	number	number	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	previous	previous	JJ	_	5	NMOD
5	studies	study	NNS	_	3	PMOD
6	have	have	VBP	_	0	ROOT
7	shown	show	VBN	_	6	VC
8	that	that	IN	_	7	OBJ
9	obese	obese	JJ	_	10	NMOD
10	individuals	individual	NNS	_	11	SBJ
11	have	have	VBP	_	8	SUB
12	fewer	few	JJR	_	14	NMOD
13	oxidative	oxidative	JJ	_	14	NMOD
14	fibers	fiber	NNS	_	11	OBJ
15	,	,	,	_	11	P
16	implying	imply	VBG	_	11	ADV
17	that	that	IN	_	16	OBJ
18	the	the	DT	_	19	NMOD
19	presence	presence	NN	_	24	SBJ
20	of	of	IN	_	19	NMOD
21	oxidative	oxidative	JJ	_	22	NMOD
22	fibers	fiber	NNS	_	20	PMOD
23	alone	alone	RB	_	19	NMOD
24	may	may	MD	_	17	SUB
25	play	play	VB	_	24	VC
26	a	a	DT	_	27	NMOD
27	part	part	NN	_	25	OBJ
28	in	in	IN	_	25	ADV
29	obesity	obesity	NN	_	30	NMOD
30	resistance	resistance	NN	_	28	PMOD
31	.	.	.	_	6	P

1	To	to	TO	_	7	PRP
2	test	test	VB	_	1	IM
3	this	this	DT	_	4	NMOD
4	possibility	possibility	NN	_	2	OBJ
5	,	,	,	_	7	P
6	we	we	PRP	_	7	SBJ
7	fed	feed	VBD	_	0	ROOT
8	the	the	DT	_	10	NMOD
9	transgenic	transgenic	JJ	_	10	NMOD
10	mice	mouse	NNS	_	7	OBJ
11	and	and	CC	_	10	COORD
12	their	their	PRP$	_	16	NMOD
13	wild	wild	JJ	_	15	NMOD
14	-	-	HYPH	_	13	P
15	type	type	NN	_	16	NMOD
16	littermates	littermates	NNS	_	11	CONJ
17	with	with	IN	_	7	MNR
18	a	a	DT	_	22	NMOD
19	high	high	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	fat	fat	NN	_	22	NMOD
22	diet	diet	NN	_	17	PMOD
23	for	for	IN	_	7	TMP
24	97	0	CD	_	25	NMOD
25	d	d	NNS	_	23	PMOD
26	.	.	.	_	7	P

1	Although	although	IN	_	17	ADV
2	the	the	DT	_	5	NMOD
3	initial	initial	JJ	_	5	NMOD
4	body	body	NN	_	5	NMOD
5	weights	weight	NNS	_	10	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	9	NMOD
8	two	two	CD	_	9	NMOD
9	groups	group	NNS	_	6	PMOD
10	were	be	VBD	_	1	SUB
11	very	very	RB	_	12	AMOD
12	similar	similar	JJ	_	10	PRD
13	,	,	,	_	17	P
14	the	the	DT	_	16	NMOD
15	transgenic	transgenic	JJ	_	16	NMOD
16	mice	mouse	NNS	_	17	SBJ
17	had	have	VBD	_	0	ROOT
18	gained	gain	VBN	_	17	VC
19	less	less	JJR	_	22	NMOD
20	than	than	IN	_	19	QMOD
21	50	0	CD	_	19	QMOD
22	%	%	NN	_	18	OBJ
23	at	at	IN	_	18	TMP
24	day	day	NN	_	23	PMOD
25	47	0	CD	_	24	NMOD
26	,	,	,	_	18	P
27	and	and	CC	_	18	COORD
28	only	only	RB	_	31	NMOD
29	one	one	RB	_	31	NMOD
30	-	-	HYPH	_	29	P
31	third	$#ORD#$	RB	_	27	GAP
32	at	at	IN	_	31	TMP
33	day	day	NN	_	32	PMOD
34	97	0	CD	_	33	NMOD
35	,	,	,	_	31	P
36	of	of	IN	_	31	NMOD
37	the	the	DT	_	38	NMOD
38	weight	weight	NN	_	36	PMOD
39	gained	gain	VBN	_	38	NMOD
40	by	by	IN	_	39	LGS
41	the	the	DT	_	45	NMOD
42	wild	wild	JJ	_	44	NMOD
43	-	-	HYPH	_	42	P
44	type	type	NN	_	45	NMOD
45	animals	animal	NNS	_	40	PMOD
46	(	(	-LRB-	_	47	P
47	Figure	figure	NN	_	18	PRN
48	4A	0a	CD	_	47	NMOD
49	)	)	-RRB-	_	47	P
50	.	.	.	_	17	P

1	The	the	DT	_	3	NMOD
2	transgenic	transgenic	JJ	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	displayed	display	VBD	_	0	ROOT
5	significantly	significantly	RB	_	6	AMOD
6	higher	high	JJR	_	8	NMOD
7	oxygen	oxygen	NN	_	8	NMOD
8	consumption	consumption	NN	_	4	OBJ
9	on	on	IN	_	8	NMOD
10	the	the	DT	_	14	NMOD
11	high	high	JJ	_	13	NMOD
12	-	-	HYPH	_	11	P
13	fat	fat	NN	_	14	NMOD
14	diet	diet	NN	_	9	PMOD
15	than	than	IN	_	8	NMOD
16	the	the	DT	_	18	NMOD
17	control	control	NN	_	18	NMOD
18	littermates	littermates	NNS	_	15	PMOD
19	(	(	-LRB-	_	21	P
20	unpublished	unpublished	JJ	_	21	NMOD
21	data	datum	NNS	_	4	PRN
22	)	)	-RRB-	_	21	P
23	.	.	.	_	4	P

1	By	by	IN	_	11	TMP
2	the	the	DT	_	3	NMOD
3	end	end	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	experiment	experiment	NN	_	4	PMOD
7	,	,	,	_	11	P
8	the	the	DT	_	10	NMOD
9	control	control	NN	_	10	NMOD
10	littermates	littermates	NNS	_	11	SBJ
11	became	become	VBD	_	0	ROOT
12	obese	obese	JJ	_	11	PRD
13	,	,	,	_	11	P
14	whereas	whereas	IN	_	11	ADV
15	the	the	DT	_	17	NMOD
16	transgenic	transgenic	JJ	_	17	NMOD
17	mice	mouse	NNS	_	19	SBJ
18	still	still	RB	_	19	ADV
19	maintained	maintain	VBD	_	14	SUB
20	a	a	DT	_	23	NMOD
21	normal	normal	JJ	_	23	NMOD
22	body	body	NN	_	23	NMOD
23	weight	weight	NN	_	19	OBJ
24	and	and	CC	_	23	COORD
25	fat	fat	NN	_	26	NMOD
26	mass	mass	NN	_	27	NMOD
27	composition	composition	NN	_	24	CONJ
28	(	(	-LRB-	_	29	P
29	Figure	figure	NN	_	19	PRN
30	4A	0a	CD	_	29	NMOD
31	)	)	-RRB-	_	29	P
32	.	.	.	_	11	P

1	A	a	DT	_	3	NMOD
2	histological	histological	JJ	_	3	NMOD
3	analysis	analysis	NN	_	8	SBJ
4	of	of	IN	_	3	NMOD
5	inguinal	inguinal	JJ	_	7	NMOD
6	fat	fat	NN	_	7	NMOD
7	pad	pad	NN	_	4	PMOD
8	revealed	reveal	VBD	_	0	ROOT
9	a	a	DT	_	13	NMOD
10	much	much	RB	_	11	AMOD
11	smaller	small	JJR	_	13	NMOD
12	cell	cell	NN	_	13	NMOD
13	size	size	NN	_	8	OBJ
14	in	in	IN	_	8	LOC
15	the	the	DT	_	17	NMOD
16	transgenic	transgenic	JJ	_	17	NMOD
17	mice	mouse	NNS	_	14	PMOD
18	(	(	-LRB-	_	19	P
19	Figure	figure	NN	_	8	PRN
20	4B	0b	CD	_	19	NMOD
21	)	)	-RRB-	_	19	P
22	,	,	,	_	8	P
23	due	due	IN	_	8	PRP
24	to	to	IN	_	23	PMOD
25	the	the	DT	_	29	NMOD
26	increased	increase	VBN	_	29	NMOD
27	muscle	muscle	NN	_	29	NMOD
28	oxidative	oxidative	JJ	_	29	NMOD
29	capacity	capacity	NN	_	23	PMOD
30	.	.	.	_	8	P

1	While	while	IN	_	15	ADV
2	there	there	EX	_	3	SBJ
3	was	be	VBD	_	1	SUB
4	no	no	DT	_	6	NMOD
5	significant	significant	JJ	_	6	NMOD
6	difference	difference	NN	_	3	PRD
7	in	in	IN	_	6	NMOD
8	intramuscular	intramuscular	JJ	_	10	NMOD
9	glycogen	glycogen	NN	_	10	NMOD
10	content	content	NN	_	7	PMOD
11	,	,	,	_	15	P
12	the	the	DT	_	14	NMOD
13	triglyceride	triglyceride	NN	_	14	NMOD
14	content	content	NN	_	15	SBJ
15	was	be	VBD	_	0	ROOT
16	much	much	RB	_	17	AMOD
17	less	less	JJR	_	15	PRD
18	in	in	IN	_	15	LOC
19	the	the	DT	_	21	NMOD
20	transgenic	transgenic	JJ	_	21	NMOD
21	mice	mouse	NNS	_	18	PMOD
22	(	(	-LRB-	_	23	P
23	Figure	figure	NN	_	15	PRN
24	4C	0c	CD	_	23	NMOD
25	and	and	CC	_	24	COORD
26	4D	0d	CD	_	25	CONJ
27	)	)	-RRB-	_	23	P
28	,	,	,	_	15	P
29	which	which	WDT	_	30	SBJ
30	may	may	MD	_	15	ADV
31	explain	explain	VB	_	30	VC
32	their	their	PRP$	_	35	NMOD
33	improved	improve	VBN	_	35	NMOD
34	glucose	glucose	NN	_	35	NMOD
35	tolerance	tolerance	NN	_	31	OBJ
36	(	(	-LRB-	_	37	P
37	Figure	figure	NN	_	31	PRN
38	4E	0e	CD	_	37	NMOD
39	)	)	-RRB-	_	37	P
40	.	.	.	_	15	P

1	We	we	PRP	_	3	SBJ
2	also	also	RB	_	3	ADV
3	placed	place	VBD	_	0	ROOT
4	wild	wild	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	type	type	NN	_	8	NMOD
7	C57BJ6	c0bj0	NN	_	8	NMOD
8	mice	mouse	NNS	_	3	OBJ
9	on	on	IN	_	3	ADV
10	the	the	DT	_	14	NMOD
11	high	high	JJ	_	13	NMOD
12	-	-	HYPH	_	11	P
13	fat	fat	NN	_	14	NMOD
14	diet	diet	NN	_	9	PMOD
15	and	and	CC	_	3	COORD
16	treated	treat	VBN	_	15	CONJ
17	them	them	PRP	_	16	OBJ
18	with	with	IN	_	16	MNR
19	either	either	CC	_	20	COORD
20	vehicle	vehicle	NN	_	18	PMOD
21	or	or	CC	_	20	COORD
22	the	the	DT	_	25	NMOD
23	PPARδ	pparδ	NN	_	24	NMOD
24	agonist	agonist	NN	_	25	NMOD
25	GW501516	gw0	NN	_	21	CONJ
26	for	for	IN	_	16	TMP
27	2	0	CD	_	28	NMOD
28	mo	mo	NN	_	26	PMOD
29	.	.	.	_	3	P

1	GW501516	gw0	NN	_	2	SBJ
2	produced	produce	VBD	_	21	DEP
3	a	a	DT	_	5	NMOD
4	sustained	sustain	VBN	_	5	NMOD
5	induction	induction	NN	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	genes	gene	NNS	_	6	PMOD
8	for	for	IN	_	7	NMOD
9	type	type	NN	_	12	NMOD
10	I	i	CD	_	9	NMOD
11	muscle	muscle	NN	_	12	NMOD
12	fibers	fiber	NNS	_	8	PMOD
13	;	;	:	_	21	P
14	this	this	DT	_	21	SBJ
15	,	,	,	_	21	P
16	at	at	RB	_	18	PMOD
17	least	least	RBS	_	16	AMOD
18	in	in	IN	_	21	ADV
19	part	part	JJ	_	18	PMOD
20	,	,	,	_	21	P
21	resulted	result	VBD	_	0	ROOT
22	in	in	IN	_	21	ADV
23	an	an	DT	_	27	NMOD
24	only	only	RB	_	25	QMOD
25	30	0	CD	_	26	NMOD
26	%	%	NN	_	27	NMOD
27	gain	gain	NN	_	22	PMOD
28	in	in	IN	_	27	NMOD
29	body	body	NN	_	30	NMOD
30	weight	weight	NN	_	28	PMOD
31	,	,	,	_	27	P
32	a	a	DT	_	37	NMOD
33	dramatically	dramatically	RB	_	34	AMOD
34	reduced	reduce	VBN	_	37	NMOD
35	fat	fat	NN	_	36	NMOD
36	mass	mass	NN	_	37	NMOD
37	accumulation	accumulation	NN	_	27	CONJ
38	,	,	,	_	37	P
39	and	and	CC	_	37	COORD
40	improved	improve	VBN	_	42	NMOD
41	glucose	glucose	NN	_	42	NMOD
42	tolerance	tolerance	NN	_	39	CONJ
43	,	,	,	_	27	P
44	compared	compare	VBN	_	27	NMOD
45	to	to	IN	_	44	PMOD
46	the	the	DT	_	50	NMOD
47	vehicle	vehicle	NN	_	49	AMOD
48	-	-	HYPH	_	47	P
49	treated	treat	VBN	_	50	NMOD
50	group	group	NN	_	45	PMOD
51	(	(	-LRB-	_	52	P
52	Figure	figure	NN	_	21	PRN
53	5	0	CD	_	52	NMOD
54	)	)	-RRB-	_	52	P
55	.	.	.	_	21	P

1	Thus	thus	RB	_	16	ADV
2	,	,	,	_	16	P
3	muscle	muscle	NN	_	4	NMOD
4	fiber	fiber	NN	_	5	NMOD
5	conversion	conversion	NN	_	16	SBJ
6	by	by	IN	_	5	NMOD
7	stimulation	stimulation	NN	_	6	PMOD
8	with	with	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	PPARδ	pparδ	NN	_	11	NMOD
11	agonist	agonist	NN	_	8	PMOD
12	or	or	CC	_	11	COORD
13	the	the	DT	_	15	NMOD
14	activated	activate	VBN	_	15	NMOD
15	transgene	transgene	NN	_	12	CONJ
16	has	have	VBZ	_	0	ROOT
17	a	a	DT	_	19	NMOD
18	protective	protective	JJ	_	19	NMOD
19	role	role	NN	_	16	OBJ
20	against	against	IN	_	19	NMOD
21	obesity	obesity	NN	_	20	PMOD
22	.	.	.	_	16	P

1	Activation	activation	NN	_	4	SBJ
2	of	of	IN	_	1	NMOD
3	PPARδ	pparδ	NN	_	2	PMOD
4	Enhances	enhance	VBZ	_	0	ROOT
5	Physical	physical	JJ	_	6	NMOD
6	Performance	performance	NN	_	4	OBJ

1	Muscle	muscle	NN	_	3	NMOD
2	oxidative	oxidative	JJ	_	3	NMOD
3	capacity	capacity	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	a	a	DT	_	7	NMOD
6	crucial	crucial	JJ	_	7	NMOD
7	factor	factor	NN	_	4	PRD
8	for	for	IN	_	7	NMOD
9	determining	determine	VBG	_	8	PMOD
10	endurance	endurance	NN	_	9	OBJ
11	and	and	CC	_	10	COORD
12	fatigue	fatigue	NN	_	11	CONJ
13	.	.	.	_	4	P

1	Indeed	indeed	RB	_	11	ADV
2	,	,	,	_	11	P
3	type	type	NN	_	5	NMOD
4	I	i	CD	_	3	NMOD
5	fibers	fiber	NNS	_	11	SBJ
6	adaptively	adaptively	RB	_	7	MNR
7	generated	generate	VBN	_	5	NMOD
8	through	through	IN	_	7	MNR
9	exercise	exercise	NN	_	10	NMOD
10	training	training	NN	_	8	PMOD
11	are	be	VBP	_	0	ROOT
12	considered	consider	VBN	_	11	VC
13	to	to	TO	_	12	OPRD
14	be	be	VB	_	13	IM
15	fatigue	fatigue	NN	_	16	AMOD
16	resistant	resistant	JJ	_	14	PRD
17	.	.	.	_	11	P

1	However	however	RB	_	24	ADV
2	,	,	,	_	24	P
3	whether	whether	IN	_	24	SBJ
4	the	the	DT	_	7	NMOD
5	type	type	NN	_	7	NMOD
6	I	i	CD	_	5	NMOD
7	fibers	fiber	NNS	_	13	SBJ
8	generated	generate	VBN	_	7	NMOD
9	molecularly	molecularly	RB	_	8	MNR
10	via	via	IN	_	8	MNR
11	PPARδ	pparδ	NN	_	12	NMOD
12	expression	expression	NN	_	10	PMOD
13	can	can	MD	_	3	SUB
14	contribute	contribute	VB	_	13	VC
15	to	to	IN	_	14	ADV
16	enhanced	enhance	VBN	_	17	NMOD
17	performance	performance	NN	_	15	PMOD
18	in	in	IN	_	14	ADV
19	the	the	DT	_	20	NMOD
20	absence	absence	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	previous	previous	JJ	_	23	NMOD
23	training	training	NN	_	21	PMOD
24	is	be	VBZ	_	0	ROOT
25	unclear	unclear	JJ	_	24	PRD
26	.	.	.	_	24	P

1	In	in	IN	_	14	ADV
2	fact	fact	NN	_	1	PMOD
3	,	,	,	_	14	P
4	the	the	DT	_	5	NMOD
5	consequence	consequence	NN	_	14	SBJ
6	of	of	IN	_	5	NMOD
7	genetically	genetically	RB	_	8	AMOD
8	induced	induce	VBN	_	10	NMOD
9	fiber	fiber	NN	_	10	NMOD
10	switch	switch	NN	_	6	PMOD
11	on	on	IN	_	5	NMOD
12	running	run	VBG	_	13	NMOD
13	capacity	capacity	NN	_	11	PMOD
14	has	have	VBZ	_	0	ROOT
15	to	to	IN	_	14	ADV
16	our	our	PRP$	_	17	NMOD
17	knowledge	knowledge	NN	_	15	PMOD
18	never	never	RB	_	14	ADV
19	been	be	VBN	_	14	VC
20	evaluated	evaluate	VBN	_	19	VC
21	.	.	.	_	14	P

1	We	we	PRP	_	3	SBJ
2	thus	thus	RB	_	3	ADV
3	compared	compare	VBD	_	0	ROOT
4	exercise	exercise	NN	_	5	NMOD
5	performance	performance	NN	_	3	OBJ
6	between	between	IN	_	3	ADV
7	untrained	untrained	JJ	_	19	NMOD
8	,	,	,	_	19	P
9	body	body	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	weight	weight	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	matched	match	VBN	_	19	NMOD
14	transgenic	transgenic	JJ	_	19	NMOD
15	and	and	CC	_	14	COORD
16	wild	wild	JJ	_	18	NMOD
17	-	-	HYPH	_	16	P
18	type	type	NN	_	15	CONJ
19	littermates	littermates	NNS	_	6	PMOD
20	.	.	.	_	3	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	run	run	VBN	_	2	VC
4	on	on	IN	_	3	ADV
5	oxygen	oxygen	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	infused	infuse	VBN	_	10	NMOD
8	,	,	,	_	10	P
9	enclosed	enclose	VBN	_	10	NMOD
10	treadmills	treadmill	NNS	_	4	PMOD
11	until	until	IN	_	3	TMP
12	exhaustion	exhaustion	NN	_	11	PMOD
13	.	.	.	_	2	P

1	Strikingly	strikingly	RB	_	15	ADV
2	,	,	,	_	15	P
3	the	the	DT	_	5	NMOD
4	running	running	NN	_	5	NMOD
5	time	time	NN	_	15	SBJ
6	and	and	CC	_	5	COORD
7	distance	distance	NN	_	6	CONJ
8	the	the	DT	_	10	NMOD
9	transgenic	transgenic	JJ	_	10	NMOD
10	mice	mouse	NNS	_	11	SBJ
11	were	be	VBD	_	5	NMOD
12	able	able	JJ	_	11	PRD
13	to	to	TO	_	12	AMOD
14	sustain	sustain	VB	_	13	IM
15	were	be	VBD	_	0	ROOT
16	increased	increase	VBN	_	15	VC
17	by	by	IN	_	16	EXT
18	67	0	CD	_	19	NMOD
19	%	%	NN	_	17	PMOD
20	and	and	CC	_	19	COORD
21	92	0	CD	_	22	NMOD
22	%	%	NN	_	20	CONJ
23	,	,	,	_	16	P
24	respectively	respectively	RB	_	16	ADV
25	(	(	-LRB-	_	30	P
26	Figure	figure	NN	_	30	DEP
27	6A	0a	CD	_	26	NMOD
28	;	;	:	_	30	P
29	also	also	RB	_	30	ADV
30	see	see	VB	_	16	PRN
31	Videos	video	NNS	_	32	NMOD
32	S1	s0	NN	_	30	OBJ
33	and	and	CC	_	32	COORD
34	S2	s0	NN	_	33	CONJ
35	)	)	-RRB-	_	30	P
36	.	.	.	_	15	P

1	The	the	DT	_	3	NMOD
2	transgenic	transgenic	JJ	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	ran	run	VBD	_	0	ROOT
5	about	about	RB	_	6	QMOD
6	1	0	CD	_	7	NMOD
7	h	h	NN	_	8	AMOD
8	longer	longer	RBR	_	4	TMP
9	than	than	IN	_	8	AMOD
10	the	the	DT	_	11	NMOD
11	controls	control	NNS	_	9	PMOD
12	,	,	,	_	4	P
13	which	which	WDT	_	14	SBJ
14	translates	translate	VBZ	_	4	ADV
15	to	to	IN	_	14	ADV
16	nearly	nearly	RB	_	17	QMOD
17	a	a	DT	_	18	NMOD
18	kilometer	kilometer	NN	_	19	AMOD
19	further	far	RBR	_	15	PMOD
20	.	.	.	_	4	P

1	No	no	DT	_	3	NMOD
2	significant	significant	JJ	_	3	NMOD
3	differences	difference	NNS	_	44	SBJ
4	in	in	IN	_	3	NMOD
5	muscle	muscle	NN	_	6	NMOD
6	mass	mass	NN	_	4	PMOD
7	(	(	-LRB-	_	9	P
8	unpublished	unpublished	JJ	_	9	NMOD
9	data	datum	NNS	_	6	PRN
10	)	)	-RRB-	_	9	P
11	and	and	CC	_	6	COORD
12	daily	daily	JJ	_	13	NMOD
13	activity	activity	NN	_	11	CONJ
14	(	(	-LRB-	_	42	P
15	total	total	JJ	_	16	NMOD
16	counts	count	NNS	_	42	DEP
17	of	of	IN	_	16	NMOD
18	activity	activity	NN	_	17	PMOD
19	per	per	IN	_	18	NMOD
20	hour	hour	NN	_	19	PMOD
21	:	:	:	_	42	P
22	1618	0	CD	_	42	DEP
23	±	±	SYM	_	22	P
24	209	0	CD	_	22	QMOD
25	for	for	IN	_	22	NMOD
26	transgenic	transgenic	JJ	_	25	PMOD
27	versus	versus	CC	_	22	COORD
28	1987	0	CD	_	27	CONJ
29	±	±	SYM	_	28	P
30	301	0	CD	_	28	QMOD
31	for	for	IN	_	28	NMOD
32	wild	wild	JJ	_	34	NMOD
33	-	-	HYPH	_	32	P
34	type	type	NN	_	31	PMOD
35	,	,	,	_	42	P
36	p	p	NN	_	38	SBJ
37	>	>	SYM	_	38	P
38	0.35	0	CD	_	42	DEP
39	,	,	,	_	42	P
40	n	n	NN	_	42	SBJ
41	=	=	SYM	_	42	P
42	4	0	CD	_	13	PRN
43	)	)	-RRB-	_	42	P
44	were	be	VBD	_	0	ROOT
45	observed	observe	VBN	_	44	VC
46	between	between	IN	_	45	ADV
47	the	the	DT	_	51	NMOD
48	transgenic	transgenic	JJ	_	51	NMOD
49	and	and	CC	_	48	COORD
50	control	control	NN	_	49	CONJ
51	mice	mouse	NNS	_	46	PMOD
52	.	.	.	_	44	P

1	Thus	thus	RB	_	8	ADV
2	,	,	,	_	8	P
3	the	the	DT	_	5	NMOD
4	remarkable	remarkable	JJ	_	5	NMOD
5	increase	increase	NN	_	8	SBJ
6	in	in	IN	_	5	NMOD
7	endurance	endurance	NN	_	6	PMOD
8	is	be	VBZ	_	0	ROOT
9	the	the	DT	_	11	NMOD
10	physiologic	physiologic	JJ	_	11	NMOD
11	manifestation	manifestation	NN	_	8	PRD
12	of	of	IN	_	11	NMOD
13	muscle	muscle	NN	_	14	NMOD
14	fiber	fiber	NN	_	15	NMOD
15	transformation	transformation	NN	_	12	PMOD
16	.	.	.	_	8	P

1	This	this	DT	_	2	SBJ
2	suggests	suggest	VBZ	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	genetically	genetically	RB	_	5	AMOD
5	directed	direct	VBN	_	8	NMOD
6	muscle	muscle	NN	_	7	NMOD
7	fiber	fiber	NN	_	8	NMOD
8	switch	switch	NN	_	9	SBJ
9	is	be	VBZ	_	3	SUB
10	physiologically	physiologically	RB	_	13	AMOD
11	and	and	CC	_	10	COORD
12	functionally	functionally	RB	_	11	CONJ
13	relevant	relevant	JJ	_	9	PRD
14	.	.	.	_	2	P

1	In	in	IN	_	5	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	5	P
4	we	we	PRP	_	5	SBJ
5	looked	look	VBD	_	0	ROOT
6	at	at	IN	_	5	ADV
7	what	what	WDT	_	8	NMOD
8	effect	effect	NN	_	14	OBJ
9	the	the	DT	_	10	NMOD
10	absence	absence	NN	_	14	SBJ
11	of	of	IN	_	10	NMOD
12	PPARδ	pparδ	NN	_	13	NMOD
13	function	function	NN	_	11	PMOD
14	has	have	VBZ	_	6	PMOD
15	on	on	IN	_	14	ADV
16	exercise	exercise	NN	_	17	NMOD
17	endurance	endurance	NN	_	15	PMOD
18	.	.	.	_	5	P

1	In	in	IN	_	11	ADV
2	the	the	DT	_	4	NMOD
3	treadmill	treadmill	NN	_	4	NMOD
4	test	test	NN	_	1	PMOD
5	,	,	,	_	11	P
6	the	the	DT	_	10	NMOD
7	PPARδ	pparδ	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	null	null	JJ	_	10	NMOD
10	mice	mouse	NNS	_	11	SBJ
11	could	could	MD	_	0	ROOT
12	sustain	sustain	VB	_	11	VC
13	only	only	RB	_	15	NMOD
14	38	0	CD	_	15	NMOD
15	%	%	NN	_	12	OBJ
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	running	running	NN	_	19	NMOD
19	time	time	NN	_	16	PMOD
20	and	and	CC	_	15	COORD
21	34	0	CD	_	22	NMOD
22	%	%	NN	_	20	CONJ
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	distance	distance	NN	_	23	PMOD
26	of	of	IN	_	25	NMOD
27	their	their	PRP$	_	37	NMOD
28	age	age	NN	_	33	AMOD
29	-	-	HYPH	_	28	P
30	and	and	CC	_	28	COORD
31	weight	weight	NN	_	30	CONJ
32	-	-	HYPH	_	28	P
33	matched	match	VBN	_	37	NMOD
34	wild	wild	JJ	_	36	NMOD
35	-	-	HYPH	_	34	P
36	type	type	NN	_	37	NMOD
37	counterparts	counterpart	NNS	_	26	PMOD
38	(	(	-LRB-	_	39	P
39	Figure	figure	NN	_	12	PRN
40	6B	0b	CD	_	39	NMOD
41	)	)	-RRB-	_	39	P
42	.	.	.	_	11	P

1	These	these	DT	_	2	NMOD
2	results	result	NNS	_	4	SBJ
3	further	far	RB	_	4	ADV
4	support	support	VBP	_	0	ROOT
5	a	a	DT	_	6	NMOD
6	role	role	NN	_	4	OBJ
7	for	for	IN	_	6	NMOD
8	PPARδ	pparδ	NN	_	7	PMOD
9	in	in	IN	_	6	NMOD
10	enhancement	enhancement	NN	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	physical	physical	JJ	_	13	NMOD
13	performance	performance	NN	_	11	PMOD
14	.	.	.	_	4	P

1	Discussion	discussion	NN	_	0	ROOT

1	Our	our	PRP$	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	reveal	reveal	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	a	a	DT	_	10	NMOD
6	PPARδ	pparδ	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	mediated	mediate	VBN	_	10	NMOD
9	transcriptional	transcriptional	JJ	_	10	NMOD
10	pathway	pathway	NN	_	11	SBJ
11	can	can	MD	_	4	SUB
12	regulate	regulate	VB	_	11	VC
13	muscle	muscle	NN	_	14	NMOD
14	fiber	fiber	NN	_	15	NMOD
15	specification	specification	NN	_	12	OBJ
16	,	,	,	_	12	P
17	enabling	enable	VBG	_	12	ADV
18	the	the	DT	_	19	NMOD
19	generation	generation	NN	_	17	OBJ
20	of	of	IN	_	19	NMOD
21	a	a	DT	_	22	NMOD
22	strain	strain	NN	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	mice	mouse	NNS	_	23	PMOD
25	with	with	IN	_	22	NMOD
26	a	a	DT	_	33	NMOD
27	“	“	``	_	33	P
28	long	long	JJ	_	30	NMOD
29	-	-	HYPH	_	28	P
30	distance	distance	NN	_	31	NMOD
31	running	running	NN	_	33	NMOD
32	”	”	''	_	33	P
33	phenotype	phenotype	NN	_	25	PMOD
34	.	.	.	_	3	P

1	We	we	PRP	_	2	SBJ
2	show	show	VBP	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	targeted	target	VBN	_	5	NMOD
5	expression	expression	NN	_	12	SBJ
6	of	of	IN	_	5	NMOD
7	an	an	DT	_	9	NMOD
8	activated	activated	JJ	_	9	NMOD
9	form	form	NN	_	6	PMOD
10	of	of	IN	_	9	NMOD
11	PPARδ	pparδ	NN	_	10	PMOD
12	produces	produce	VBZ	_	3	SUB
13	profound	profound	JJ	_	16	NMOD
14	and	and	CC	_	13	COORD
15	coordinated	coordinate	VBN	_	14	CONJ
16	increases	increase	NNS	_	12	OBJ
17	in	in	IN	_	16	NMOD
18	oxidation	oxidation	NN	_	19	NMOD
19	enzymes	enzyme	NNS	_	36	NMOD
20	,	,	,	_	19	P
21	mitochondrial	mitochondrial	JJ	_	22	NMOD
22	biogenesis	biogenesis	NN	_	19	CONJ
23	,	,	,	_	22	P
24	and	and	CC	_	22	COORD
25	production	production	NN	_	24	CONJ
26	of	of	IN	_	25	NMOD
27	specialized	specialize	VBN	_	32	NMOD
28	type	type	NN	_	30	NMOD
29	I	i	CD	_	28	NMOD
30	fiber	fiber	NN	_	32	NMOD
31	contractile	contractile	JJ	_	32	NMOD
32	proteins	protein	NN	_	26	PMOD
33	—	—	:	_	36	P
34	the	the	DT	_	36	NMOD
35	three	three	CD	_	36	NMOD
36	hallmarks	hallmark	NNS	_	17	PMOD
37	for	for	IN	_	36	NMOD
38	muscle	muscle	NN	_	39	NMOD
39	fiber	fiber	NN	_	41	NMOD
40	type	type	NN	_	41	NMOD
41	switching	switching	NN	_	37	PMOD
42	(	(	-LRB-	_	43	P
43	Figure	figure	NN	_	12	PRN
44	6C	0c	CD	_	43	NMOD
45	)	)	-RRB-	_	43	P
46	.	.	.	_	2	P

1	While	while	IN	_	53	ADV
2	induction	induction	NN	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	muscle	muscle	NN	_	6	NMOD
5	oxidation	oxidation	NN	_	6	NMOD
6	enzymes	enzyme	NNS	_	3	PMOD
7	by	by	IN	_	2	NMOD
8	PPARδ	pparδ	NN	_	7	PMOD
9	has	have	VBZ	_	1	SUB
10	been	be	VBN	_	9	VC
11	seen	see	VBN	_	10	VC
12	both	both	CC	_	14	COORD
13	in	in	FW	_	14	AMOD
14	vivo	vivo	FW	_	11	MNR
15	and	and	CC	_	14	COORD
16	in	in	FW	_	17	AMOD
17	vitro	vitro	FW	_	15	CONJ
18	(	(	-LRB-	_	19	P
19	Muoio	muoio	NNP	_	11	CIT
20	et	et	FW	_	19	DEP
21	al.	al.	FW	_	19	DEP
22	2002	0	CD	_	19	DEP
23	;	;	:	_	19	P
24	Dressel	dressel	NNP	_	19	DEP
25	et	et	FW	_	19	DEP
26	al.	al.	FW	_	19	DEP
27	2003	0	CD	_	19	DEP
28	;	;	:	_	19	P
29	Luquet	luquet	NNP	_	19	DEP
30	et	et	FW	_	19	DEP
31	al.	al.	FW	_	19	DEP
32	2003	0	CD	_	19	DEP
33	;	;	:	_	19	P
34	Tanaka	tanaka	NNP	_	19	DEP
35	et	et	FW	_	19	DEP
36	al.	al.	FW	_	19	DEP
37	2003	0	CD	_	19	DEP
38	;	;	:	_	19	P
39	Wang	wang	NNP	_	19	DEP
40	et	et	FW	_	19	DEP
41	al.	al.	FW	_	19	DEP
42	2003	0	CD	_	19	DEP
43	)	)	-RRB-	_	19	P
44	,	,	,	_	53	P
45	its	its	PRP$	_	46	NMOD
46	effects	effect	NNS	_	53	SBJ
47	shown	show	VBN	_	46	NMOD
48	here	here	RB	_	47	ADV
49	on	on	IN	_	47	ADV
50	muscle	muscle	NN	_	51	NMOD
51	fiber	fiber	NN	_	52	NMOD
52	switching	switching	NN	_	49	PMOD
53	are	be	VBP	_	0	ROOT
54	unexpected	unexpected	JJ	_	53	PRD
55	.	.	.	_	53	P

1	These	these	DT	_	3	NMOD
2	progressive	progressive	JJ	_	3	NMOD
3	changes	change	NNS	_	17	SBJ
4	in	in	IN	_	3	NMOD
5	oxidative	oxidative	JJ	_	6	NMOD
6	capacity	capacity	NN	_	4	PMOD
7	in	in	IN	_	3	NMOD
8	conjunction	conjunction	NN	_	7	PMOD
9	with	with	IN	_	8	NMOD
10	eventual	eventual	JJ	_	11	NMOD
11	changes	change	NNS	_	9	PMOD
12	in	in	IN	_	11	LOC
13	type	type	NN	_	16	NMOD
14	I	i	CD	_	13	NMOD
15	muscle	muscle	NN	_	16	NMOD
16	fiber	fiber	NN	_	12	PMOD
17	lead	lead	VBP	_	0	ROOT
18	to	to	IN	_	17	ADV
19	a	a	DT	_	23	NMOD
20	dramatically	dramatically	RB	_	21	AMOD
21	improved	improve	VBN	_	23	NMOD
22	exercise	exercise	NN	_	23	NMOD
23	profile	profile	NN	_	18	PMOD
24	and	and	CC	_	23	COORD
25	protection	protection	NN	_	24	CONJ
26	against	against	IN	_	25	NMOD
27	obesity	obesity	NN	_	26	PMOD
28	.	.	.	_	17	P

1	This	this	DT	_	2	SBJ
2	does	do	VBZ	_	0	ROOT
3	not	not	RB	_	2	ADV
4	solely	solely	RB	_	2	ADV
5	depend	depend	VB	_	2	VC
6	on	on	IN	_	5	ADV
7	achieving	achieve	VBG	_	6	PMOD
8	a	a	DT	_	13	NMOD
9	directed	direct	VBN	_	13	NMOD
10	muscle	muscle	NN	_	11	NMOD
11	fiber	fiber	NN	_	13	NMOD
12	type	type	NN	_	13	NMOD
13	switch	switch	NN	_	7	OBJ
14	but	but	CC	_	2	COORD
15	also	also	RB	_	16	ADV
16	requires	require	VBZ	_	14	CONJ
17	all	all	PDT	_	20	NMOD
18	the	the	DT	_	20	NMOD
19	associated	associate	VBN	_	20	NMOD
20	changes	change	NNS	_	16	OBJ
21	in	in	IN	_	20	NMOD
22	neural	neural	JJ	_	23	NMOD
23	innervation	innervation	NN	_	21	PMOD
24	,	,	,	_	23	P
25	motor	motor	NN	_	26	NMOD
26	neuron	neuron	NN	_	27	NMOD
27	function	function	NN	_	23	CONJ
28	,	,	,	_	27	P
29	and	and	CC	_	27	COORD
30	peripheral	peripheral	JJ	_	32	NMOD
31	metabolic	metabolic	JJ	_	32	NMOD
32	adaptation	adaptation	NN	_	29	CONJ
33	to	to	TO	_	16	PRP
34	enable	enable	VB	_	33	IM
35	a	a	DT	_	39	NMOD
36	new	new	JJ	_	39	NMOD
37	integrated	integrate	VBN	_	39	NMOD
38	physiological	physiological	JJ	_	39	NMOD
39	response	response	NN	_	34	OBJ
40	.	.	.	_	2	P

1	Accordingly	accordingly	RB	_	8	ADV
2	,	,	,	_	8	P
3	activation	activation	NN	_	8	SBJ
4	of	of	IN	_	3	NMOD
5	muscle	muscle	NN	_	6	NMOD
6	PPARδ	pparδ	NN	_	4	PMOD
7	essentially	essentially	RB	_	8	ADV
8	recapitulates	recapitulate	VBZ	_	0	ROOT
9	the	the	DT	_	10	NMOD
10	effects	effect	NNS	_	8	OBJ
11	of	of	IN	_	10	NMOD
12	exercise	exercise	NN	_	13	NMOD
13	training	training	NN	_	11	PMOD
14	even	even	RB	_	15	PMOD
15	in	in	IN	_	8	ADV
16	the	the	DT	_	17	NMOD
17	absence	absence	NN	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	training	train	VBG	_	20	NMOD
20	itself	itself	PRP	_	18	PMOD
21	.	.	.	_	8	P

1	To	to	IN	_	6	ADV
2	our	our	PRP$	_	3	NMOD
3	knowledge	knowledge	NN	_	1	PMOD
4	,	,	,	_	6	P
5	this	this	DT	_	6	SBJ
6	has	have	VBZ	_	0	ROOT
7	not	not	RB	_	6	ADV
8	been	be	VBN	_	6	VC
9	directly	directly	RB	_	8	MNR
10	described	describe	VBN	_	8	VC
11	for	for	IN	_	10	ADV
12	any	any	DT	_	15	NMOD
13	other	other	JJ	_	15	NMOD
14	transcriptional	transcriptional	JJ	_	15	NMOD
15	factor	factor	NN	_	11	PMOD
16	.	.	.	_	6	P

1	The	the	DT	_	3	NMOD
2	muscle	muscle	NN	_	3	NMOD
3	phenotypes	phenotype	NNS	_	6	SBJ
4	described	describe	VBN	_	3	NMOD
5	here	here	RB	_	4	ADV
6	are	be	VBP	_	0	ROOT
7	remarkably	remarkably	RB	_	8	AMOD
8	similar	similar	JJ	_	6	PRD
9	to	to	IN	_	8	AMOD
10	those	those	DT	_	9	PMOD
11	of	of	IN	_	10	NMOD
12	transgenic	transgenic	JJ	_	13	NMOD
13	mice	mouse	NNS	_	11	PMOD
14	expressing	express	VBG	_	13	NMOD
15	either	either	CC	_	16	COORD
16	calcineurin	calcineurin	NN	_	14	OBJ
17	,	,	,	_	16	P
18	calmodulin	calmodulin	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	dependent	dependent	JJ	_	21	NMOD
21	kinase	kinase	NN	_	16	CONJ
22	,	,	,	_	21	P
23	or	or	CC	_	21	COORD
24	PGC	pgc	NN	_	23	CONJ
25	-	-	HYPH	_	24	P
26	1α	0α	CD	_	24	NMOD
27	(	(	-LRB-	_	28	P
28	Naya	naya	NNP	_	6	CIT
29	et	et	FW	_	28	DEP
30	al.	al.	FW	_	28	DEP
31	2000	0	CD	_	28	DEP
32	;	;	:	_	28	P
33	Lin	lin	NNP	_	28	DEP
34	et	et	FW	_	28	DEP
35	al.	al.	FW	_	28	DEP
36	2002	0	CD	_	28	DEP
37	;	;	:	_	28	P
38	Wu	wu	NNP	_	28	DEP
39	et	et	FW	_	28	DEP
40	al.	al.	FW	_	28	DEP
41	2002	0	CD	_	28	DEP
42	)	)	-RRB-	_	28	P
43	,	,	,	_	6	P
44	indicating	indicate	VBG	_	6	ADV
45	that	that	IN	_	44	OBJ
46	PPARδ	pparδ	NN	_	47	SBJ
47	could	could	MD	_	45	SUB
48	be	be	VB	_	47	VC
49	one	one	CD	_	48	PRD
50	of	of	IN	_	49	NMOD
51	the	the	DT	_	55	NMOD
52	hypothetical	hypothetical	JJ	_	55	NMOD
53	downstream	downstream	JJ	_	55	NMOD
54	transcription	transcription	NN	_	55	NMOD
55	factors	factor	NNS	_	50	PMOD
56	of	of	IN	_	55	NMOD
57	these	these	DT	_	58	NMOD
58	pathways	pathway	NNS	_	56	PMOD
59	.	.	.	_	6	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	important	important	JJ	_	2	PRD
4	to	to	TO	_	2	OPRD
5	note	note	VB	_	4	IM
6	that	that	IN	_	5	OBJ
7	,	,	,	_	6	P
8	from	from	IN	_	21	ADV
9	our	our	PRP$	_	18	NMOD
10	ligand	ligand	NN	_	18	NMOD
11	and	and	CC	_	10	COORD
12	gain	gain	NN	_	11	CONJ
13	-	-	HYPH	_	12	P
14	of	of	IN	_	12	NMOD
15	-	-	HYPH	_	14	P
16	function	function	NN	_	14	PMOD
17	transgenic	transgenic	JJ	_	18	NMOD
18	studies	study	NNS	_	8	PMOD
19	,	,	,	_	21	P
20	PPARδ	pparδ	NN	_	21	SBJ
21	needs	need	VBZ	_	6	SUB
22	to	to	TO	_	21	OPRD
23	be	be	VB	_	22	IM
24	activated	activate	VBN	_	23	VC
25	in	in	IN	_	24	PRP
26	order	order	NN	_	25	PMOD
27	to	to	TO	_	26	NMOD
28	direct	direct	VB	_	27	IM
29	the	the	DT	_	32	NMOD
30	muscle	muscle	NN	_	31	NMOD
31	fiber	fiber	NN	_	32	NMOD
32	switch	switch	NN	_	28	OBJ
33	.	.	.	_	2	P

1	Indeed	indeed	RB	_	24	ADV
2	,	,	,	_	24	P
3	in	in	IN	_	24	ADV
4	a	a	DT	_	6	NMOD
5	recent	recent	JJ	_	6	NMOD
6	report	report	NN	_	3	PMOD
7	by	by	IN	_	6	NMOD
8	Luquet	luquet	NNP	_	7	PMOD
9	et	et	FW	_	10	AMOD
10	al.	al.	FW	_	8	NMOD
11	(	(	-LRB-	_	8	P
12	2003	0	CD	_	8	TMP
13	)	)	-RRB-	_	8	P
14	,	,	,	_	24	P
15	simple	simple	JJ	_	16	NMOD
16	overexpression	overexpression	NN	_	24	SBJ
17	of	of	IN	_	16	NMOD
18	wild	wild	JJ	_	20	NMOD
19	-	-	HYPH	_	18	P
20	type	type	NN	_	21	NMOD
21	PPARδ	pparδ	NN	_	17	PMOD
22	in	in	IN	_	16	LOC
23	muscle	muscle	NN	_	22	PMOD
24	was	be	VBD	_	0	ROOT
25	found	find	VBN	_	24	VC
26	not	not	RB	_	27	ADV
27	to	to	TO	_	25	OPRD
28	be	be	VB	_	27	IM
29	sufficient	sufficient	JJ	_	28	PRD
30	to	to	TO	_	29	AMOD
31	promote	promote	VB	_	30	IM
32	a	a	DT	_	34	NMOD
33	fiber	fiber	NN	_	34	NMOD
34	switch	switch	NN	_	31	OBJ
35	or	or	CC	_	34	COORD
36	obesity	obesity	NN	_	37	NMOD
37	resistance	resistance	NN	_	35	CONJ
38	,	,	,	_	28	P
39	although	although	IN	_	28	ADV
40	certain	certain	JJ	_	42	NMOD
41	oxidation	oxidation	NN	_	42	NMOD
42	enzymes	enzyme	NNS	_	43	SBJ
43	were	be	VBD	_	39	SUB
44	increased	increase	VBN	_	43	VC
45	.	.	.	_	24	P

1	This	this	DT	_	2	SBJ
2	supports	support	VBZ	_	0	ROOT
3	the	the	DT	_	4	NMOD
4	model	model	NN	_	2	OBJ
5	in	in	IN	_	4	LOC
6	Figure	figure	NN	_	5	PMOD
7	6C	0c	CD	_	6	NMOD
8	that	that	IN	_	4	NMOD
9	the	the	DT	_	11	NMOD
10	activating	activate	VBG	_	11	NMOD
11	signal	signal	NN	_	20	SBJ
12	or	or	CC	_	11	COORD
13	ligand	ligand	NN	_	12	CONJ
14	,	,	,	_	11	P
15	but	but	CC	_	11	COORD
16	not	not	RB	_	15	ADV
17	the	the	DT	_	18	NMOD
18	receptor	receptor	NN	_	15	CONJ
19	,	,	,	_	20	P
20	is	be	VBZ	_	8	SUB
21	limiting	limit	VBG	_	20	PRD
22	.	.	.	_	2	P

1	Thus	thus	RB	_	15	ADV
2	,	,	,	_	15	P
3	PPARδ	pparδ	NN	_	4	NMOD
4	activation	activation	NN	_	15	SBJ
5	,	,	,	_	4	P
6	rather	rather	RB	_	7	ADV
7	than	than	IN	_	4	COORD
8	merely	merely	RB	_	10	NMOD
9	an	an	DT	_	10	NMOD
10	increase	increase	NN	_	7	CONJ
11	of	of	IN	_	10	NMOD
12	PPARδ	pparδ	NN	_	13	NMOD
13	levels	level	NNS	_	11	PMOD
14	,	,	,	_	15	P
15	is	be	VBZ	_	0	ROOT
16	an	an	DT	_	18	NMOD
17	essential	essential	JJ	_	18	NMOD
18	element	element	NN	_	15	PRD
19	for	for	IN	_	18	NMOD
20	fiber	fiber	NN	_	21	NMOD
21	switching	switching	NN	_	19	PMOD
22	and	and	CC	_	21	COORD
23	its	its	PRP$	_	26	NMOD
24	associated	associate	VBN	_	26	NMOD
25	functional	functional	JJ	_	26	NMOD
26	manifestations	manifestation	NNS	_	22	CONJ
27	.	.	.	_	15	P

1	How	how	WRB	_	5	MNR
2	might	might	MD	_	0	ROOT
3	endogenous	endogenous	JJ	_	4	NMOD
4	PPARδ	pparδ	NN	_	2	SBJ
5	become	become	VB	_	2	VC
6	activated	activate	VBN	_	5	PRD
7	naturally	naturally	RB	_	5	MNR
8	by	by	IN	_	5	MNR
9	exercise	exercise	NN	_	10	NMOD
10	training	training	NN	_	8	PMOD
11	?	?	.	_	2	P

1	First	$#ORD#$	RB	_	4	ADV
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	possible	possible	JJ	_	4	PRD
6	that	that	IN	_	4	OBJ
7	exercise	exercise	NN	_	8	SBJ
8	generates	generate	VBZ	_	6	SUB
9	or	or	CC	_	8	COORD
10	increases	increase	VBZ	_	9	CONJ
11	endogenous	endogenous	JJ	_	12	NMOD
12	ligands	ligand	NNS	_	8	OBJ
13	for	for	IN	_	8	ADV
14	PPARδ	pparδ	NN	_	13	PMOD
15	as	as	IN	_	8	TMP
16	tissues	tissue	NNS	_	17	SBJ
17	are	be	VBP	_	15	SUB
18	undergoing	undergo	VBG	_	17	VC
19	substantial	substantial	JJ	_	20	NMOD
20	increases	increase	NNS	_	18	OBJ
21	in	in	IN	_	20	NMOD
22	fatty	fatty	JJ	_	24	NMOD
23	-	-	HYPH	_	22	P
24	acid	acid	NN	_	25	NMOD
25	internalization	internalization	NN	_	21	PMOD
26	and	and	CC	_	25	COORD
27	burning	burning	NN	_	26	CONJ
28	.	.	.	_	4	P

1	Fatty	fatty	JJ	_	2	NMOD
2	acids	acid	NNS	_	6	SBJ
3	and	and	CC	_	2	COORD
4	their	their	PRP$	_	5	NMOD
5	metabolites	metabolite	NNS	_	3	CONJ
6	can	can	MD	_	0	ROOT
7	activate	activate	VB	_	6	VC
8	PPARδ	pparδ	NN	_	7	OBJ
9	.	.	.	_	6	P

1	A	a	DT	_	3	NMOD
2	second	$#ORD#$	JJ	_	3	NMOD
3	model	model	NN	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	that	that	IN	_	4	PRD
6	exercise	exercise	NN	_	7	SBJ
7	may	may	MD	_	5	SUB
8	induce	induce	VB	_	7	VC
9	expression	expression	NN	_	8	OBJ
10	of	of	IN	_	9	NMOD
11	PGC	pgc	NN	_	10	PMOD
12	-	-	HYPH	_	11	P
13	1α	0α	CD	_	11	NMOD
14	(	(	-LRB-	_	15	P
15	Goto	goto	NNP	_	8	CIT
16	et	et	FW	_	15	DEP
17	al.	al.	FW	_	15	DEP
18	2000	0	CD	_	15	DEP
19	)	)	-RRB-	_	15	P
20	and	and	CC	_	8	COORD
21	thereby	thereby	RB	_	22	ADV
22	activate	activate	VBP	_	20	CONJ
23	PPARδ	pparδ	NN	_	22	OBJ
24	.	.	.	_	4	P

1	This	this	DT	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	consistent	consistent	JJ	_	2	PRD
4	with	with	IN	_	3	AMOD
5	previous	previous	JJ	_	6	NMOD
6	work	work	NN	_	4	PMOD
7	in	in	IN	_	11	ADV
8	which	which	WDT	_	7	PMOD
9	we	we	PRP	_	10	SBJ
10	have	have	VBP	_	6	NMOD
11	shown	show	VBN	_	10	VC
12	that	that	IN	_	11	OBJ
13	PGC	pgc	NN	_	17	SBJ
14	-	-	HYPH	_	13	P
15	1α	0α	CD	_	13	NMOD
16	physically	physically	RB	_	17	ADV
17	associates	associate	VBZ	_	12	SUB
18	with	with	IN	_	17	ADV
19	PPARδ	pparδ	NN	_	18	PMOD
20	in	in	IN	_	17	LOC
21	muscle	muscle	NN	_	22	NMOD
22	tissue	tissue	NN	_	20	PMOD
23	and	and	CC	_	17	COORD
24	can	can	MD	_	23	CONJ
25	powerfully	powerfully	RB	_	24	ADV
26	activate	activate	VB	_	24	VC
27	it	it	PRP	_	26	OBJ
28	even	even	RB	_	29	PMOD
29	in	in	IN	_	26	ADV
30	the	the	DT	_	31	NMOD
31	absence	absence	NN	_	29	PMOD
32	of	of	IN	_	31	NMOD
33	ligands	ligand	NNS	_	32	PMOD
34	(	(	-LRB-	_	35	P
35	Wang	wang	NNP	_	11	CIT
36	et	et	FW	_	35	DEP
37	al.	al.	FW	_	35	DEP
38	2003	0	CD	_	35	DEP
39	)	)	-RRB-	_	35	P
40	.	.	.	_	2	P

1	Alternatively	alternatively	RB	_	4	ADV
2	,	,	,	_	4	P
3	PPARδ	pparδ	NN	_	4	SBJ
4	may	may	MD	_	0	ROOT
5	be	be	VB	_	4	VC
6	activated	activate	VBN	_	5	VC
7	by	by	IN	_	6	LGS
8	a	a	DT	_	12	NMOD
9	distal	distal	JJ	_	12	NMOD
10	upstream	upstream	JJ	_	12	NMOD
11	signaling	signaling	NN	_	12	NMOD
12	component	component	NN	_	7	PMOD
13	such	such	JJ	_	14	PMOD
14	as	as	IN	_	12	NMOD
15	a	a	DT	_	17	NMOD
16	kinase	kinase	NN	_	17	NMOD
17	cascade	cascade	NN	_	14	PMOD
18	.	.	.	_	4	P

1	Further	far	RB	_	2	ADV
2	dissecting	dissect	VBG	_	11	SBJ
3	the	the	DT	_	4	NMOD
4	interactions	interaction	NNS	_	2	OBJ
5	between	between	IN	_	4	NMOD
6	PPARδ	pparδ	NN	_	5	PMOD
7	and	and	CC	_	6	COORD
8	its	its	PRP$	_	10	NMOD
9	regulatory	regulatory	JJ	_	10	NMOD
10	components	component	NNS	_	7	CONJ
11	will	will	MD	_	0	ROOT
12	be	be	VB	_	11	VC
13	necessary	necessary	JJ	_	12	PRD
14	to	to	TO	_	12	PRP
15	fully	fully	RB	_	14	ADV
16	understand	understand	VB	_	14	IM
17	the	the	DT	_	19	NMOD
18	molecular	molecular	JJ	_	19	NMOD
19	basis	base	NN	_	16	OBJ
20	of	of	IN	_	19	NMOD
21	muscle	muscle	NN	_	22	NMOD
22	fiber	fiber	NN	_	23	NMOD
23	determination	determination	NN	_	20	PMOD
24	pertinent	pertinent	JJ	_	19	NMOD
25	to	to	IN	_	24	AMOD
26	exercise	exercise	NN	_	27	NMOD
27	training	training	NN	_	25	PMOD
28	.	.	.	_	11	P

1	Skeletal	skeletal	JJ	_	2	NMOD
2	muscle	muscle	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	a	a	DT	_	6	NMOD
5	major	major	JJ	_	6	NMOD
6	site	site	NN	_	3	PRD
7	to	to	TO	_	6	NMOD
8	regulate	regulate	VB	_	7	IM
9	whole	whole	JJ	_	11	NMOD
10	-	-	HYPH	_	9	P
11	body	body	NN	_	17	NMOD
12	fatty	fatty	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	acid	acid	NN	_	17	NMOD
15	and	and	CC	_	14	COORD
16	glucose	glucose	NN	_	15	CONJ
17	metabolism	metabolism	NN	_	8	OBJ
18	.	.	.	_	3	P

1	We	we	PRP	_	2	SBJ
2	show	show	VBP	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	mice	mouse	NNS	_	9	SBJ
5	with	with	IN	_	4	NMOD
6	increased	increase	VBN	_	8	NMOD
7	oxidative	oxidative	JJ	_	8	NMOD
8	fibers	fiber	NNS	_	5	PMOD
9	are	be	VBP	_	3	SUB
10	resistant	resistant	JJ	_	9	PRD
11	to	to	IN	_	10	AMOD
12	high	high	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	fat	fat	NN	_	16	AMOD
15	-	-	HYPH	_	14	P
16	induced	induce	VBN	_	17	NMOD
17	obesity	obesity	NN	_	11	PMOD
18	and	and	CC	_	17	COORD
19	glucose	glucose	NN	_	20	NMOD
20	intolerance	intolerance	NN	_	18	CONJ
21	.	.	.	_	2	P

1	Moreover	moreover	RB	_	5	ADV
2	,	,	,	_	5	P
3	ligand	ligand	NN	_	4	NMOD
4	studies	study	NNS	_	5	SBJ
5	provide	provide	VBP	_	0	ROOT
6	compelling	compelling	JJ	_	7	NMOD
7	evidence	evidence	NN	_	5	OBJ
8	that	that	IN	_	7	NMOD
9	activation	activation	NN	_	13	SBJ
10	of	of	IN	_	9	NMOD
11	endogenous	endogenous	JJ	_	12	NMOD
12	PPARδ	pparδ	NN	_	10	PMOD
13	can	can	MD	_	8	SUB
14	produce	produce	VB	_	13	VC
15	similar	similar	JJ	_	16	NMOD
16	effects	effect	NNS	_	14	OBJ
17	.	.	.	_	5	P

1	Might	might	MD	_	0	ROOT
2	PPARδ	pparδ	NN	_	1	SBJ
3	have	have	VB	_	1	VC
4	any	any	DT	_	6	NMOD
5	beneficial	beneficial	JJ	_	6	NMOD
6	effects	effect	NNS	_	3	OBJ
7	on	on	IN	_	6	NMOD
8	glucose	glucose	NN	_	9	NMOD
9	metabolism	metabolism	NN	_	7	PMOD
10	in	in	IN	_	3	LOC
11	the	the	DT	_	13	NMOD
12	lean	lean	JJ	_	13	NMOD
13	condition	condition	NN	_	10	PMOD
14	?	?	.	_	1	P

1	This	this	DT	_	2	SBJ
2	has	have	VBZ	_	14	DEP
3	not	not	RB	_	2	ADV
4	been	be	VBN	_	2	VC
5	explored	explore	VBN	_	4	VC
6	;	;	:	_	14	P
7	however	however	RB	_	14	ADV
8	,	,	,	_	14	P
9	insulin	insulin	NN	_	10	NMOD
10	resistance	resistance	NN	_	14	SBJ
11	in	in	IN	_	10	LOC
12	the	the	DT	_	13	NMOD
13	elderly	elderly	JJ	_	11	PMOD
14	is	be	VBZ	_	0	ROOT
15	confined	confine	VBN	_	14	VC
16	mostly	mostly	RB	_	17	PMOD
17	to	to	IN	_	15	ADV
18	skeletal	skeletal	JJ	_	19	NMOD
19	muscle	muscle	NN	_	17	PMOD
20	and	and	CC	_	15	COORD
21	may	may	MD	_	20	CONJ
22	be	be	VB	_	21	VC
23	due	due	IN	_	22	PRP
24	to	to	IN	_	23	PMOD
25	reduction	reduction	NN	_	23	PMOD
26	of	of	IN	_	25	NMOD
27	mitochondrial	mitochondrial	JJ	_	28	NMOD
28	number	number	NN	_	26	PMOD
29	and	and	CC	_	28	COORD
30	/	/	HYPH	_	29	P
31	or	or	CC	_	29	COORD
32	function	function	NN	_	29	CONJ
33	(	(	-LRB-	_	34	P
34	Petersen	petersen	NNP	_	15	CIT
35	et	et	FW	_	34	DEP
36	al.	al.	FW	_	34	DEP
37	2003	0	CD	_	34	DEP
38	)	)	-RRB-	_	34	P
39	.	.	.	_	14	P

1	The	the	DT	_	2	NMOD
2	ability	ability	NN	_	12	SBJ
3	of	of	IN	_	2	NMOD
4	PPARδ	pparδ	NN	_	3	PMOD
5	to	to	TO	_	2	NMOD
6	stimulate	stimulate	VB	_	5	IM
7	mitochondrial	mitochondrial	JJ	_	8	NMOD
8	biogenesis	biogenesis	NN	_	6	OBJ
9	and	and	CC	_	8	COORD
10	oxidative	oxidative	JJ	_	11	NMOD
11	function	function	NN	_	9	CONJ
12	suggests	suggest	VBZ	_	0	ROOT
13	that	that	IN	_	12	OBJ
14	PPARδ	pparδ	NN	_	15	SBJ
15	could	could	MD	_	13	SUB
16	be	be	VB	_	15	VC
17	important	important	JJ	_	16	PRD
18	for	for	IN	_	16	ADV
19	control	control	NN	_	18	PMOD
20	of	of	IN	_	19	NMOD
21	insulin	insulin	NN	_	22	NMOD
22	resistance	resistance	NN	_	20	PMOD
23	during	during	IN	_	16	TMP
24	normal	normal	JJ	_	25	NMOD
25	aging	aging	NN	_	23	PMOD
26	.	.	.	_	12	P

1	Together	together	RB	_	5	ADV
2	,	,	,	_	5	P
3	these	these	DT	_	4	NMOD
4	data	datum	NNS	_	5	SBJ
5	indicate	indicate	VBP	_	0	ROOT
6	that	that	IN	_	5	OBJ
7	PPARδ	pparδ	NN	_	11	SBJ
8	and	and	CC	_	7	COORD
9	its	its	PRP$	_	10	NMOD
10	ligands	ligand	NNS	_	8	CONJ
11	comprise	comprise	VBP	_	6	SUB
12	a	a	DT	_	15	NMOD
13	key	key	JJ	_	15	NMOD
14	molecular	molecular	JJ	_	15	NMOD
15	switch	switch	NN	_	11	OBJ
16	to	to	TO	_	15	NMOD
17	regulate	regulate	VB	_	16	IM
18	muscle	muscle	NN	_	19	NMOD
19	fiber	fiber	NN	_	20	NMOD
20	specification	specification	NN	_	17	OBJ
21	,	,	,	_	20	P
22	obesity	obesity	NN	_	23	NMOD
23	resistance	resistance	NN	_	20	CONJ
24	,	,	,	_	23	P
25	insulin	insulin	NN	_	26	NMOD
26	sensitivity	sensitivity	NN	_	23	CONJ
27	,	,	,	_	26	P
28	and	and	CC	_	26	COORD
29	,	,	,	_	28	P
30	most	most	RBS	_	31	AMOD
31	surprisingly	surprisingly	RB	_	34	NMOD
32	,	,	,	_	34	P
33	physical	physical	JJ	_	34	NMOD
34	endurance	endurance	NN	_	28	CONJ
35	.	.	.	_	5	P

1	This	this	DT	_	2	NMOD
2	work	work	NN	_	3	SBJ
3	demonstrates	demonstrate	VBZ	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	complex	complex	JJ	_	7	NMOD
6	physiologic	physiologic	JJ	_	7	NMOD
7	properties	property	NNS	_	17	SBJ
8	such	such	JJ	_	9	PMOD
9	as	as	IN	_	7	NMOD
10	fatigue	fatigue	NN	_	9	PMOD
11	,	,	,	_	10	P
12	endurance	endurance	NN	_	10	CONJ
13	,	,	,	_	12	P
14	and	and	CC	_	12	COORD
15	running	running	NN	_	16	NMOD
16	capacity	capacity	NN	_	14	CONJ
17	can	can	MD	_	4	SUB
18	be	be	VB	_	17	VC
19	genetically	genetically	RB	_	18	MNR
20	manipulated	manipulate	VBN	_	18	VC
21	.	.	.	_	3	P

1	Materials	material	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Methods	method	NNS	_	2	CONJ

1	Animals	animal	NNS	_	0	ROOT
2	.	.	.	_	1	P

1	The	the	DT	_	3	NMOD
2	transactivation	transactivation	NN	_	3	NMOD
3	domain	domain	NN	_	19	SBJ
4	(	(	-LRB-	_	8	P
5	78	0	CD	_	8	NMOD
6	amino	amino	NN	_	7	NMOD
7	acid	acid	NN	_	8	NMOD
8	residues	residue	NNS	_	3	PRN
9	,	,	,	_	8	P
10	corresponding	correspond	VBG	_	8	NMOD
11	to	to	IN	_	10	ADV
12	residues	residue	NNS	_	13	NMOD
13	413	0	CD	_	11	PMOD
14	–	–	SYM	_	15	P
15	490	0	CD	_	13	NMOD
16	)	)	-RRB-	_	8	P
17	of	of	IN	_	3	NMOD
18	VP16	vp0	NN	_	17	PMOD
19	was	be	VBD	_	0	ROOT
20	fused	fuse	VBN	_	19	VC
21	in	in	IN	_	20	ADV
22	frame	frame	NN	_	21	PMOD
23	with	with	IN	_	20	ADV
24	the	the	DT	_	27	NMOD
25	N	n	NN	_	27	NMOD
26	-	-	HYPH	_	25	P
27	terminus	terminus	NN	_	23	PMOD
28	of	of	IN	_	27	NMOD
29	mouse	mouse	NN	_	30	NMOD
30	PPARδ	pparδ	NN	_	28	PMOD
31	.	.	.	_	19	P

1	The	the	DT	_	6	NMOD
2	VP16	vp0	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	PPARδ	pparδ	NN	_	6	NMOD
5	fusion	fusion	NN	_	6	NMOD
6	cDNA	cdna	NN	_	7	SBJ
7	was	be	VBD	_	0	ROOT
8	placed	place	VBN	_	7	VC
9	downstream	downstream	RB	_	8	LOC
10	of	of	IN	_	9	AMOD
11	the	the	DT	_	17	NMOD
12	human	human	JJ	_	17	NMOD
13	α	α	NN	_	15	AMOD
14	-	-	HYPH	_	13	P
15	skeletal	skeletal	JJ	_	17	NMOD
16	actin	actin	NN	_	17	NMOD
17	promoter	promoter	NN	_	10	PMOD
18	(	(	-LRB-	_	19	P
19	Brennan	brennan	NNP	_	17	NMOD
20	and	and	CC	_	19	COORD
21	Hardeman	hardeman	NNP	_	20	CONJ
22	1993	0	CD	_	19	DEP
23	)	)	-RRB-	_	19	P
24	,	,	,	_	9	P
25	and	and	CC	_	9	COORD
26	upstream	upstream	RB	_	25	CONJ
27	of	of	IN	_	26	AMOD
28	the	the	DT	_	36	NMOD
29	SV40	sv0	NN	_	30	NMOD
30	intron	intron	NN	_	34	NMOD
31	/	/	HYPH	_	30	P
32	poly	poly	NN	_	34	NMOD
33	(	(	-LRB-	_	34	P
34	A	a	NN	_	36	NMOD
35	)	)	-RRB-	_	34	P
36	sequence	sequence	NN	_	27	PMOD
37	.	.	.	_	7	P

1	The	the	DT	_	2	NMOD
2	transgene	transgene	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	purified	purify	VBN	_	3	VC
5	and	and	CC	_	4	COORD
6	injected	inject	VBN	_	5	CONJ
7	into	into	IN	_	4	ADV
8	C57BL	c0bl	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	6J	0j	NN	_	12	NMOD
11	×	×	SYM	_	12	P
12	CBA	cba	NN	_	14	NMOD
13	F1	f0	NN	_	14	NMOD
14	zygotes	zygote	NNS	_	7	PMOD
15	.	.	.	_	3	P

1	Transgenic	transgenic	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	backcrossed	backcross	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	C57BL	c0bl	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	6J	0j	NN	_	5	PMOD
9	for	for	IN	_	4	TMP
10	two	two	CD	_	11	NMOD
11	generations	generation	NNS	_	9	PMOD
12	.	.	.	_	3	P

1	Wild	wild	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	type	type	NN	_	4	NMOD
4	littermates	littermates	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	used	use	VBN	_	5	VC
7	as	as	IN	_	6	MNR
8	controls	control	NNS	_	7	PMOD
9	throughout	throughout	IN	_	6	TMP
10	the	the	DT	_	11	NMOD
11	study	study	NN	_	9	PMOD
12	.	.	.	_	5	P

1	On	on	IN	_	14	ADV
2	normal	normal	JJ	_	4	NMOD
3	chow	chow	NN	_	4	NMOD
4	diet	diet	NN	_	1	PMOD
5	,	,	,	_	14	P
6	the	the	DT	_	8	NMOD
7	transgenic	transgenic	JJ	_	8	NMOD
8	mice	mouse	NNS	_	14	SBJ
9	and	and	CC	_	8	COORD
10	control	control	NN	_	11	NMOD
11	littermates	littermates	NNS	_	9	CONJ
12	used	use	VBN	_	8	NMOD
13	here	here	RB	_	12	ADV
14	had	have	VBD	_	0	ROOT
15	similar	similar	JJ	_	17	NMOD
16	body	body	NN	_	17	NMOD
17	weights	weight	NNS	_	14	OBJ
18	.	.	.	_	14	P

1	PPARδ	pparδ	NN	_	3	AMOD
2	-	-	HYPH	_	1	P
3	null	null	JJ	_	4	NMOD
4	mice	mouse	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	previously	previously	RB	_	5	TMP
7	generated	generate	VBN	_	5	VC
8	(	(	-LRB-	_	9	P
9	Barak	barak	NNP	_	7	CIT
10	et	et	FW	_	9	DEP
11	al.	al.	FW	_	9	DEP
12	2002	0	CD	_	9	DEP
13	)	)	-RRB-	_	9	P
14	.	.	.	_	5	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	fed	feed	VBN	_	2	VC
4	either	either	CC	_	7	COORD
5	a	a	DT	_	7	NMOD
6	standard	standard	JJ	_	7	NMOD
7	chow	chow	NN	_	3	OBJ
8	with	with	IN	_	7	NMOD
9	4	0	CD	_	10	NMOD
10	%	%	NN	_	17	NMOD
11	(	(	-LRB-	_	12	P
12	w	w	NN	_	17	PRN
13	/	/	SYM	_	14	P
14	w	w	NN	_	12	NMOD
15	)	)	-RRB-	_	12	P
16	fat	fat	NN	_	17	NMOD
17	content	content	NN	_	8	PMOD
18	(	(	-LRB-	_	20	P
19	Harlan	harlan	NNP	_	20	NMOD
20	Teklad	teklad	NNP	_	7	PRN
21	,	,	,	_	20	P
22	Harlan	harlan	NNP	_	20	APPO
23	,	,	,	_	22	P
24	Indianapolis	indianapolis	NNP	_	22	APPO
25	,	,	,	_	24	P
26	Indiana	indiana	NNP	_	24	APPO
27	,	,	,	_	26	P
28	United	united	NNP	_	29	NMOD
29	States	state	NNP	_	26	APPO
30	)	)	-RRB-	_	20	P
31	or	or	CC	_	7	COORD
32	a	a	DT	_	36	NMOD
33	high	high	JJ	_	35	NMOD
34	-	-	HYPH	_	33	P
35	fat	fat	NN	_	36	NMOD
36	diet	diet	NN	_	31	CONJ
37	containing	contain	VBG	_	36	NMOD
38	35	0	CD	_	39	NMOD
39	%	%	NN	_	46	NMOD
40	(	(	-LRB-	_	41	P
41	w	w	NN	_	46	PRN
42	/	/	SYM	_	43	P
43	w	w	NN	_	41	NMOD
44	)	)	-RRB-	_	41	P
45	fat	fat	NN	_	46	NMOD
46	content	content	NN	_	37	OBJ
47	(	(	-LRB-	_	49	P
48	product	product	NN	_	49	NMOD
49	F3282	f0	NN	_	36	PRN
50	,	,	,	_	49	P
51	Bioserv	bioserv	NNP	_	49	APPO
52	,	,	,	_	51	P
53	Frenchtown	frenchtown	NNP	_	51	APPO
54	,	,	,	_	53	P
55	New	new	NNP	_	56	NMOD
56	Jersey	jersey	NNP	_	53	APPO
57	,	,	,	_	56	P
58	United	united	NNP	_	59	NMOD
59	States	state	NNP	_	56	APPO
60	)	)	-RRB-	_	49	P
61	as	as	IN	_	3	ADV
62	indicated	indicate	VBN	_	61	SUB
63	.	.	.	_	2	P

1	For	for	IN	_	6	ADV
2	ligand	ligand	NN	_	3	NMOD
3	experiments	experiment	NNS	_	1	PMOD
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	synthesized	synthesize	VBD	_	0	ROOT
7	the	the	DT	_	9	NMOD
8	GW501516	gw0	NN	_	9	NMOD
9	compound	compound	NN	_	6	OBJ
10	and	and	CC	_	6	COORD
11	mice	mouse	NNS	_	12	SBJ
12	were	be	VBD	_	10	CONJ
13	orally	orally	RB	_	12	TMP
14	gavaged	gavaged	VBN	_	12	VC
15	daily	daily	RB	_	14	TMP
16	(	(	-LRB-	_	18	P
17	10	0	CD	_	18	NMOD
18	mg	mg	NNS	_	14	PRN
19	/	/	SYM	_	20	P
20	kg	kg	NN	_	18	NMOD
21	or	or	CC	_	18	COORD
22	vehicle	vehicle	NN	_	21	CONJ
23	alone	alone	RB	_	22	NMOD
24	)	)	-RRB-	_	18	P
25	.	.	.	_	6	P

1	Gene	gene	NN	_	2	NMOD
2	expression	expression	NN	_	3	NMOD
3	analysis	analysis	NN	_	0	ROOT
4	and	and	CC	_	3	COORD
5	physiological	physiological	JJ	_	6	NMOD
6	studies	study	NNS	_	4	CONJ

1	Mouse	mouse	NN	_	3	NMOD
2	EST	est	NN	_	3	NMOD
3	clones	clone	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	obtained	obtain	VBN	_	4	VC
6	from	from	IN	_	5	ADV
7	ATCC	atcc	NN	_	6	PMOD
8	(	(	-LRB-	_	9	P
9	Manassas	manassas	NNP	_	7	PRN
10	,	,	,	_	9	P
11	Virginia	virginia	NNP	_	9	APPO
12	,	,	,	_	11	P
13	United	united	NNP	_	14	NMOD
14	States	state	NNP	_	11	APPO
15	)	)	-RRB-	_	9	P
16	,	,	,	_	5	P
17	verified	verify	VBN	_	5	CONJ
18	by	by	IN	_	17	MNR
19	sequencing	sequencing	NN	_	18	PMOD
20	,	,	,	_	17	P
21	and	and	CC	_	17	COORD
22	used	use	VBN	_	21	CONJ
23	as	as	IN	_	22	MNR
24	Northern	northern	NNP	_	25	NMOD
25	probes	probe	NNS	_	23	PMOD
26	.	.	.	_	4	P

1	Antibodies	antibody	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	obtained	obtain	VBN	_	2	VC
4	from	from	IN	_	3	ADV
5	Santa	santa	NNP	_	6	NMOD
6	Cruz	cruz	NNP	_	7	NMOD
7	Biotechnology	biotechnology	NNP	_	4	PMOD
8	(	(	-LRB-	_	7	P
9	Santa	santa	NNP	_	10	NMOD
10	Cruz	cruz	NNP	_	7	LOC
11	,	,	,	_	10	P
12	California	california	NNP	_	10	APPO
13	,	,	,	_	12	P
14	United	united	NNP	_	15	NMOD
15	States	state	NNP	_	12	APPO
16	)	)	-RRB-	_	7	P
17	.	.	.	_	2	P

1	Total	total	JJ	_	4	NMOD
2	muscle	muscle	NN	_	3	NMOD
3	protein	protein	NN	_	4	NMOD
4	extracts	extract	NNS	_	20	SBJ
5	(	(	-LRB-	_	6	P
6	Lin	lin	NNP	_	4	NMOD
7	et	et	FW	_	6	DEP
8	al.	al.	FW	_	6	DEP
9	2002	0	CD	_	6	DEP
10	)	)	-RRB-	_	6	P
11	and	and	CC	_	4	COORD
12	nuclear	nuclear	JJ	_	13	NMOD
13	proteins	protein	NNS	_	11	CONJ
14	(	(	-LRB-	_	15	P
15	Wang	wang	NNP	_	13	NMOD
16	et	et	FW	_	15	DEP
17	al.	al.	FW	_	15	DEP
18	2003	0	CD	_	15	DEP
19	)	)	-RRB-	_	15	P
20	were	be	VBD	_	0	ROOT
21	prepared	prepare	VBN	_	20	VC
22	as	as	IN	_	21	ADV
23	described	describe	VBN	_	22	SUB
24	.	.	.	_	20	P

1	Prior	prior	JJ	_	2	PMOD
2	to	to	IN	_	10	TMP
3	the	the	DT	_	6	NMOD
4	exercise	exercise	NN	_	6	NMOD
5	performance	performance	NN	_	6	NMOD
6	test	test	NN	_	2	PMOD
7	,	,	,	_	10	P
8	the	the	DT	_	9	NMOD
9	mice	mouse	NNS	_	10	SBJ
10	were	be	VBD	_	0	ROOT
11	accustomed	accustom	VBN	_	10	VC
12	to	to	IN	_	11	ADV
13	the	the	DT	_	14	NMOD
14	treadmill	treadmill	NN	_	12	PMOD
15	(	(	-LRB-	_	17	P
16	Columbus	columbus	NNP	_	17	NMOD
17	Instruments	instrument	NNP	_	14	PRN
18	,	,	,	_	17	P
19	Columbus	columbus	NNP	_	17	APPO
20	,	,	,	_	19	P
21	Ohio	ohio	NNP	_	19	APPO
22	,	,	,	_	21	P
23	United	united	NNP	_	24	NMOD
24	States	state	NNP	_	21	APPO
25	)	)	-RRB-	_	17	P
26	with	with	IN	_	11	MNR
27	a	a	DT	_	31	NMOD
28	5	0	CD	_	30	NMOD
29	-	-	HYPH	_	28	P
30	min	min	NN	_	31	NMOD
31	run	run	NN	_	26	PMOD
32	at	at	IN	_	31	NMOD
33	7	0	CD	_	34	NMOD
34	m	m	NNS	_	32	PMOD
35	/	/	SYM	_	36	P
36	min	min	NN	_	34	NMOD
37	once	once	RB	_	11	TMP
38	per	per	IN	_	37	NMOD
39	day	day	NN	_	38	PMOD
40	for	for	IN	_	11	TMP
41	2	0	CD	_	42	NMOD
42	d	d	NNS	_	40	PMOD
43	.	.	.	_	10	P

1	The	the	DT	_	4	NMOD
2	exercise	exercise	NN	_	4	NMOD
3	test	test	NN	_	4	NMOD
4	regimen	regimen	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	10	0	CD	_	7	NMOD
7	m	m	NNS	_	5	PRD
8	/	/	SYM	_	9	P
9	min	min	NN	_	7	NMOD
10	for	for	IN	_	5	TMP
11	the	the	DT	_	14	NMOD
12	first	$#ORD#$	JJ	_	14	NMOD
13	60	0	CD	_	14	NMOD
14	min	min	NN	_	10	PMOD
15	,	,	,	_	5	P
16	followed	follow	VBN	_	5	ADV
17	by	by	IN	_	16	PMOD
18	1	0	CD	_	19	NMOD
19	m	m	NN	_	22	NMOD
20	/	/	SYM	_	21	P
21	min	min	NN	_	19	NMOD
22	increment	increment	NN	_	17	PMOD
23	increases	increase	VBZ	_	22	NMOD
24	at	at	IN	_	22	NMOD
25	15	0	CD	_	27	NMOD
26	-	-	HYPH	_	25	P
27	min	min	NN	_	28	NMOD
28	intervals	interval	NNS	_	24	PMOD
29	.	.	.	_	5	P

1	Exhaustion	exhaustion	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	defined	define	VBN	_	2	VC
4	when	when	WRB	_	6	TMP
5	mice	mouse	NNS	_	6	SBJ
6	were	be	VBD	_	3	TMP
7	unable	unable	JJ	_	6	PRD
8	to	to	TO	_	7	AMOD
9	avoid	avoid	VB	_	8	IM
10	repetitive	repetitive	JJ	_	12	NMOD
11	electrical	electrical	JJ	_	12	NMOD
12	shocks	shock	NNS	_	9	OBJ
13	.	.	.	_	2	P

1	Muscle	muscle	NN	_	2	NMOD
2	fiber	fiber	NN	_	3	NMOD
3	typing	typing	NN	_	0	ROOT
4	and	and	CC	_	3	COORD
5	mitochondrial	mitochondrial	JJ	_	6	NMOD
6	DNA	dna	NN	_	7	NMOD
7	isolation	isolation	NN	_	4	CONJ

1	Muscle	muscle	NN	_	2	NMOD
2	fiber	fiber	NN	_	3	NMOD
3	typing	typing	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	essentially	essentially	RB	_	4	ADV
6	performed	perform	VBN	_	4	VC
7	using	use	VBG	_	6	MNR
8	metachromatic	metachromatic	JJ	_	9	NMOD
9	dye	dye	NN	_	11	NMOD
10	–	–	HYPH	_	9	P
11	ATPase	atpase	NN	_	12	NMOD
12	methods	method	NNS	_	7	OBJ
13	as	as	IN	_	6	ADV
14	described	describe	VBN	_	13	SUB
15	(	(	-LRB-	_	16	P
16	Ogilvie	ogilvie	NNP	_	14	CIT
17	and	and	CC	_	16	COORD
18	Feeback	feeback	NNP	_	17	CONJ
19	1990	0	CD	_	16	DEP
20	)	)	-RRB-	_	16	P
21	.	.	.	_	4	P

1	Muscle	muscle	NN	_	2	NMOD
2	mitochondria	mitochondrion	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	isolated	isolate	VBN	_	3	VC
5	(	(	-LRB-	_	6	P
6	Scholte	scholte	NNP	_	4	CIT
7	et	et	FW	_	6	DEP
8	al.	al.	FW	_	6	DEP
9	1997	0	CD	_	6	DEP
10	)	)	-RRB-	_	6	P
11	.	.	.	_	3	P

1	Mitochondrial	mitochondrial	JJ	_	2	NMOD
2	DNA	dna	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	prepared	prepare	VBN	_	3	VC
5	and	and	CC	_	4	COORD
6	analyzed	analyze	VBN	_	5	CONJ
7	on	on	IN	_	4	LOC
8	1	0	CD	_	9	NMOD
9	%	%	NN	_	11	NMOD
10	agarose	agarose	NN	_	11	NMOD
11	gel	gel	NN	_	7	PMOD
12	.	.	.	_	3	P

1	Statistical	statistical	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	Number	number	NN	_	10	SBJ
2	of	of	IN	_	1	NMOD
3	mice	mouse	NNS	_	2	PMOD
4	for	for	IN	_	1	NMOD
5	each	each	DT	_	6	NMOD
6	group	group	NN	_	4	PMOD
7	used	use	VBN	_	6	NMOD
8	in	in	IN	_	7	ADV
9	experiments	experiment	NNS	_	8	PMOD
10	is	be	VBZ	_	0	ROOT
11	indicated	indicate	VBN	_	10	VC
12	in	in	IN	_	11	ADV
13	figure	figure	NN	_	14	NMOD
14	legends	legend	NNS	_	12	PMOD
15	.	.	.	_	10	P

1	Values	value	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	presented	present	VBN	_	2	VC
4	as	as	IN	_	3	ADV
5	mean	mean	NN	_	7	NMOD
6	±	±	SYM	_	7	P
7	SEM	sem	NN	_	4	PMOD
8	.	.	.	_	2	P

1	A	a	DT	_	8	NMOD
2	two	two	CD	_	4	AMOD
3	-	-	HYPH	_	2	P
4	tailed	tail	VBN	_	8	NMOD
5	Student	student	NNP	_	8	NMOD
6	's	's	POS	_	5	NMOD
7	t	t	NN	_	8	NMOD
8	test	test	NN	_	9	SBJ
9	was	be	VBD	_	0	ROOT
10	used	use	VBN	_	9	VC
11	to	to	TO	_	10	PRP
12	calculate	calculate	VB	_	11	IM
13	p	p	NN	_	15	NMOD
14	-	-	HYPH	_	13	P
15	values	value	NNS	_	12	OBJ
16	.	.	.	_	9	P

1	Supporting	support	VBG	_	2	NMOD
2	Information	information	NN	_	0	ROOT

1	Video	video	NN	_	2	NMOD
2	S1	s0	NN	_	0	ROOT

1	Beginning	beginning	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Running	running	NN	_	4	NMOD
4	Test	test	NN	_	2	PMOD

1	This	this	DT	_	2	NMOD
2	video	video	NN	_	3	SBJ
3	shows	show	VBZ	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	exercise	exercise	NN	_	6	NMOD
6	performance	performance	NN	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	a	a	DT	_	9	NMOD
9	representative	representative	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	transgenic	transgenic	JJ	_	13	NMOD
13	mice	mouse	NNS	_	10	PMOD
14	(	(	-LRB-	_	16	P
15	right	right	JJ	_	16	NMOD
16	chamber	chamber	NN	_	13	PRN
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	9	COORD
19	a	a	DT	_	20	NMOD
20	representative	representative	NN	_	18	CONJ
21	of	of	IN	_	20	NMOD
22	wild	wild	JJ	_	24	NMOD
23	-	-	HYPH	_	22	P
24	type	type	NN	_	26	NMOD
25	control	control	NN	_	26	NMOD
26	littermates	littermates	NNS	_	21	PMOD
27	(	(	-LRB-	_	29	P
28	left	left	JJ	_	29	NMOD
29	chamber	chamber	NN	_	26	PRN
30	)	)	-RRB-	_	29	P
31	on	on	IN	_	3	LOC
32	the	the	DT	_	33	NMOD
33	treadmill	treadmill	NN	_	31	PMOD
34	15	0	CD	_	35	NMOD
35	min	min	NN	_	36	ADV
36	into	into	IN	_	3	TMP
37	the	the	DT	_	39	NMOD
38	exercise	exercise	NN	_	39	NMOD
39	challenge	challenge	NN	_	36	PMOD
40	.	.	.	_	3	P

1	(	(	-LRB-	_	4	P
2	52.4	0	CD	_	3	NMOD
3	MB	mb	NN	_	4	NMOD
4	MOV	mov	NN	_	0	ROOT
5	)	)	-RRB-	_	4	P
6	.	.	.	_	4	P

1	Click	click	VB	_	0	ROOT
2	here	here	RB	_	1	ADV
3	for	for	IN	_	1	PRP
4	additional	additional	JJ	_	6	NMOD
5	data	datum	NNS	_	6	NMOD
6	file	file	NN	_	3	PMOD
7	.	.	.	_	1	P

1	Video	video	NN	_	2	NMOD
2	S2	s0	NN	_	0	ROOT

1	Running	running	NN	_	2	NMOD
2	Test	test	NN	_	0	ROOT
3	90	0	CD	_	4	NMOD
4	Min	min	NN	_	5	AMOD
5	Later	later	RB	_	2	TMP

1	This	this	DT	_	2	NMOD
2	video	video	NN	_	3	SBJ
3	shows	show	VBZ	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	exercise	exercise	NN	_	6	NMOD
6	performance	performance	NN	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	a	a	DT	_	9	NMOD
9	representative	representative	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	transgenic	transgenic	JJ	_	13	NMOD
13	mice	mouse	NNS	_	10	PMOD
14	(	(	-LRB-	_	16	P
15	right	right	JJ	_	16	NMOD
16	chamber	chamber	NN	_	13	PRN
17	)	)	-RRB-	_	16	P
18	and	and	CC	_	9	COORD
19	a	a	DT	_	20	NMOD
20	representative	representative	NN	_	18	CONJ
21	of	of	IN	_	20	NMOD
22	wild	wild	JJ	_	24	NMOD
23	-	-	HYPH	_	22	P
24	type	type	NN	_	26	NMOD
25	control	control	NN	_	26	NMOD
26	littermates	littermates	NNS	_	21	PMOD
27	(	(	-LRB-	_	29	P
28	left	left	JJ	_	29	NMOD
29	chamber	chamber	NN	_	26	PRN
30	)	)	-RRB-	_	29	P
31	on	on	IN	_	3	LOC
32	the	the	DT	_	33	NMOD
33	treadmill	treadmill	NN	_	31	PMOD
34	90	0	CD	_	35	NMOD
35	min	min	NN	_	36	ADV
36	into	into	IN	_	3	TMP
37	the	the	DT	_	39	NMOD
38	exercise	exercise	NN	_	39	NMOD
39	challenge	challenge	NN	_	36	PMOD
40	.	.	.	_	3	P

1	(	(	-LRB-	_	4	P
2	41.7	0	CD	_	3	NMOD
3	MB	mb	NN	_	4	NMOD
4	MOV	mov	NN	_	0	ROOT
5	)	)	-RRB-	_	4	P
6	.	.	.	_	4	P

1	Click	click	VB	_	0	ROOT
2	here	here	RB	_	1	ADV
3	for	for	IN	_	1	PRP
4	additional	additional	JJ	_	6	NMOD
5	data	datum	NNS	_	6	NMOD
6	file	file	NN	_	3	PMOD
7	.	.	.	_	1	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	thank	thank	VBP	_	0	ROOT
3	Dr.	dr.	NNP	_	5	NMOD
4	M.	m.	NNP	_	5	NMOD
5	Downes	downes	NNP	_	2	OBJ
6	for	for	IN	_	2	PRP
7	providing	provide	VBG	_	6	PMOD
8	the	the	DT	_	13	NMOD
9	α	α	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	skeletal	skeletal	JJ	_	13	NMOD
12	actin	actin	NN	_	13	NMOD
13	promoter	promoter	NN	_	7	OBJ
14	;	;	:	_	2	P
15	Dr.	dr.	NNP	_	18	NMOD
16	G.	g.	NNP	_	18	NMOD
17	D.	d.	NNP	_	18	NMOD
18	Barish	barish	NNP	_	2	GAP
19	for	for	IN	_	18	PRP
20	comments	comment	NNS	_	19	PMOD
21	on	on	IN	_	20	NMOD
22	the	the	DT	_	23	NMOD
23	manuscript	manuscript	NN	_	21	PMOD
24	;	;	:	_	18	P
25	M.A.	m.a.	NNP	_	26	NMOD
26	Lawrence	lawrence	NNP	_	18	GAP
27	for	for	IN	_	26	PRP
28	histology	histology	NN	_	27	PMOD
29	;	;	:	_	26	P
30	Dr.	dr.	NNP	_	32	NMOD
31	S.	s.	NNP	_	32	NMOD
32	Pfaff	pfaff	NNP	_	26	GAP
33	for	for	IN	_	32	PRP
34	the	the	DT	_	35	NMOD
35	use	use	NN	_	33	PMOD
36	of	of	IN	_	35	NMOD
37	microscopes	microscope	NNS	_	36	PMOD
38	and	and	CC	_	37	COORD
39	photographic	photographic	JJ	_	40	NMOD
40	equipment	equipment	NN	_	38	CONJ
41	;	;	:	_	32	P
42	M.	m.	NNP	_	43	NMOD
43	Lieberman	lieberman	NNP	_	32	GAP
44	and	and	CC	_	43	COORD
45	K.L.	k.l.	NNP	_	46	NMOD
46	Schnoeker	schnoeker	NNP	_	44	CONJ
47	for	for	IN	_	43	PRP
48	photography	photography	NN	_	47	PMOD
49	;	;	:	_	43	P
50	J.M.	j.m.	NNP	_	51	NMOD
51	Shelton	shelton	NNP	_	43	GAP
52	for	for	IN	_	51	PRP
53	advice	advice	NN	_	52	PMOD
54	on	on	IN	_	53	NMOD
55	fiber	fiber	NN	_	56	NMOD
56	staining	staining	NN	_	54	PMOD
57	;	;	:	_	51	P
58	and	and	CC	_	51	COORD
59	E.	e.	NNP	_	60	NMOD
60	Stevens	stevens	NNP	_	58	GAP
61	and	and	CC	_	60	COORD
62	E.	e.	NNP	_	63	NMOD
63	Ong	ong	NNP	_	61	CONJ
64	for	for	IN	_	60	PRP
65	administrative	administrative	JJ	_	66	NMOD
66	assistance	assistance	NN	_	64	PMOD
67	.	.	.	_	2	P

1	YXW	yxw	NNP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	supported	support	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	a	a	DT	_	7	NMOD
6	postdoctoral	postdoctoral	JJ	_	7	NMOD
7	fellowship	fellowship	NN	_	4	PMOD
8	from	from	IN	_	7	NMOD
9	California	california	NNP	_	15	NMOD
10	Tobacco	tobacco	NNP	_	12	AMOD
11	-	-	HYPH	_	10	P
12	Related	relate	VBN	_	13	NMOD
13	Disease	disease	NNP	_	15	NMOD
14	Research	research	NNP	_	15	NMOD
15	Program	program	NNP	_	8	PMOD
16	.	.	.	_	2	P

1	JH	jh	NNP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	supported	support	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	the	the	DT	_	7	NMOD
6	BK21	bk0	NN	_	7	NMOD
7	program	program	NN	_	4	PMOD
8	,	,	,	_	7	P
9	Ministry	ministry	NNP	_	7	APPO
10	of	of	IN	_	9	NMOD
11	Education	education	NNP	_	10	PMOD
12	,	,	,	_	9	P
13	Korea	korea	NNP	_	9	APPO
14	.	.	.	_	2	P

1	HK	hk	NNP	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	supported	support	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	grant	grant	NN	_	6	NMOD
6	M1	m0	NN	_	4	PMOD
7	–	–	HYPH	_	6	P
8	0311	0	CD	_	6	NMOD
9	-	-	HYPH	_	8	P
10	00	0	CD	_	6	NMOD
11	–	–	HYPH	_	10	P
12	0145	0	CD	_	6	NMOD
13	from	from	IN	_	6	NMOD
14	the	the	DT	_	20	NMOD
15	Molecular	molecular	NNP	_	20	NMOD
16	and	and	CC	_	15	COORD
17	Cellular	cellular	NNP	_	16	CONJ
18	BioDiscovery	biodiscovery	NNP	_	20	NMOD
19	Research	research	NNP	_	20	NMOD
20	Program	program	NNP	_	13	PMOD
21	,	,	,	_	20	P
22	Ministry	ministry	NNP	_	20	APPO
23	of	of	IN	_	22	NMOD
24	Science	science	NNP	_	23	PMOD
25	and	and	CC	_	24	COORD
26	Technology	technology	NNP	_	25	CONJ
27	,	,	,	_	22	P
28	Korea	korea	NNP	_	22	APPO
29	.	.	.	_	2	P

1	RME	rme	NNP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	an	an	DT	_	4	NMOD
4	Investigator	investigator	NN	_	2	PRD
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	Howard	howard	NNP	_	8	NMOD
8	Hughes	hughes	NNP	_	10	NMOD
9	Medical	medical	NNP	_	10	NMOD
10	Institute	institute	NNP	_	5	PMOD
11	at	at	IN	_	4	NMOD
12	the	the	DT	_	14	NMOD
13	Salk	salk	NNP	_	14	NMOD
14	Institute	institute	NNP	_	11	PMOD
15	for	for	IN	_	14	NMOD
16	Biological	biological	NNP	_	17	NMOD
17	Studies	study	NNP	_	15	PMOD
18	and	and	CC	_	4	COORD
19	March	march	NNP	_	22	NMOD
20	of	of	IN	_	19	NMOD
21	Dimes	dime	NNP	_	20	PMOD
22	Chair	chair	NNP	_	18	CONJ
23	in	in	IN	_	22	NMOD
24	Molecular	molecular	NNP	_	27	NMOD
25	and	and	CC	_	24	COORD
26	Developmental	developmental	NNP	_	25	CONJ
27	Biology	biology	NNP	_	23	PMOD
28	.	.	.	_	2	P

1	This	this	DT	_	2	NMOD
2	work	work	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	supported	support	VBN	_	3	VC
5	by	by	IN	_	4	LGS
6	the	the	DT	_	10	NMOD
7	Howard	howard	NNP	_	8	NMOD
8	Hughes	hughes	NNP	_	10	NMOD
9	Medical	medical	NNP	_	10	NMOD
10	Institute	institute	NNP	_	5	PMOD
11	and	and	CC	_	10	COORD
12	the	the	DT	_	14	NMOD
13	Hillblom	hillblom	NNP	_	14	NMOD
14	Foundation	foundation	NNP	_	11	CONJ
15	.	.	.	_	3	P

1	Abbreviations	abbreviation	NNS	_	0	ROOT

1	COX	cox	NN	_	5	NMOD
2	-	-	:	_	5	P
3	cytochrome	cytochrome	NN	_	4	NMOD
4	c	c	NN	_	5	NMOD
5	oxidase	oxidase	NN	_	0	ROOT

1	mCPT1	mcpt0	NN	_	5	NMOD
2	-	-	:	_	5	P
3	muscle	muscle	NN	_	5	NMOD
4	carnitine	carnitine	NN	_	5	NMOD
5	palmitoyltransferase	palmitoyltransferase	NN	_	0	ROOT
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD

1	PGC	pgc	NN	_	12	NMOD
2	-	-	:	_	1	P
3	1α	0α	CD	_	1	NMOD
4	-	-	HYPH	_	1	P
5	Peroxisome	peroxisome	NN	_	6	NMOD
6	proliferator	proliferator	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	activated	activate	VBN	_	12	NMOD
9	receptor	receptor	NN	_	12	NMOD
10	-	-	HYPH	_	9	P
11	gamma	gamma	NN	_	12	NMOD
12	coactivator	coactivator	NN	_	0	ROOT
13	1α	0α	CD	_	12	NMOD

1	PPAR	ppar	NN	_	7	NMOD
2	-	-	:	_	7	P
3	peroxisome	peroxisome	NN	_	4	NMOD
4	proliferator	proliferator	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	activated	activate	VBN	_	7	NMOD
7	receptor	receptor	NN	_	0	ROOT

1	UCP	ucp	NN	_	4	NMOD
2	-	-	:	_	4	P
3	uncoupling	uncouple	VBG	_	4	NMOD
4	protein	protein	NN	_	0	ROOT

1	Figures	figure	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Tables	table	NNS	_	2	CONJ

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Expression	expression	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Endogenous	endogenous	JJ	_	9	NMOD
4	PPARδ	pparδ	NN	_	9	NMOD
5	and	and	CC	_	4	COORD
6	VP16	vp0	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	PPARδ	pparδ	NN	_	5	CONJ
9	Transgene	transgene	NN	_	2	PMOD
10	in	in	IN	_	1	LOC
11	Muscle	muscle	NN	_	10	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	18	DEP
3	)	)	-RRB-	_	2	P
4	Pooled	pool	VBN	_	5	NMOD
5	RNA	rna	NN	_	18	SBJ
6	isolated	isolate	VBN	_	5	NMOD
7	from	from	IN	_	6	ADV
8	various	various	JJ	_	9	NMOD
9	muscles	muscle	NNS	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	five	five	CD	_	17	NMOD
12	wild	wild	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	type	type	NN	_	17	NMOD
15	male	male	JJ	_	17	NMOD
16	C57B6	c0b0	NN	_	17	NMOD
17	mice	mouse	NNS	_	10	PMOD
18	was	be	VBD	_	0	ROOT
19	hybridized	hybridize	VBN	_	18	VC
20	with	with	IN	_	19	MNR
21	indicated	indicate	VBN	_	22	NMOD
22	probes	probe	NNS	_	20	PMOD
23	.	.	.	_	18	P

1	EDL	edl	NN	_	0	ROOT
2	,	,	,	_	1	P
3	extensor	extensor	NN	_	5	NMOD
4	digitorum	digitorum	NN	_	5	NMOD
5	longus	longus	NN	_	1	APPO
6	;	;	,	_	1	P
7	Gastro	gastro	NN	_	1	APPO
8	,	,	,	_	7	P
9	gastrocnemius	gastrocnemius	NN	_	7	APPO
10	.	.	.	_	1	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	23	DEP
3	)	)	-RRB-	_	2	P
4	Pooled	pool	VBN	_	6	NMOD
5	nuclear	nuclear	JJ	_	6	NMOD
6	proteins	protein	NNS	_	23	SBJ
7	(	(	-LRB-	_	9	P
8	15	0	CD	_	9	NMOD
9	μg	μg	NNS	_	6	PRN
10	/	/	SYM	_	11	P
11	lane	lane	NN	_	9	NMOD
12	)	)	-RRB-	_	9	P
13	isolated	isolate	VBN	_	6	NMOD
14	from	from	IN	_	13	ADV
15	muscles	muscle	NNS	_	14	PMOD
16	of	of	IN	_	15	NMOD
17	five	five	CD	_	22	NMOD
18	wild	wild	JJ	_	20	NMOD
19	-	-	HYPH	_	18	P
20	type	type	NN	_	22	NMOD
21	male	male	JJ	_	22	NMOD
22	C57B6	c0b0	NN	_	16	PMOD
23	were	be	VBD	_	0	ROOT
24	probed	probe	VBN	_	23	VC
25	with	with	IN	_	24	MNR
26	anti-PPARδ	anti-pparδ	JJ	_	27	NMOD
27	antibody	antibody	NN	_	25	PMOD
28	.	.	.	_	23	P

1	RNA	rna	NN	_	2	NMOD
2	polymerase	polymerase	NN	_	5	NMOD
3	II	ii	CD	_	2	NMOD
4	(	(	-LRB-	_	5	P
5	Pol	pol	NN	_	8	SBJ
6	II	ii	CD	_	5	NMOD
7	)	)	-RRB-	_	5	P
8	is	be	VBZ	_	0	ROOT
9	shown	show	VBN	_	8	VC
10	as	as	IN	_	9	ADV
11	a	a	DT	_	13	NMOD
12	loading	loading	NN	_	13	NMOD
13	control	control	NN	_	10	PMOD
14	.	.	.	_	8	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Expression	expression	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	VP16	vp0	NN	_	9	NMOD
8	-	-	HYPH	_	7	P
9	PPARδ	pparδ	NN	_	10	NMOD
10	transgene	transgene	NN	_	5	PMOD
11	in	in	IN	_	4	LOC
12	various	various	JJ	_	13	NMOD
13	tissues	tissue	NNS	_	11	PMOD
14	.	.	.	_	4	P

1	10	0	CD	_	2	NMOD
2	μg	μg	NNS	_	9	SBJ
3	of	of	IN	_	2	NMOD
4	total	total	JJ	_	5	NMOD
5	RNA	rna	NN	_	3	PMOD
6	from	from	IN	_	5	NMOD
7	each	each	DT	_	8	NMOD
8	tissue	tissue	NN	_	6	PMOD
9	was	be	VBD	_	0	ROOT
10	hybridized	hybridize	VBN	_	9	VC
11	with	with	IN	_	10	MNR
12	a	a	DT	_	15	NMOD
13	VP16	vp0	NN	_	14	NMOD
14	cDNA	cdna	NN	_	15	NMOD
15	probe	probe	NN	_	11	PMOD
16	.	.	.	_	9	P

1	Gastrocnemius	gastrocnemius	NN	_	2	NMOD
2	muscle	muscle	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	used	use	VBN	_	3	VC
5	here	here	RB	_	4	ADV
6	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	32	DEP
3	)	)	-RRB-	_	2	P
4	Nuclear	nuclear	JJ	_	5	NMOD
5	proteins	protein	NNS	_	32	SBJ
6	(	(	-LRB-	_	8	P
7	15	0	CD	_	8	NMOD
8	μg	μg	NNS	_	5	PRN
9	/	/	SYM	_	10	P
10	lane	lane	NN	_	8	NMOD
11	)	)	-RRB-	_	8	P
12	isolated	isolate	VBN	_	5	NMOD
13	from	from	IN	_	12	ADV
14	gastrocnemius	gastrocnemius	NN	_	15	NMOD
15	muscle	muscle	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	transgenic	transgenic	JJ	_	19	NMOD
19	mice	mouse	NNS	_	16	PMOD
20	(	(	-LRB-	_	21	P
21	TG	tg	JJ	_	19	PRN
22	)	)	-RRB-	_	21	P
23	and	and	CC	_	19	COORD
24	the	the	DT	_	28	NMOD
25	wild	wild	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	type	type	NN	_	28	NMOD
28	littermates	littermates	NNS	_	23	CONJ
29	(	(	-LRB-	_	30	P
30	WT	wt	NN	_	28	PRN
31	)	)	-RRB-	_	30	P
32	were	be	VBD	_	0	ROOT
33	probed	probe	VBN	_	32	VC
34	with	with	IN	_	33	MNR
35	indicated	indicated	JJ	_	36	NMOD
36	antibodies	antibody	NNS	_	34	PMOD
37	.	.	.	_	32	P

1	The	the	DT	_	5	NMOD
2	upper	upper	JJ	_	5	NMOD
3	,	,	,	_	5	P
4	nonspecific	nonspecific	JJ	_	5	NMOD
5	band	band	NN	_	12	SBJ
6	that	that	WDT	_	7	SBJ
7	cross-reacted	cross-reacted	VBD	_	5	NMOD
8	with	with	IN	_	7	ADV
9	the	the	DT	_	11	NMOD
10	anti-PPARδ	anti-pparδ	JJ	_	11	NMOD
11	antibody	antibody	NN	_	8	PMOD
12	serves	serve	VBZ	_	0	ROOT
13	a	a	DT	_	15	NMOD
14	loading	loading	NN	_	15	NMOD
15	control	control	NN	_	12	OBJ
16	.	.	.	_	12	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Increased	increase	VBN	_	5	NMOD
2	Oxidative	oxidative	JJ	_	5	NMOD
3	Type	type	NN	_	5	NMOD
4	I	i	CD	_	3	NMOD
5	Fibers	fiber	NNS	_	0	ROOT
6	in	in	IN	_	5	LOC
7	the	the	DT	_	9	NMOD
8	Transgenic	transgenic	JJ	_	9	NMOD
9	Mice	mouse	NNS	_	6	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	13	DEP
3	and	and	CC	_	2	COORD
4	B	b	LS	_	3	CONJ
5	)	)	-RRB-	_	2	P
6	Muscles	muscle	NNS	_	13	SBJ
7	in	in	IN	_	6	LOC
8	transgenic	transgenic	JJ	_	9	NMOD
9	mice	mouse	NNS	_	7	PMOD
10	(	(	-LRB-	_	11	P
11	TG	tg	JJ	_	9	PRN
12	)	)	-RRB-	_	11	P
13	are	be	VBP	_	0	ROOT
14	redder	red	JJR	_	13	PRD
15	than	than	IN	_	14	AMOD
16	those	those	DT	_	15	PMOD
17	in	in	IN	_	16	LOC
18	wild	wild	JJ	_	20	NMOD
19	-	-	HYPH	_	18	P
20	type	type	NN	_	21	NMOD
21	mice	mouse	NNS	_	17	PMOD
22	(	(	-LRB-	_	23	P
23	WT	wt	NN	_	21	PRN
24	)	)	-RRB-	_	23	P
25	.	.	.	_	13	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	5	NMOD
3	)	)	-RRB-	_	2	P
4	Metachromatic	metachromatic	JJ	_	5	NMOD
5	staining	staining	NN	_	0	ROOT
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	11	NMOD
8	type	type	NN	_	11	NMOD
9	II	ii	CD	_	8	NMOD
10	plantaris	plantaris	NN	_	11	NMOD
11	muscle	muscle	NN	_	6	PMOD
12	.	.	.	_	5	P

1	Type	type	NN	_	3	NMOD
2	I	i	CD	_	1	NMOD
3	fibers	fiber	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	stained	stain	VBN	_	4	VC
6	dark	dark	RB	_	7	AMOD
7	blue	blue	JJ	_	5	OPRD
8	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Activation	activation	NN	_	4	SBJ
2	of	of	IN	_	1	NMOD
3	PPARδ	pparδ	NN	_	2	PMOD
4	Induces	induce	VBZ	_	0	ROOT
5	Genes	gene	NNS	_	4	OBJ
6	Typical	typical	JJ	_	5	NMOD
7	for	for	IN	_	6	AMOD
8	Type	type	NN	_	10	NMOD
9	I	i	CD	_	8	NMOD
10	Fibers	fiber	NNS	_	7	PMOD
11	and	and	CC	_	4	COORD
12	Promotes	promote	VBZ	_	11	CONJ
13	Mitochondrial	mitochondrial	JJ	_	14	NMOD
14	Biogenesis	biogenesis	NN	_	12	OBJ

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	29	DEP
3	)	)	-RRB-	_	2	P
4	Total	total	JJ	_	5	NMOD
5	RNA	rna	NN	_	29	SBJ
6	(	(	-LRB-	_	8	P
7	10	0	CD	_	8	NMOD
8	μg	μg	NNS	_	5	PRN
9	/	/	SYM	_	10	P
10	lane	lane	NN	_	8	NMOD
11	)	)	-RRB-	_	8	P
12	prepared	prepare	VBN	_	5	NMOD
13	from	from	IN	_	12	ADV
14	gastrocnemius	gastrocnemius	NN	_	15	NMOD
15	muscle	muscle	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	transgenic	transgenic	JJ	_	28	NMOD
18	(	(	-LRB-	_	19	P
19	TG	tg	JJ	_	17	PRN
20	)	)	-RRB-	_	19	P
21	and	and	CC	_	17	COORD
22	wild	wild	JJ	_	24	NMOD
23	-	-	HYPH	_	22	P
24	type	type	NN	_	21	CONJ
25	(	(	-LRB-	_	26	P
26	WT	wt	NN	_	24	PRN
27	)	)	-RRB-	_	26	P
28	littermates	littermates	NNS	_	16	PMOD
29	was	be	VBD	_	0	ROOT
30	probed	probe	VBN	_	29	VC
31	with	with	IN	_	30	MNR
32	indicated	indicate	VBN	_	33	NMOD
33	probes	probe	NNS	_	31	PMOD
34	.	.	.	_	29	P

1	The	the	DT	_	3	NMOD
2	fold	fold	JJ	_	3	NMOD
3	increase	increase	NN	_	9	SBJ
4	of	of	IN	_	3	NMOD
5	induction	induction	NN	_	4	PMOD
6	of	of	IN	_	5	NMOD
7	each	each	DT	_	8	NMOD
8	gene	gene	NN	_	6	PMOD
9	is	be	VBZ	_	0	ROOT
10	shown	show	VBN	_	9	VC
11	.	.	.	_	9	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	17	DEP
3	)	)	-RRB-	_	2	P
4	Total	total	JJ	_	6	NMOD
5	genomic	genomic	JJ	_	6	NMOD
6	DNA	dna	NN	_	17	SBJ
7	(	(	-LRB-	_	9	P
8	10	0	CD	_	9	NMOD
9	μg	μg	NNS	_	6	PRN
10	/	/	SYM	_	11	P
11	lane	lane	NN	_	9	NMOD
12	)	)	-RRB-	_	9	P
13	prepared	prepare	VBN	_	6	NMOD
14	from	from	IN	_	13	ADV
15	gastrocnemius	gastrocnemius	NN	_	16	NMOD
16	muscle	muscle	NN	_	14	PMOD
17	was	be	VBD	_	0	ROOT
18	digested	digest	VBN	_	17	VC
19	with	with	IN	_	18	MNR
20	Nco1	nco0	NN	_	19	PMOD
21	and	and	CC	_	18	COORD
22	subjected	subject	VBN	_	21	CONJ
23	to	to	IN	_	22	ADV
24	Southern	southern	NNP	_	25	NMOD
25	analysis	analysis	NN	_	23	PMOD
26	with	with	IN	_	22	MNR
27	COXII	coxii	NN	_	43	NMOD
28	(	(	-LRB-	_	32	P
29	mitochondrial	mitochondrial	JJ	_	30	NMOD
30	genome	genome	NN	_	32	AMOD
31	–	–	HYPH	_	30	P
32	encoded	encode	VBN	_	27	PRN
33	)	)	-RRB-	_	32	P
34	and	and	CC	_	27	COORD
35	MCIP1	mcip0	NN	_	34	CONJ
36	(	(	-LRB-	_	40	P
37	nuclear	nuclear	JJ	_	38	NMOD
38	genome	genome	NN	_	40	AMOD
39	–	–	HYPH	_	38	P
40	encoded	encode	VBN	_	35	PRN
41	)	)	-RRB-	_	40	P
42	DNA	dna	NN	_	43	NMOD
43	probes	probe	NNS	_	26	PMOD
44	.	.	.	_	17	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	9	DEP
3	)	)	-RRB-	_	2	P
4	Equal	equal	JJ	_	5	NMOD
5	amounts	amount	NNS	_	9	SBJ
6	of	of	IN	_	5	NMOD
7	gastrocnemius	gastrocnemius	NN	_	8	NMOD
8	muscle	muscle	NN	_	6	PMOD
9	were	be	VBD	_	0	ROOT
10	collected	collect	VBN	_	9	VC
11	from	from	IN	_	10	ADV
12	both	both	CC	_	14	COORD
13	transgenic	transgenic	JJ	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	and	and	CC	_	14	COORD
16	control	control	NN	_	17	NMOD
17	littermates	littermates	NNS	_	15	CONJ
18	.	.	.	_	9	P

1	Total	total	JJ	_	3	NMOD
2	mitochondrial	mitochondrial	JJ	_	3	NMOD
3	DNA	dna	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	isolated	isolate	VBN	_	4	VC
6	and	and	CC	_	5	COORD
7	separated	separate	VBN	_	6	CONJ
8	on	on	IN	_	5	LOC
9	1	0	CD	_	10	NMOD
10	%	%	NN	_	12	NMOD
11	agarose	agarose	NN	_	12	NMOD
12	gel	gel	NN	_	8	PMOD
13	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	relative	relative	JJ	_	3	NMOD
3	abundance	abundance	NN	_	14	SBJ
4	of	of	IN	_	3	NMOD
5	mitochondrial	mitochondrial	JJ	_	6	NMOD
6	DNA	dna	NN	_	4	PMOD
7	in	in	IN	_	3	LOC
8	transgenic	transgenic	JJ	_	13	NMOD
9	and	and	CC	_	8	COORD
10	wild	wild	JJ	_	12	NMOD
11	-	-	HYPH	_	10	P
12	type	type	NN	_	9	CONJ
13	mice	mouse	NNS	_	7	PMOD
14	is	be	VBZ	_	0	ROOT
15	presented	present	VBN	_	14	VC
16	.	.	.	_	14	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Western	western	NNP	_	5	NMOD
5	blot	blot	NN	_	6	NMOD
6	analysis	analysis	NN	_	0	ROOT
7	of	of	IN	_	6	NMOD
8	muscle	muscle	NN	_	9	NMOD
9	fiber	fiber	NN	_	10	NMOD
10	markers	marker	NNS	_	7	PMOD
11	and	and	CC	_	10	COORD
12	mitochondrial	mitochondrial	JJ	_	13	NMOD
13	components	component	NNS	_	11	CONJ
14	.	.	.	_	6	P

1	Each	each	DT	_	2	NMOD
2	lane	lane	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	loaded	load	VBN	_	3	VC
5	with	with	IN	_	4	ADV
6	80	0	CD	_	7	NMOD
7	μg	μg	NNS	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	total	total	JJ	_	12	NMOD
10	gastrocnemius	gastrocnemius	NN	_	11	NMOD
11	muscle	muscle	NN	_	12	NMOD
12	extracts	extract	NNS	_	8	PMOD
13	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	E	e	LS	_	9	DEP
3	)	)	-RRB-	_	2	P
4	Wild	wild	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	type	type	NN	_	8	NMOD
7	C57B6	c0b0	NN	_	8	NMOD
8	mice	mouse	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	treated	treat	VBN	_	9	VC
11	with	with	IN	_	10	ADV
12	vehicle	vehicle	NN	_	11	PMOD
13	or	or	CC	_	12	COORD
14	PPARδ	pparδ	NN	_	15	NMOD
15	agonist	agonist	NN	_	16	NMOD
16	GW501516	gw0	NN	_	13	CONJ
17	for	for	IN	_	10	TMP
18	10	0	CD	_	19	NMOD
19	d	d	NN	_	17	PMOD
20	.	.	.	_	9	P

1	Total	total	JJ	_	2	NMOD
2	RNA	rna	NN	_	14	SBJ
3	(	(	-LRB-	_	5	P
4	10	0	CD	_	5	NMOD
5	μg	μg	NNS	_	2	PRN
6	/	/	SYM	_	7	P
7	lane	lane	NN	_	5	NMOD
8	)	)	-RRB-	_	5	P
9	prepared	prepare	VBN	_	2	NMOD
10	from	from	IN	_	9	ADV
11	the	the	DT	_	13	NMOD
12	gastrocnemius	gastrocnemius	NN	_	13	NMOD
13	muscle	muscle	NN	_	10	PMOD
14	was	be	VBD	_	0	ROOT
15	probed	probe	VBN	_	14	VC
16	with	with	IN	_	15	MNR
17	indicated	indicate	VBN	_	18	NMOD
18	probes	probe	NNS	_	16	PMOD
19	.	.	.	_	14	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Resistance	resistance	NN	_	0	ROOT
2	to	to	IN	_	1	NMOD
3	High	high	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	Fat	fat	NN	_	7	AMOD
6	-	-	HYPH	_	5	P
7	Induced	induce	VBN	_	8	NMOD
8	Obesity	obesity	NN	_	2	PMOD
9	in	in	IN	_	1	LOC
10	the	the	DT	_	12	NMOD
11	Transgenic	transgenic	JJ	_	12	NMOD
12	Mice	mouse	NNS	_	9	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	31	DEP
3	)	)	-RRB-	_	2	P
4	Seven	seven	CD	_	6	NMOD
5	-	-	HYPH	_	4	P
6	week	week	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	old	old	JJ	_	20	NMOD
9	transgenic	transgenic	JJ	_	20	NMOD
10	(	(	-LRB-	_	11	P
11	TG	tg	JJ	_	9	PRN
12	)	)	-RRB-	_	11	P
13	and	and	CC	_	9	COORD
14	wild	wild	JJ	_	16	NMOD
15	-	-	HYPH	_	14	P
16	type	type	NN	_	13	CONJ
17	(	(	-LRB-	_	18	P
18	WT	wt	NN	_	16	PRN
19	)	)	-RRB-	_	18	P
20	littermates	littermates	NNS	_	31	SBJ
21	(	(	-LRB-	_	24	P
22	n	n	NN	_	24	SBJ
23	=	=	SYM	_	24	P
24	5	0	CD	_	20	PRN
25	–	–	SYM	_	24	P
26	6	0	CD	_	24	QMOD
27	for	for	IN	_	24	ADV
28	each	each	DT	_	29	NMOD
29	group	group	NN	_	27	PMOD
30	)	)	-RRB-	_	24	P
31	were	be	VBD	_	0	ROOT
32	fed	feed	VBN	_	31	VC
33	with	with	IN	_	32	MNR
34	a	a	DT	_	38	NMOD
35	high	high	JJ	_	37	NMOD
36	-	-	HYPH	_	35	P
37	fat	fat	NN	_	38	NMOD
38	diet	diet	NN	_	33	PMOD
39	for	for	IN	_	32	TMP
40	97	0	CD	_	41	NMOD
41	d	d	NN	_	39	PMOD
42	.	.	.	_	31	P

1	Left	left	JJ	_	2	NMOD
2	panel	panel	NN	_	3	SBJ
3	shows	show	VBZ	_	0	ROOT
4	net	net	JJ	_	7	NMOD
5	body	body	NN	_	6	NMOD
6	weight	weight	NN	_	7	NMOD
7	gain	gain	NN	_	3	OBJ
8	,	,	,	_	7	P
9	which	which	WDT	_	10	SBJ
10	was	be	VBD	_	7	NMOD
11	calculated	calculate	VBN	_	10	VC
12	for	for	IN	_	11	ADV
13	individual	individual	JJ	_	14	NMOD
14	mice	mouse	NNS	_	12	PMOD
15	and	and	CC	_	11	COORD
16	then	then	RB	_	17	TMP
17	averaged	average	VBN	_	15	CONJ
18	.	.	.	_	3	P

1	Right	right	JJ	_	2	NMOD
2	panel	panel	NN	_	3	SBJ
3	shows	show	VBZ	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	body	body	NN	_	6	NMOD
6	weights	weight	NNS	_	3	OBJ
7	before	before	IN	_	3	TMP
8	(	(	-LRB-	_	9	P
9	Day	day	NN	_	7	PRN
10	0	0	CD	_	9	NMOD
11	)	)	-RRB-	_	9	P
12	and	and	CC	_	7	COORD
13	after	after	IN	_	12	CONJ
14	(	(	-LRB-	_	15	P
15	Day	day	NN	_	13	PRN
16	97	0	CD	_	15	NMOD
17	)	)	-RRB-	_	15	P
18	high	high	JJ	_	20	NMOD
19	-	-	HYPH	_	18	P
20	fat	fat	NN	_	21	NMOD
21	feeding	feeding	NN	_	13	PMOD
22	.	.	.	_	3	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Histology	histology	NN	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	inguinal	inguinal	JJ	_	8	NMOD
7	fat	fat	NN	_	8	NMOD
8	pad	pad	NN	_	5	PMOD
9	in	in	IN	_	4	LOC
10	the	the	DT	_	16	NMOD
11	transgenic	transgenic	JJ	_	16	NMOD
12	and	and	CC	_	11	COORD
13	wild	wild	JJ	_	15	NMOD
14	-	-	HYPH	_	13	P
15	type	type	NN	_	12	CONJ
16	littermates	littermates	NNS	_	9	PMOD
17	under	under	IN	_	4	NMOD
18	a	a	DT	_	22	NMOD
19	high	high	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	fat	fat	NN	_	22	NMOD
22	diet	diet	NN	_	17	PMOD
23	for	for	IN	_	4	TMP
24	2	0	CD	_	25	NMOD
25	mo	mo	NN	_	23	PMOD
26	.	.	.	_	4	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	8	NMOD
3	and	and	CC	_	2	COORD
4	D	d	LS	_	3	CONJ
5	)	)	-RRB-	_	2	P
6	Intramuscular	intramuscular	JJ	_	8	NMOD
7	glycogen	glycogen	NN	_	8	NMOD
8	content	content	NN	_	0	ROOT
9	(	(	-LRB-	_	10	P
10	C	c	NN	_	8	PRN
11	)	)	-RRB-	_	10	P
12	and	and	CC	_	8	COORD
13	triglyceride	triglyceride	NN	_	14	NMOD
14	content	content	NN	_	12	CONJ
15	(	(	-LRB-	_	16	P
16	D	d	NN	_	14	PRN
17	)	)	-RRB-	_	16	P
18	of	of	IN	_	8	NMOD
19	mice	mouse	NNS	_	18	PMOD
20	in	in	IN	_	19	LOC
21	(	(	-LRB-	_	20	P
22	A	a	NN	_	20	PMOD
23	)	)	-RRB-	_	20	P
24	after	after	IN	_	8	TMP
25	high	high	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	fat	fat	NN	_	28	NMOD
28	feeding	feeding	NN	_	24	PMOD
29	(	(	-LRB-	_	32	P
30	n	n	NN	_	32	SBJ
31	=	=	SYM	_	32	P
32	6	0	CD	_	8	PRN
33	)	)	-RRB-	_	32	P
34	.	.	.	_	8	P

1	(	(	-LRB-	_	2	P
2	E	e	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Glucose	glucose	NN	_	5	NMOD
5	tolerance	tolerance	NN	_	6	NMOD
6	test	test	NN	_	0	ROOT
7	.	.	.	_	6	P

1	Mice	mouse	NNS	_	11	SBJ
2	in	in	IN	_	1	LOC
3	(	(	-LRB-	_	2	P
4	A	a	NN	_	2	PMOD
5	)	)	-RRB-	_	2	P
6	after	after	IN	_	1	TMP
7	high	high	JJ	_	9	NMOD
8	-	-	HYPH	_	7	P
9	fat	fat	NN	_	10	NMOD
10	feeding	feeding	NN	_	6	PMOD
11	were	be	VBD	_	0	ROOT
12	fasted	fast	VBN	_	11	VC
13	for	for	IN	_	12	TMP
14	6	0	CD	_	15	NMOD
15	h	h	NN	_	13	PMOD
16	and	and	CC	_	12	COORD
17	then	then	RB	_	18	TMP
18	injected	inject	VBN	_	16	CONJ
19	with	with	IN	_	18	ADV
20	glucose	glucose	NN	_	19	PMOD
21	at	at	IN	_	18	ADV
22	a	a	DT	_	23	NMOD
23	concentration	concentration	NN	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	1g	0g	NN	_	24	PMOD
26	/	/	SYM	_	29	P
27	kg	kg	NN	_	29	NMOD
28	body	body	NN	_	29	NMOD
29	weight	weight	NN	_	25	NMOD
30	.	.	.	_	11	P

1	Then	then	RB	_	5	TMP
2	blood	blood	NN	_	3	NMOD
3	glucose	glucose	NN	_	4	NMOD
4	levels	level	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	measured	measure	VBN	_	5	VC
7	periodically	periodically	RB	_	6	ADV
8	over	over	IN	_	6	TMP
9	2	0	CD	_	10	NMOD
10	h	h	NN	_	8	PMOD
11	(	(	-LRB-	_	14	P
12	n	n	NN	_	14	SBJ
13	=	=	SYM	_	14	P
14	6	0	CD	_	6	PRN
15	)	)	-RRB-	_	14	P
16	.	.	.	_	5	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	PPARδ	pparδ	NN	_	2	NMOD
2	Agonists	agonist	NNS	_	3	SBJ
3	Counteract	counteract	VBP	_	0	ROOT
4	Obesity	obesity	NN	_	3	OBJ
5	Induced	induce	VBN	_	4	NMOD
6	by	by	IN	_	5	LGS
7	High	high	JJ	_	9	NMOD
8	-	-	HYPH	_	7	P
9	Fat	fat	NN	_	10	NMOD
10	Diet	diet	NN	_	6	PMOD

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	14	DEP
3	)	)	-RRB-	_	2	P
4	Eleven	eleven	CD	_	6	NMOD
5	-	-	HYPH	_	4	P
6	week	week	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	old	old	JJ	_	13	NMOD
9	wild	wild	JJ	_	11	NMOD
10	-	-	HYPH	_	9	P
11	type	type	NN	_	13	NMOD
12	C57B6	c0b0	NN	_	13	NMOD
13	mice	mouse	NNS	_	14	SBJ
14	were	be	VBD	_	0	ROOT
15	fed	feed	VBN	_	14	VC
16	a	a	DT	_	20	NMOD
17	high	high	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	fat	fat	NN	_	20	NMOD
20	diet	diet	NN	_	15	OBJ
21	in	in	IN	_	15	ADV
22	combination	combination	NN	_	21	PMOD
23	with	with	IN	_	22	NMOD
24	vehicle	vehicle	NN	_	23	PMOD
25	or	or	CC	_	24	COORD
26	GW501516	gw0	NN	_	25	CONJ
27	for	for	IN	_	15	TMP
28	57	0	CD	_	29	NMOD
29	d	d	NN	_	27	PMOD
30	.	.	.	_	14	P

1	Total	total	JJ	_	2	NMOD
2	RNA	rna	NN	_	14	SBJ
3	(	(	-LRB-	_	5	P
4	10	0	CD	_	5	NMOD
5	μg	μg	NNS	_	2	PRN
6	/	/	SYM	_	7	P
7	lane	lane	NN	_	5	NMOD
8	)	)	-RRB-	_	5	P
9	prepared	prepare	VBN	_	2	NMOD
10	from	from	IN	_	9	ADV
11	the	the	DT	_	13	NMOD
12	gastrocnemius	gastrocnemius	NN	_	13	NMOD
13	muscle	muscle	NN	_	10	PMOD
14	was	be	VBD	_	0	ROOT
15	probed	probe	VBN	_	14	VC
16	with	with	IN	_	15	MNR
17	indicated	indicate	VBN	_	18	NMOD
18	probes	probe	NNS	_	16	PMOD
19	.	.	.	_	14	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	16	DEP
3	)	)	-RRB-	_	2	P
4	Net	net	JJ	_	7	NMOD
5	body	body	NN	_	6	NMOD
6	weight	weight	NN	_	7	NMOD
7	gain	gain	NN	_	16	SBJ
8	for	for	IN	_	7	NMOD
9	mice	mouse	NNS	_	8	PMOD
10	in	in	IN	_	9	NMOD
11	(	(	-LRB-	_	10	P
12	A	a	NN	_	10	PMOD
13	)	)	-RRB-	_	9	P
14	after	after	IN	_	7	TMP
15	treatment	treatment	NN	_	14	PMOD
16	was	be	VBD	_	0	ROOT
17	calculated	calculate	VBN	_	16	VC
18	for	for	IN	_	17	ADV
19	individual	individual	JJ	_	20	NMOD
20	mice	mouse	NNS	_	18	PMOD
21	and	and	CC	_	17	COORD
22	averaged	average	VBN	_	21	CONJ
23	.	.	.	_	16	P

1	Initial	initial	JJ	_	3	NMOD
2	body	body	NN	_	3	NMOD
3	weights	weight	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	28.54	0	CD	_	8	NMOD
6	±	±	SYM	_	5	P
7	1.04	0	CD	_	5	QMOD
8	g	g	NNS	_	4	PRD
9	for	for	IN	_	8	NMOD
10	vehicle	vehicle	NN	_	11	NMOD
11	group	group	NN	_	9	PMOD
12	(	(	-LRB-	_	15	P
13	n	n	NN	_	15	SBJ
14	=	=	SYM	_	15	P
15	5	0	CD	_	8	PRN
16	)	)	-RRB-	_	15	P
17	and	and	CC	_	8	COORD
18	28.86	0	CD	_	21	NMOD
19	±	±	SYM	_	18	P
20	0.80	0	CD	_	18	QMOD
21	g	g	NNS	_	17	CONJ
22	for	for	IN	_	21	NMOD
23	GW501516	gw0	NN	_	24	NMOD
24	group	group	NN	_	22	PMOD
25	(	(	-LRB-	_	28	P
26	n	n	NN	_	28	SBJ
27	=	=	SYM	_	28	P
28	5	0	CD	_	21	PRN
29	)	)	-RRB-	_	28	P
30	.	.	.	_	4	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Various	various	JJ	_	6	NMOD
5	tissue	tissue	NN	_	6	NMOD
6	weights	weight	NNS	_	0	ROOT
7	for	for	IN	_	6	NMOD
8	mice	mouse	NNS	_	7	PMOD
9	in	in	IN	_	8	NMOD
10	(	(	-LRB-	_	9	P
11	A	a	NN	_	9	PMOD
12	)	)	-RRB-	_	9	P
13	after	after	IN	_	6	TMP
14	treatment	treatment	NN	_	13	PMOD
15	.	.	.	_	6	P

1	ifat	ifat	NN	_	0	ROOT
2	,	,	,	_	1	P
3	inguinal	inguinal	JJ	_	4	NMOD
4	fat	fat	NN	_	1	APPO
5	;	;	,	_	1	P
6	rdfat	rdfat	NN	_	1	APPO
7	,	,	,	_	6	P
8	reproductive	reproductive	JJ	_	9	NMOD
9	fat	fat	NN	_	6	APPO
10	;	;	,	_	6	P
11	retrofat	retrofat	NN	_	6	APPO
12	,	,	,	_	11	P
13	retroperitoneal	retroperitoneal	JJ	_	14	NMOD
14	fat	fat	NN	_	11	APPO
15	.	.	.	_	1	P

1	(	(	-LRB-	_	2	P
2	D	d	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Glucose	glucose	NN	_	5	NMOD
5	tolerance	tolerance	NN	_	6	NMOD
6	test	test	NN	_	0	ROOT
7	.	.	.	_	6	P

1	Mice	mouse	NNS	_	8	SBJ
2	in	in	IN	_	1	NMOD
3	(	(	-LRB-	_	2	P
4	A	a	NN	_	2	PMOD
5	)	)	-RRB-	_	1	P
6	after	after	IN	_	1	TMP
7	treatment	treatment	NN	_	6	PMOD
8	were	be	VBD	_	0	ROOT
9	fasted	fast	VBN	_	8	VC
10	for	for	IN	_	9	TMP
11	6	0	CD	_	12	NMOD
12	h	h	NN	_	10	PMOD
13	and	and	CC	_	9	COORD
14	then	then	RB	_	15	TMP
15	injected	inject	VBN	_	13	CONJ
16	with	with	IN	_	15	ADV
17	glucose	glucose	NN	_	16	PMOD
18	at	at	IN	_	17	NMOD
19	a	a	DT	_	20	NMOD
20	concentration	concentration	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	1g	0g	NN	_	21	PMOD
23	/	/	SYM	_	26	P
24	kg	kg	NN	_	26	NMOD
25	body	body	NN	_	26	NMOD
26	weight	weight	NN	_	22	NMOD
27	.	.	.	_	8	P

1	Blood	blood	NN	_	2	NMOD
2	glucose	glucose	NN	_	3	NMOD
3	levels	level	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	then	then	RB	_	4	TMP
6	measured	measure	VBN	_	4	VC
7	periodically	periodically	RB	_	6	ADV
8	over	over	IN	_	6	TMP
9	2	0	CD	_	10	NMOD
10	h	h	NN	_	8	PMOD
11	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	6	0	CD	_	1	NMOD

1	PPARδ	pparδ	NN	_	2	SBJ
2	Regulates	regulate	VBZ	_	0	ROOT
3	Exercise	exercise	NN	_	4	NMOD
4	Endurance	endurance	NN	_	2	OBJ

1	(	(	-LRB-	_	2	P
2	A	a	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Enhanced	enhance	VBN	_	6	NMOD
5	exercise	exercise	NN	_	6	NMOD
6	performance	performance	NN	_	0	ROOT
7	in	in	IN	_	6	LOC
8	the	the	DT	_	10	NMOD
9	transgenic	transgenic	JJ	_	10	NMOD
10	mice	mouse	NNS	_	7	PMOD
11	.	.	.	_	6	P

1	Fourteen	fourteen	CD	_	3	NMOD
2	-	-	HYPH	_	1	P
3	week	week	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	old	old	JJ	_	12	NMOD
6	male	male	JJ	_	12	NMOD
7	transgenic	transgenic	JJ	_	12	NMOD
8	and	and	CC	_	7	COORD
9	wild	wild	JJ	_	11	NMOD
10	-	-	HYPH	_	9	P
11	type	type	NN	_	8	CONJ
12	littermates	littermates	NNS	_	25	SBJ
13	with	with	IN	_	12	NMOD
14	similar	similar	JJ	_	16	NMOD
15	body	body	NN	_	16	NMOD
16	weights	weight	NNS	_	13	PMOD
17	(	(	-LRB-	_	20	P
18	n	n	NN	_	20	SBJ
19	=	=	SYM	_	20	P
20	4	0	CD	_	12	PRN
21	for	for	IN	_	20	ADV
22	each	each	DT	_	23	NMOD
23	group	group	NN	_	21	PMOD
24	)	)	-RRB-	_	20	P
25	were	be	VBD	_	0	ROOT
26	subjected	subject	VBN	_	25	VC
27	to	to	IN	_	26	ADV
28	a	a	DT	_	32	NMOD
29	forced	force	VBN	_	31	NMOD
30	treadmill	treadmill	NN	_	31	NMOD
31	exercise	exercise	NN	_	32	NMOD
32	test	test	NN	_	27	PMOD
33	.	.	.	_	25	P

1	(	(	-LRB-	_	2	P
2	B	b	LS	_	6	NMOD
3	)	)	-RRB-	_	2	P
4	Compromised	compromise	VBN	_	6	NMOD
5	exercise	exercise	NN	_	6	NMOD
6	performance	performance	NN	_	0	ROOT
7	in	in	IN	_	6	LOC
8	PPARδ	pparδ	NN	_	10	AMOD
9	-	-	HYPH	_	8	P
10	null	null	JJ	_	11	NMOD
11	mice	mouse	NNS	_	7	PMOD
12	.	.	.	_	6	P

1	Two	two	CD	_	3	NMOD
2	-	-	HYPH	_	1	P
3	month	month	NN	_	5	AMOD
4	-	-	HYPH	_	3	P
5	old	old	JJ	_	10	NMOD
6	male	male	JJ	_	10	NMOD
7	PPARδ	pparδ	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	null	null	JJ	_	10	NMOD
10	mice	mouse	NNS	_	28	SBJ
11	and	and	CC	_	10	COORD
12	wild	wild	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	type	type	NN	_	15	NMOD
15	controls	control	NNS	_	11	CONJ
16	with	with	IN	_	10	NMOD
17	similar	similar	JJ	_	19	NMOD
18	body	body	NN	_	19	NMOD
19	weights	weight	NNS	_	16	PMOD
20	(	(	-LRB-	_	23	P
21	n	n	NN	_	23	SBJ
22	=	=	SYM	_	23	P
23	6	0	CD	_	10	PRN
24	for	for	IN	_	23	ADV
25	each	each	DT	_	26	NMOD
26	group	group	NN	_	24	PMOD
27	)	)	-RRB-	_	23	P
28	were	be	VBD	_	0	ROOT
29	subjected	subject	VBN	_	28	VC
30	to	to	IN	_	29	ADV
31	a	a	DT	_	35	NMOD
32	forced	force	VBN	_	34	NMOD
33	treadmill	treadmill	NN	_	34	NMOD
34	exercise	exercise	NN	_	35	NMOD
35	test	test	NN	_	30	PMOD
36	.	.	.	_	28	P

1	(	(	-LRB-	_	2	P
2	C	c	LS	_	4	NMOD
3	)	)	-RRB-	_	2	P
4	Functions	function	NNS	_	0	ROOT
5	of	of	IN	_	4	NMOD
6	PPARδ	pparδ	NN	_	5	PMOD
7	in	in	IN	_	4	LOC
8	skeletal	skeletal	JJ	_	9	NMOD
9	muscle	muscle	NN	_	7	PMOD
10	.	.	.	_	4	P

1	Footnotes	footnote	NNS	_	0	ROOT

1	Conflicts	conflict	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	interest	interest	NN	_	2	PMOD
4	.	.	.	_	1	P

1	The	the	DT	_	2	NMOD
2	authors	author	NNS	_	3	DEP
3	have	have	VBP	_	0	ROOT
4	declared	declare	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	no	no	DT	_	7	NMOD
7	conflicts	conflict	NNS	_	10	SBJ
8	of	of	IN	_	7	NMOD
9	interest	interest	NN	_	8	PMOD
10	exist	exist	VBP	_	5	SUB
11	.	.	.	_	3	P

1	Author	author	NN	_	2	NMOD
2	contributions	contribution	NNS	_	0	ROOT
3	.	.	.	_	2	P

1	YXW	yxw	NNP	_	4	SBJ
2	and	and	CC	_	1	COORD
3	RME	rme	NNP	_	2	CONJ
4	conceived	conceive	VBD	_	0	ROOT
5	and	and	CC	_	4	COORD
6	designed	design	VBD	_	5	CONJ
7	the	the	DT	_	8	NMOD
8	experiments	experiment	NNS	_	4	OBJ
9	.	.	.	_	4	P

1	YXW	yxw	NNP	_	11	SBJ
2	,	,	,	_	1	P
3	CLZ	clz	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	RTY	rty	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	MCN	mcn	NNP	_	5	CONJ
8	,	,	,	_	7	P
9	and	and	CC	_	7	COORD
10	CRBO	crbo	NNP	_	9	CONJ
11	performed	perform	VBD	_	0	ROOT
12	the	the	DT	_	13	NMOD
13	experiments	experiment	NNS	_	11	OBJ
14	.	.	.	_	11	P

1	YXW	yxw	NNP	_	7	SBJ
2	,	,	,	_	1	P
3	CLZ	clz	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	and	and	CC	_	3	COORD
6	RME	rme	NNP	_	5	CONJ
7	analyzed	analyze	VBD	_	0	ROOT
8	the	the	DT	_	9	NMOD
9	data	datum	NNS	_	7	OBJ
10	.	.	.	_	7	P

1	HKC	hkc	NNP	_	7	SBJ
2	,	,	,	_	1	P
3	JH	jh	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	and	and	CC	_	3	COORD
6	HK	hk	NNP	_	5	CONJ
7	contributed	contribute	VBD	_	0	ROOT
8	reagents	reagent	NNS	_	13	NMOD
9	/	/	HYPH	_	8	P
10	materials	material	NNS	_	13	NMOD
11	/	/	HYPH	_	10	P
12	analysis	analysis	NN	_	13	NMOD
13	tools	tool	NNS	_	7	OBJ
14	.	.	.	_	7	P

1	YXW	yxw	NNP	_	4	SBJ
2	and	and	CC	_	1	COORD
3	RME	rme	NNP	_	2	CONJ
4	wrote	write	VBD	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	paper	paper	NN	_	4	OBJ
7	.	.	.	_	4	P

1	Academic	academic	JJ	_	2	NMOD
2	Editor	editor	NN	_	0	ROOT
3	:	:	:	_	2	P
4	Steve	steve	NNP	_	5	NMOD
5	O'Rahilly	o'rahilly	NNP	_	2	OPRD
6	,	,	,	_	5	P
7	University	university	NNP	_	5	APPO
8	of	of	IN	_	7	NMOD
9	Cambridge	cambridge	NNP	_	8	PMOD

1	Citation	citation	NN	_	0	ROOT
2	:	:	:	_	1	P
3	Wang	wang	NNP	_	4	NMOD
4	YX	yx	NNP	_	1	DEP
5	,	,	,	_	4	P
6	Zhang	zhang	NNP	_	7	NMOD
7	CL	cl	NNP	_	4	CONJ
8	,	,	,	_	7	P
9	Yu	yu	NNP	_	10	NMOD
10	RT	rt	NNP	_	7	CONJ
11	,	,	,	_	10	P
12	Cho	cho	NNP	_	13	NMOD
13	HK	hk	NNP	_	10	CONJ
14	,	,	,	_	13	P
15	Nelson	nelson	NNP	_	16	NMOD
16	MC	mc	NNP	_	13	CONJ
17	,	,	,	_	16	P
18	et	et	FW	_	19	AMOD
19	al.	al.	FW	_	16	CONJ
20	(	(	-LRB-	_	4	P
21	2004	0	CD	_	4	TMP
22	)	)	-RRB-	_	4	P
23	Regulation	regulation	NN	_	4	DEP
24	of	of	IN	_	23	NMOD
25	muscle	muscle	NN	_	26	NMOD
26	fiber	fiber	NN	_	27	NMOD
27	type	type	NN	_	24	PMOD
28	and	and	CC	_	27	COORD
29	running	running	NN	_	30	NMOD
30	endurance	endurance	NN	_	28	CONJ
31	by	by	IN	_	23	NMOD
32	PPARδ	pparδ	NN	_	31	PMOD
33	.	.	.	_	1	P

1	PLoS	plo	NNP	_	6	NMOD
2	Biol	biol	NNP	_	6	NMOD
3	2	0	CD	_	6	NMOD
4	(	(	NN	_	6	NMOD
5	10	0	CD	_	6	NMOD
6	)	)	NN	_	0	ROOT
7	:	:	:	_	6	P
8	e294	e0	NN	_	6	DEP
9	.	.	.	_	6	P

